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1 Introduction 
 
1.1 Chlamydiae – a paradigm of obligate intracellular lifestyle 
 
The phylum Chlamydiae represents an independent major lineage within the domain Bacteria. 
For a long time members of this phylum were believed to belong to a single family, namely the 
Chlamydiaceae, in the order Chlamydiales. The Chlamydiaceae, also known as “clinical 
chlamydiae”, comprise well-established representatives of animal and human pathogens, like 
Chlamydia trachomatis or Chlamydophila pneumaniae. C. trachomatis is the most frequently 
sexually transmitted bacterial human pathogen, causing infections that can lead to possible 
infertility and also to blindness after infection of the eye (Mabey and Fraser-Hurt, 2003; Peipert, 
2003). 
 
The discovery of chlamydia-like bacteria in the 1990s marked the beginning of changes in the 
order Chlamydiales, as it turned out that diversity and occurrence in the environment had been 
highly underestimated (Horn and Wagner, 2004). The discovery of these “environmental 
chlamydiae” (Horn and Wagner, 2001), also known as “novel chlamydiae” (Corsaro and Greub, 
2006), led to an eminent expansion of the diversity of the order Chlamydiales based on 16S 
rRNA sequence analysis. In addition to the Chlamydiaceae, the families Parachlamydiaceae, 
Waddliaceae and Simkaniaceae were discovered (Everett et al., 1999; Rurangirwa et al., 1999) 
and are now together with the families Rhabdochlamydiaceae ((Kostanjsek et al., 2004; Corsaro 
et al., 2007), Piscichlamydiaceae (Draghi et al., 2004), Clavochlamydiaceae (Karlsen et al., 
2008) and Criblamydiaceae (Thomas et al., 2006) representing the order Chlamydiales (Figure 
1).  
 
Members of the Chlamydiae can be considered as obligate intracellular endosymbionts, implying 
chlamydial growth and replication only in an intracellular environment. So far, Chlamydiae 
could neither be isolated nor cultivated in cell-free media (Fritsche et al., 2000). 
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Figure 1. The recently discovered diversity of the order Chlamydiales is shown in a phylogenetic tree, based on 
comparative 16S rRNA analysis (Horn, 2008). 
 
 
1.1.1 The chlamydial developmental cycle 
 
Chlamydial growth is associated with a characteristic biphasic developmental cycle 
(Abdelrahman and Belland, 2005) first described in 1932 (Bedson, 1932). The current knowledge 
of the developmental cycle of environmental chlamydiae is restricted to studies focusing on 
Parachlamydia acanthamoebae and Simkania negevensis (Greub and Raoult, 2002; Kahane et 
al., 2002). New insights into the developmental cycle of Protochlamydia amoebophila UWE25 
(P. amoebophila UWE25) were obtained recently (König, 2008). 
 
During an active infection two distinct developmental stages can be distinguished, whereby the 
stage of elementary bodies (EB) alternates with the stage of reticulate bodies (RB). EBs are well 
adapted to the survival in extracellular environments by an osmotically unusually stable cell 
envelope (Hatch, 1996). While EBs represent the metabolically inert but infectious form, 
involved in attachment to and endocytosis by the host cell, metabolically active but not infectious 
RBs multiply inside the host. As an exception, infectivity has been reported for RBs of Simkania 
negevensis (Kahane et al., 2002).  
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Moreover, the existence of crescent bodies (CB) as an additional infective developmental stage 
has been suggested for Parachlamydia acanthamoebae (Figure 2) associated with prolonged 
incubation time (Greub and Raoult, 2002). 
 
The developmental cycle proceeds within a membrane-enclosed compartment, the so-called 
“inclusion” (Scidmore-Carlson and Hackstadt, 2000), where EBs first differentiate into RBs, 
which then start to undergo binary fission. Several rounds of replication are followed by re-
differentiation of RBs back to EBs, and finally the release of progeny takes place in order to 
infect new host cells (Abdelrahman and Belland, 2005) (Figure 2/E). Chlamydial exit is mainly 
associated with host cell lysis (Todd and Storz, 1975) but another mode of chlamydial release has 
been discussed. This way of chlamydial exit is called extrusion, where an intact host cell and 
parts of the inclusion are left behind (Hybiske and Stephens, 2007). 
 
Environmental chlamydiae are able to establish a symbiosis with their host cell and maintain a 
stable host-parasite ratio in favourable environmental conditions (Amann et al., 1997; Horn et 
al., 2000). In vitro observations of pathogenic chlamydiae also suggest an alternative life cycle, 
known as persistence which is characterized by an atypical third developmental form (Hogan et 
al., 2004). Persistence has been described for the Chlamydiaceae by the absence of growth and 
the reduction of infectious forms (Beatty et al., 1994) leading to temporarily latent chlamydial 
infections (Hogan et al., 2004). 
 
 
Figure 2. Schematic view of the unique biphasic lifecycle of chlamydiae. After invasion of a host cell by 
infectious EBs (blue), EBs differentiate to metabolically active RBs (red), followed by several rounds of binary 
fission. After re-differentiation from RBs to EBs, infectious progeny is released to start a new infection. Modified 
from Horn, 2008. 
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1.2 Symbiosis between chlamydia-like bacteria and amoebae 
 
“The living together of unlike organisms” - this definition of the term “symbiosis” by Anton de 
Bary in 1879 does not consider the effects resulting from this intimate association, thereby 
including mutualism and commensalism as well as parasitism (de Bary, 1879). Chlamydia-like 
bacteria that have been identified so far were discovered in a wide variety of habitats. They occur 
as symbionts in various eukaryotic hosts, like in insects (Thao et al., 2003), terrestrial isopods 
(Kostanjsek et al., 2004), mammals (Rurangirwa et al., 1999; Chua et al., 2005), fish (Draghi et 
al., 2004; Karlsen et al., 2008) or the marine worm Xenoturbella (Israelsson, 2007) as well as in 
free-living amoebae (Amann et al., 1997; Fritsche et al., 2000; Horn et al., 2000). 
 
Free living amoebae are ubiquitous protozoa and beside their own pathogenic potential, they also 
have clinical relevance as reservoirs and vectors for bacterial pathogens (Horn and Wagner, 
2004). About 25% of isolated Acanthamoeba species harbor bacterial endosymbionts which are 
stably integrated in the cytoplasm (Fritsche et al., 1993). Fritsche et al. could further show that about 
5% of these studied Acanthamoeba isolates were harboring intracellular chlamydia-like bacteria 
(Fritsche et al., 2000). Since some bacteria have apparently developed strategies to survive and to 
multiply inside amoeba hosts, they are also referred to as “trojan horses of the microbial world” 
(Barker and Brown, 1994). 
 
 
 
1.3 Protochlamydia amoebophila UWE25 - a symbiont of Acanthamoeba 
castellanii Neff  
 
One representative of the Parachlamydiaceae is the amoeba endosymbiont Protochlamydia 
amoebophila UWE25 (E25). P. amoebophila was discovered as an obligate symbiont of an 
Acanthamoeba sp. soil isolate (Fritsche et al., 1993). It is able to maintain a stable symbiotic 
interaction with various Acanthamoeba sp. isolates including the widely used strain 
Acanthamoeba castellanii Neff.  
 
In 2004, the genome sequence of P. amoebophila was published, representing the first available 
genome of a chlamydia-like bacterium, and markedly facilitated all attempts of genetic 
comparison of chlamydiae (Horn and Wagner, 2004).  
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The genome sequence of P. amoebophila contains 2.4 Mb, which is nearly twice as large as the 
known genomes of clinical chlamydiae (Stephens et al., 1998; Kalman et al., 1999; Read et al., 
2000; Shirai et al., 2000; Read et al., 2003). Comparative genome analysis revealed great 
differences between pathogenic and environmental chlamydiae (Horn and Wagner, 2004). The 
genome of P. amoebophila was found to harbor reduced central metabolic and biosynthetic 
pathways, comparable to genomes of clinical chlamydiae and other obligate intracellular 
bacteria, but differs in encoding the complete tricarboxylic acid cycle. 938 out of the 2031 
predicted genes show significant homologies to the corresponding genes in other chlamydial 
genomes. Finally a core gene set of 711 genes, shared by all members of the chlamydiae, could 
be defined (Horn and Wagner, 2004). 
 
Evolutionary history reveals a last common ancestor of pathogenic chlamydiae and this member 
of the environmental chlamydiae, which has lived about 700 million years ago. It is hypothesized 
that this ancestor was already adapted to intracellular live in order to survive within early 
eukaryotes (Horn and Wagner, 2004). Recent studies suggest another unexpected but 
fundamental role of this early ancestor in the evolution of plastids. Plant genomes were found to 
contain genes of chlamydial origin and on the other hand a high number of plant- and 
cyanobacteria-like genes were identified in chlamydial genomes. This implicates an involvement 
of chlamydiae during the process of establishing a stable interaction between ancient plants and 
its cyanobacterial symbionts (Huang and Gogarten, 2007; Moustafa et al., 2008). 
 
 
1.4 Chlamydia-like bacteria - emerging human pathogens? 
 
While members of the Chlamydiaceae are parasites for humans and animals, the pathogenic 
potential of chlamydia-like organisms remains unclear. Evidently, they are using ubiquitous free-
living amoebae as environmental reservoirs without being harmful to their protozoan hosts.  
 
Protozoa may be sources of emerging pathogenic bacteria, since this symbiosis offers a way of 
protection against the harsh conditions of the extracellular environment and also possibly 
enhances their infectivity in mammals by benefiting from the structural and biochemical 
conservation of cellular processes in eukaryotes. Thus, chlamydia-like bacteria may develop 
strategies to survive within humans and animals (Harb et al., 2000). 
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Some studies have already suggested to categorize these recently discovered chlamydia-like 
bacteria as emerging human pathogens, since invasion of human cells and the subsequent 
multiplication within were observed (Greub et al., 2003; Corsaro and Greub, 2006; Baud et al., 
2007). In addition, 16S rRNA analysis assumed an association of chlamydia-like bacteria with 
respiratory tract infections (Haider et al., 2008). To date, abortion in cattle (Ruhl et al., 2009) and 
epitheliocystis in fish (Draghi et al., 2004; Karlsen et al., 2008) have already been linked to 
infections caused by chlamydia-like bacteria. 
 
 
1.5 The chlamydial cell envelope – Chlamydiaceae vs. P. amoebophila 
 
As chlamydiae belong to the Gram-negative bacteria, their cell envelope is characterized by an 
inner and an outer membrane separated by a periplasmic space. Whereas other Gram-negative 
bacteria additionally possess a layer of peptidoglycan, its presence in chlamydiae is still 
discussed controversially (McCoy and Maurelli, 2006). According to genome analyses, the 
presence of a truncated pathway for the synthesis of peptidoglycan could be assigned, but the 
detection of N-acetylmuramic acid, a key constituent of peptidoglycan, has failed so far. Since 
cysteine-rich proteins are present in the outer membrane of P. amoebophila, they are considered 
to be responsible for cell wall stability in chlamydiae and further regarded as the functional 
equivalent of peptidoglycan (Hatch, 1996). 
 
1.5.1 Porins as outer membrane components 
 
Porins are important components of the outer membrane of Gram-negative bacteria, making it 
largely permeable, whereas the inner membrane represents the major permeability barrier (Welte 
et al., 1995). These pore-forming components are water-filled channels and composed of beta-
sheets linked by beta-turns, forming a beta-barrel structure that crosses the cellular membrane 
(Nikaido, 2003).  
Porins are regarded as unspecific transporters and unlike other membrane transport proteins they 
are large enough to allow passive diffusion of molecules ranging from 600 to 5000 Da, showing 
a transport rate proportional to the concentration gradient (Welte et al., 1995) 
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1.5.2 The outer membrane of the Chlamydiaceae 
 
Components of the outer membrane are of particular importance, since they play a role during 
attachment to the host cell and the transport of nutrients and other substances across the cell 
envelope (Stephens et al., 2001). 
 
In the Chlamydiaceae, the most abundant component of the outer membrane is the major outer 
membrane protein (MOMP; 39 kDa) (Caldwell et al., 1981). In the EB cell envelope the 
cysteine-rich proteins OmcB (60 kDa) and OmcA (12 kDa) are extensively cross-linked by 
disulfide bridges. These proteins are considered to provide rigidity to the cell wall of EBs and to 
render osmotical stability, compensating the lack of peptidoglycan. Reduction of these disulfide 
bridges is characteristic for the process of transformation of EBs to osmotically fragile RBs, 
which then undergo intracellular division (Hatch, 1996). This mechanism is reversed by cross-
linking of cysteines during conversion from RBs to EBs, either spontaneously by host cell lysis 
(Hatch et al., 1986) or by an enzymatic reaction (Newhall, 1987), but the exact mechanism is not 
known. 
 
Localization and identity of both major cysteine-rich proteins were studied by testing sarcosyl 
solubility of outer membrane proteins of clinical chlamydiae (Everett and Hatch, 1995). Sarcosyl 
is a weak anionic detergent and removes cytoplasmic membrane proteins from integral outer 
membrane proteins (Filip et al., 1973). This technique was adapted to chlamydial studies by 
Caldwell et al. and Hatch et al. in order to identify chlamydial outer membrane proteins insoluble 
in sarcosyl (Caldwell et al., 1981; Hatch et al., 1981). Studies demonstrated that the small 
cysteine-rich protein OmcA is insoluble in sarcosyl, therefore associated to the outer membrane 
and firmly anchored in the inner leaflet of the outer membrane (Hatch, 1996). The large cysteine-
rich protein OmcB was first considered to be a no integrated outer membrane protein (Everett 
and Hatch, 1995). Though, its involvement into EB stability could be demonstrated, as it is 
considered to form a stabilizing lattice in the periplasm by inter- and intramolecular disulfide 
bridges (Caldwell et al., 1981; Mygind et al., 1998). However, there is evidence for regarding 
OmcB as a true outer membrane component of C. trachomatis and C. pneumonia, since 
involvement of this protein in heparin-binding on the surface of eukaryotic cells was affirmed 
(Stephens et al., 2001; Fadel and Eley, 2007; Moelleken and Hegemann, 2008). Therefore, 
OmcB is considered to occur as an outer membrane component as well as in the periplasmic 
space (Figure 3) (Heinz, 2008). 
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Figure 3. Schematic representation of the outer membrane of the Chlamydiaceae. The major outer membrane 
protein (MOMP) in blue is responsible for the transport of substrates across the outer membrane. The localization of 
OmcB either in the outer membrane or in the periplasm is shown in green (Heinz, 2008). 
 
 
OmcA, OmcB as well as MOMP are the essential subunits of the chlamydial outer membrane 
complex (COMC). Additionally, members of the polymorphic outer membrane protein (POMP) 
family, a family of autotransporters, are components of the outer membrane of pathogenic 
chlamydiae (Henderson and Lam, 2001). These proteins feature an unusually high 
polymorphism, which might be an explanation for tissue specificity of different C. trachomatis 
disease groups (Stothard et al., 2003; Gomes et al., 2006). Some members of the POMP family 
were shown to contribute to the attachment to host cells (Wehrl et al., 2004) as well as to 
expansion of the chlamydial inclusion (Jorgensen and Valdivia, 2008). 
 
 
1.5.2.1 The major outer membrane protein 
 
MOMP is the dominant component of the outer membrane of clinical chlamydiae making up 
about 60% of the chlamydial outer membrane (Caldwell et al., 1981). The secondary structure is 
composed of 16 beta-sheets forming a barrel-like structure, a typical feature of bacterial porins 
(Sun et al., 2007). This barrel structure consists of five well conserved transmembrane domains, 
connected by four variable surface exposed loops (Stephens et al., 1987; Baehr et al., 1988; Yuan 
et al., 1989). 
 
The structure of the MOMP was analyzed by Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Hatch et al. demonstrated the formation of MOMP trimers in EBs, 
whereas the monomeric form of MOMP dominated in RBs (Hatch et al., 1984).  
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First, disulfide bridges were thought to be the stabilizing agents in this trimeric structure. 
However, more recent studies suggested that disulfide bonds are present but not required for 
stability of MOMP trimers (Findlay et al., 2005; Sun et al., 2007).  
 
Several studies tried to verify the proposed function of MOMP as a porin (Caldwell et al., 1981; 
Bavoil et al., 1984; Koehler et al., 1992; Findlay et al., 2005). The first approach by Bavoil et al. 
used preparations of COMC in liposome swelling assays for functional analysis, where pore-
forming activity seemed to be regulated by disulfide bonds. The authors demonstrated that 
channel activity was up-regulated under reducing conditions which lead to breaking-up of 
disulfide bridges (Bavoil et al., 1984). These findings were consistent with the observation of 
different tasks of MOMP during the developmental cycle. MOMP operates as a stabilizing agent 
in EBs, but it functions as a transporter in RBs, where disulfide-bridges are absent (Hatch et al., 
1984). Various studies confirmed the pore-forming activity of MOMP by lipid bilayer 
measurements and liposome swelling assays, using purified native and recombinant MOMP 
(Wyllie et al., 1998; Findlay et al., 2005; Sun et al., 2007), however, opening of the pore by a 
simple reduction mechanism could not be shown for these preparations. 
 
Surface-exposed outer membrane proteins encounter direct surveillance of the immune system. 
Hence, the four variable surface-exposed domains of MOMP are considered to be responsible for 
hiding from immunological reactions by high sequence variability (Stephens et al., 1988). 
Different antibodies targeting these variable regions can be applied for serovar typing in C. 
trachomatis (Wang et al., 1985; Yuan et al., 1989). 
 
MOMP can be regarded as a strong antigen and a potentially good vaccine candidate, but the 
development of a successful general vaccine has failed so far. Only partial protection is given if 
the vaccine is based on recombinant and therefore non-native MOMP (Pal et al., 1997). Vaccines 
containing native MOMP have been shown to be protective against chlamydial diseases (Tan et 
al., 1990; Pal et al., 1997), but in either case high variation in the surface-exposed parts of 
MOMP-sequences complicates the preparation of a general vaccine. 
 
The porin function of MOMP creates problems during large scale overexpression for vaccine 
development and further analyses due to its lethal effects by pore-forming activity (Koehler et 
al., 1992). 
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Various studies focused on cloning and overexpression of MOMP in E. coli but always 
encountered toxicity of MOMP for the host cells (Koehler et al., 1992; Findlay et al., 2005). It 
was hardly possible to obtain a stable clone due to the formed holes in the outer membrane 
(Koehler et al., 1992). Successful overexpression of MOMP could be finally achieved and even 
correct processing and incorporation into the outer membrane was observed, which was closely 
associated with lethal effects on E. coli cells (Findlay et al., 2005).  
 
 
1.5.3 Expression analysis of outer membrane components of clinical chlamydiae during 
an infectious cycle 
 
Genomic transcriptional profiling of components of the outer membrane of clinical chlamydiae 
suggested specific transcriptional patterns during the developmental cycle (Belland et al., 2003; 
Maurer et al., 2007). 
 
Outer membrane components, like OmcA and OmcB, are associated with stability and cross-
linking of the outer membrane and play an important role during the differentiation from RBs to 
EBs at late stages of the developmental cycle (Hatch, 1996). Thus, up-regulation of these outer 
membrane components at late stages of the cycle characterizes those as members of the late gene 
cluster (Belland et al., 2003). Also ompA, encoding MOMP of C. trachomatis, was identified as a 
member of the late gene cluster (Gomes et al., 2005). A further differentiation into “tardy” genes, 
which are up-regulated even after the “late” genes, distinguishes EB specific mRNA from late 
genes, encoding EB proteins. Tardy genes are typically associated with EB specific mRNA, 
including omcB as an exception, since it encodes an EB protein (Maurer et al., 2007). 
 
 
1.5.4 The outer membrane of P. amoebophila 
 
Little is known about the composition and the actual components of the cell envelope of 
environmental chlamydiae. With the help of the first available genome sequence for P. 
amoebophila in 2004 (Horn et al., 2004), first insights into the outer membrane of chlamydiae 
not belonging to the Chlamydiaceae were possible. As expected, a homologue of the large 
cysteine-rich protein OmcB, pc0616, was identified and also a homologue of OmcA, pc0617, 
was detected due to its position in the genome and the high amount of cysteines in its sequence 
(Heinz, 2008).  
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Interestingly, no homologues of MOMP, PorB and members of the POMP family were found in 
P. amoebophila, implying significant differences to the outer membrane of clinical chlamydiae 
(Heinz, 2008). 
 
Analyses of outer membrane fractions of P. amoebophila approved the in silico data by 
combining 1D and 2D gel electrophoresis with mass spectrometry. Experimental analyses 
identified 38 outer membrane proteins in total. The protein pc0978 was found as frequently in 
outer membrane fractions as the cysteine-rich protein pc0616 and also contains a high number of 
cysteines. Hence, it might represent an additional component of the COMC being responsible for 
outer membrane stability (Heinz, 2008). 
 
In addition, four proteins sharing an amino acid sequence identity of 22-28% were classified as a 
novel putative porin family. Strikingly, these proteins have no homologues in other organisms 
except for the close relative Parachlamydia acanthamoebae. Two representatives of this putative 
porin family, pc1489 and pc1077, were present in high amounts in all outer membrane fractions 
(Heinz, 2008). It is suggested that these two proteins, along with pc0616, constitute the 
chlamydial outer membrane complex COMC, like OmcA, OmcB and MOMP in the 
Chlamydiaceae (Bavoil et al., 1984). Secondary structures for pc1489 and pc1077 predict the 
formation of beta-barrels and, therefore, the potential function as porins. Since both were 
proposed to encode signal peptides, pc1489 and pc1077 are thought to be the functional 
replacement of MOMP in P. amoebophila. 
 
Previous studies concentrating on the characterization of pc1489 have already visualized the 
localization of this porin candidate in the outer membrane of P. amoebophila by specific 
antibodies. Moreover, lipid-bilayer measurements proved the hypothesized function as porin by 
clearly demonstrating pore-forming features (Aistleitner, 2009). 
 
Interestingly, the function of the two other members of the new porin family, pc0870 and 
pc1860, cannot be predicted as easily. For pc0870 a signal peptide but no beta-barrel structure 
was predicted, whereas pc1860 contains signatures of beta-barrel structures as well as of 
lipoproteins (Heinz, 2008). To date, it is still not clear whether they feature porin function. 
 
1 Introduction 
12 
 
Figure 4. Schematic representation of the outer membrane of P. amoebophila. No homologue of MOMP could 
be found, whereas several other outer membrane components could be identified including a novel putative porin 
family (e.g. pc1489 – red, pc1077 – yellow) (Heinz, 2008). 
 
 
 
1.6 Chlamydial heat shock proteins 
 
Heat shock proteins (HSPs), also known as chaperones, form a family of closely related proteins, 
being distributed in the cytoplasm of many different organisms. HSPs from widely different 
sources show a remarkable structural similarity of about 40% or even higher (Amberger et al., 
1997; Karunakaran et al., 2003). The chlamydial heat shock proteins Hsp60 and Hsp70, also 
known as DnaK, show marked homology with bacterial and mammalian HSPs. 
 
In general, HSPs get drastically up-regulated in response to high temperatures in order to act as 
stabilizing agents and to prevent the aggregation of stress-denatured proteins (Lindquist and 
Craig, 1988). HSPs are able to distinguish native from partially unfolded proteins and help the 
latter to reassemble its original structure. An efficient folding into the native structure of 
denatured proteins in vivo is achieved by several binding and releasing steps by HSPs (Hendrick 
and Hartl, 1993; Bukau and Horwich, 1998).  
 
Chlamydial heat shock proteins are considered to be involved in human diseases (Taylor et al., 
1990; Wick et al., 1995; LaVerda et al., 1999; Pan et al., 1999). Since Hsp60 is widely 
distributed among bacteria and parasites, nearly all human-beings develop antibodies against it as 
a general reaction of the immune system. Chlamydial Hsp60 displays 48% homology with the 
human Hsp60, thus, molecular mimicry may contribute to autoimmune inflammatory damage 
during a chronic chlamydial infection (Brunham and Peeling, 1994). 
  1 Introduction 
  13 
1.7 Aims of this study 
 
Outer membrane proteins are considered to be key players in initial steps of host cell invasion. 
Recent studies identified components of the P. amoebophila outer membrane by an in silico 
approach and promised to improve our knowledge about the structure and actual function of 
these important structural components. 
 
Based on the prediction of a novel putative porin family in P. amoebophil this work mainly 
focused on initial studies concerning the localization and function of the four putative porins 
pc0870, pc1077, pc1489 and pc1860. 
Studies dealing with MOMP of clinical chlamydiae suggested E. coli as a suitable system for 
overexpression of proteins. Hence, the aim of the present study was to achieve a heterologous 
expression of each of the four putative porins in E. coli. In parallel, viability assays should 
contribute to a functional characterization, since correctly processed porins feature pore-forming 
activity with toxic effects for E. coli cells. 
 
An additional goal was to produce antibodies against purified porins in order to visualize the 
proposed localization in the outer membrane, supporting the theory of an outer membrane protein 
and allowing assumptions on function and importance in symbiont-host interactions. 
Nevertheless, a definite confirmation of the function as a porin would only be achieved by lipid-
bilayer measurements. 
 
In a second project, we wanted to track the transcriptional pattern of the porin pc1489 during a 
developmental cycle to provide insights into the expression profile of an important outer 
membrane protein of environmental chlamydiae. Comparable studies with representatives of 
pathogenic chlamydiae were used as a basis. 
 
Apart from that, we aimed to use a cytoplasmic protein of P. amoebophila for the generation of 
an internal standard antibody for immunofluorescence experiments. Hence, DnaK and EF-TU of 
P. amoebophila should be overexpressed using E. coli as an expression system, followed by 
protein purification and antibody production. As DnaK and EF-TU are located in the cytoplasm, 
specific antibodies against them are considered to visualize permeability of the outer membrane 
while using other antibodies simultaneously. 
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This work was conducted as a basis for follow-up studies for further characterization of the outer 
membrane of the increasingly diverse Chlamydiae, leading to a better understanding of the 
mechanisms of initial steps of host cell invasion. 
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2 Material and Methods 
 
2.1 Software 
 
Table 1. Software used in this study 
 
 
 
2.2 Technical equipment 
 
Table 2. Technical equipment used in this study 
 
Equipment Company 
AL-2000 dual pump World Precision Instruments, Sarasoto, FL, USA 
Agarose gel electrophoresis apparature Sub–Cell GT  Bio-Rad Laboratories GmbH, Munich, Germany 
CCD camera AxioCam HRc Carl Zeiss MicroImaging GmbH, Jena, Germany 
Centrifuges: 
Centrifuge 5840 R 
Mikro 22 R 
OptimaTM L-100 XP ultracentrifuge 
Rotina 35 R 
 
Eppendorf AG, Hamburg, Germany 
Andreas Hettich GmbH & Co. KG, Tuttlingen, Germany 
Beckman Coulter, Inc., Paolo Alto, CA, USA 
Andreas Hettich GmbH & Co. KG, Tuttlingen, Germany 
Concentrator 5301 Eppendorf AG, Hamburg, Germany 
Electroporator Micro PulserTM   Bio-Rad Laboratories GmbH, Munich, Germany 
Software URL/Company Reference 
Basic Local Alignment 
Search Tool (BLAST) 
http://www.ncbi.nlm.nih.gov/BLAST/ (Altschul et al., 1990) 
Clone Manager Scientific & Educational Software  
Expasy Proteomic Tools http://www.expasy.ch/tools/dna.html (Gasteiger et al., 2003) 
Finch TV Geospiza Inc., Lincoln, NE, USA  
iCycler, Optical System 
Software, Version 3.1 
Bio-Rad Laboratories GmbH, Munich, Germany  
Microsoft Office 2007 Microsoft Corporation, Redmond, WA, USA  
PIR - Pairwise Alignment http://pir.georgetown.edu/pirwww/search/pairwise.shtml (Barker et al., 1998) 
Primer3 http://biotools.umassmed.edu/bioapps/primer3_www.cgi (Rozen and Skaletsky, 
2000) 
Primer3plus 
http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi 
(Untergasser et al., 
2007) 
Reverse Complement http://www.bioinformatics.org/sms/rev_comp.html (Stothard, 2000) 
SignalP 3.0 Server http://www.cbs.dtu.dk/services/SignalP/ (Nielsen et al., 1997) 
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Fast Prep® FP120 BIO 101, Inc., Vista, CA, USA 
Devices for gelelectrophoresis: 
Electrophoresis cell (Sub-Cell GT) 
Electrophoresis power supply (PowerPac Basic) 
Gel-documentation system 
 
Bio-Rad Laboratories GmbH, Munich, Germany  
Bio-Rad Laboratories GmbH, Munich, Germany 
Biostep, Jahnsdorf, Germany 
iCycler Thermal cycler Bio-Rad Laboratories GmbH, Munich, Germany 
Mastercycler gradient Eppendorf AG, Hamburg, Germany 
Microbiological incubator KB 115 Binder GmbH, Tuttlingen, Germany 
Laminar flow hood, model 1.8 Holten, Jouan Nordic, Allerod, Denmark 
Magnetic stirrer RCT basic IKA® Werke GmbH & Co. KG, Staufen, Germany 
Microscopes: 
Inverse microscope Axiovert 25  
Epifluorescence microscope Axioplan 2 imaging 
Confocal laser scanning microscope LSM 510 Meta 
 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Carl Zeiss MicroImaging GmbH, Jena, Germany 
Mixing Block MB-102 Biozym Scientific GmbH, Hessisch Oldendorf, Germany 
NanoDrop® ND-1000 UV/Vis spectrophotometer NanoDrop Technologies Inc., Wilmington, DE, USA 
Neubauer counting chamber Paul Marienfeld GmbH & Co KG, Lauda-Königshofen, 
Germany 
Platform Shaker Innova 2300 New Brunswick Co., Inc., Madison NJ, USA 
pH meter inoLab pH Level 1 Wissenschaftlich technische Werkstätten (WTW) GmbH 
& Co. KG, Weilheim, Germany 
Scales: 
OHAUS®  Analytical Plus balance 
Sartorius BL 3100 
 
Ohaus Corporation, Pine Brook, NJ, USA 
Sartorius AG, Göttingen, Germany 
ScannerEpson Expression 1680 Pro  Epson Deutschland GmbH, Meerbusch, Germany 
Sonicator Bandelin Sonoplus HD2070 Bandelin electronic GmbH & Co. KG, Berlin, Germany 
Sonotrode Bandelin Sonoplus UW 2070 Bandelin electronic GmbH & Co. KG, Berlin, Germany 
Spectral photometer SmartSpecTM  3000 Bio-Rad Laboratories GmbH, Munich, Germany 
Sub-Cell GT UV-Transparent Gel Tray (15 x 15 cm) Bio-Rad Laboratories GmbH, Munich, Germany 
Trans-Blot® SD Semi-Dry Electrophoretic Transfer 
Cell 
Bio-Rad Laboratories GmbH, Munich, Germany 
Thermostatic circulator MultiTempTM III GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Transilluminator  Biostep GmbH, Jahnsdorf, Germany 
Ultrasonic Cleaner SC100T VWR International bvba/sprl, Leuven, Belgium 
UV sterilizing PCR workstation PeqLab Biotechnologie GmbH, Erlangen, Germany 
Vacuum pump Millipore GmbH, Vienna, Austria 
Water baths: 
DC10 
GFL® type 1004 
 
Thermo Haake GmbH, Karlsruhe, Germany 
Gesellschaft für Labortechnik GmbH, Burgwedel, 
Germany 
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Water purification system MILLI-Q® biocel Millipore GmbH, Vienna, Austria 
Watervapour high pressure autoclaves: 
Varioclav® 135 S H+P 
Varioclav® 25 T H+P 
 
H+P Labortechnik GmbH, Oberschleißheim, Germany 
 
 
 
2.3 Expendable items  
 
Table 3. Expendable items used in this study 
 
Expendable item Company 
25cm2 Tissue culture flasks 
Asahi Techno Glass Corporation, Iwaki Glass Co., Ltd., 
Funabashi-City, Japan 
500cm2 Tissue culture flasks Nunc, Roskilde, Denmark 
96-well microtiter plate MJ Research, Waltham, MA, USa 
Cellulose acetate membrane filters (0.45 µm pore 
size, 25 mm diameter) 
Sartorius AG, Göttingen, Germany 
Cover glasses 24 x 60 mm Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, 
Germany 
Cryostock caps, Viabank TM Medical Wire & Equipment, Carsham, UK 
Electroporation cuvette (0.2 cm) Bio-Rad Laboratories GmbH, Munich, Germany 
Glass beads (0.75-1.0 mm) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Greiner tubes (15 ml, 50 ml) Greiner Bio-One GmbH, Frickenhausen, Germany 
IsoporeTM polycarbonate membrane filters (0.22 µm 
pore size, 25 mm diameter, black) 
Millipore GmbH, Vienna, Austria 
Lysing Matrix A MP Biomedicals, Brussels, Belgium 
Microscope slides (76 x 26 mm) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Microscope slides, 10 well Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, 
Germany 
Multiwell dishes, polystyrene (24 wells) Nunc, Roskilde, Denmark 
Needles Sterican® (ø 0.45 x 25 mm, ø 0.90 x 40 
mm), single use, sterile 
B.Braun Melsungen AG, Melsungen, Germany 
Nitrocellulose filter (0.025 µm pore size) Millipore GmbH, Vienna, Austria 
PCR tubes (0.2 ml) Biozym Scientific GmbH, Hessisch Oldendorf, 
Germany 
Pipette Tipps (various sizes) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Plastic cuvettes Greiner Bio-One GmbH, Frickenhausen, Germany 
Plastic pipettes (10 ml, 2 ml), single use, sterile Barloworld Scientific Ltd., Staffordshire, UK 
Polyvinylidene fluoride membrane (Hydrobond P) GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Reaction tube (1.5 ml)  GenXpress Service & Vertriebs GmbH, Wiener 
Neudorf, Austria 
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Reaction tube (2 ml)  Greiner Bio-One GmbH, Frickenhausen, Germany 
Round coverslips (12 mm diameter)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Screw caps CryobankTM Mast Diagnostika Lab. Präparate GmbH, Reinfeld, 
Germany 
Syringe (1 ml) Inject® - F 1ml, single use, sterile B.Braun Melsungen AG, Melsungen, Germany 
Syringe ( 5 ml) Omnifix® single use, sterile B.Braun Melsungen AG, Melsungen, Germany 
Syringe (50 ml) Omnifix® single use, sterile B.Braun Melsungen AG, Melsungen, Germany 
Syringe filter, single use, sterile, 0.20µm pore size Asahi Techno Glass Corporation, Iwaki Glass Co., Ltd., 
Funabashi-City, Japan 
Syringe filter, single use, sterile, 0.45µm pore size Asahi Techno Glass Corporation, Iwaki Glass Co., Ltd., 
Funabashi-City, Japan 
Syringe filter, single use, sterile, 1.20µm pore size Sartorius AG, Goettingen, Germany 
Thermostable foil MJ Research, Waltham, MA, USA 
Ultracentrifuge tubes Beckham Coulter, Inc., Paolo Alto, CA, USA 
Whatman® Chromatography Paper 3MM Chr Whatman International Ltd., Maidstone, UK 
ZelluTrans, Dialyseschlauch Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
 
 
 
2.4 Kits and ready-to-use solutions 
 
Table 4. Kits used in this study 
 
 
 
 
 
 
Kit Company 
2-D Quant Kit GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Amersham HisTrap HP Columns GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
BCA Protein Assay Kit Thermo Scientific Pierce Protein Research Products, 
Waltham, Massachusetts, USA 
DNeasy Blood & Tissue Kit QIAgen, Hilden, Germany 
Hi Trap™ IgY Purification HP Column GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Platinum® SYBR® Green qPCR SuperMix-UDG Invitrogen, Carlsbad, CA, USA 
Qiaquick PCR Purification Kit QIAgen, Hilden, Germany 
Qiaprep Spin Miniprep Kit QIAgen, Hilden, Germany 
RevertAid First Strand cDNA Synthesis Kit Fermentas Inc., Hanover, MD, USA 
TOPO® XL PCR Cloning Kit Invitrogen, Carlsbad, CA, USA 
Western Lightning Chemiluminescence Plus Kit Perkin Elmer, Waltham, Massachusetts, USA 
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Table 5. Ready-to-use-solutions used in this study 
 
 
 
2.5 Chemicals 
 
Table 6. Chemicals used in this study 
 
Chemical Company 
4´,6-diamidino-2-phenylindole (DAPI) Laktan Chemikalien und Laborgeräte GmbH, Graz, 
Austria 
Acetonitrile Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Acetic acid  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Agar Fluka Chemie AG, Buchs, Switzerland 
LE Agarose  Biozym Scientific GmbH, Hessisch Oldendorf, 
Germany 
Ammonium bicarbonate Fluka Chemie AG, Buchs, Switzerland 
Ammonium persulfate (APS) GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Ampicillin Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Boric acid Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Bovine serum albumin (BSA) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Bromphenol blue  Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Calcium chloride dihydrate  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Chloramphenicol Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Citifluor AF1 Agar Scientific Ltd., Stansted, UK 
Coomassie brillant blue G-250 Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Di-ethyl-pyrocarbonat (DEPC) Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Di-methylsulfoxid (DMSO) Fluka Chemie AG, Buchs, Switzerland 
Disodiumhydrogenphosphate dihydrate (Na2HPO4 x 
2H20) 
Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Dithiothreitol (DTT) Fluka Chemie AG, Buchs, Switzerland 
Ready-to-use-solutions Company 
Gene Ruler™ 1kb DNA ladder Fermentas Inc., Hanover, MD, USA 
Gene Ruler™ 100bp DNA ladder Fermentas Inc., Hanover, MD, USA 
PageRuler™ Prestained Protein Ladder improved Fermentas Inc., Hanover, MD, USA 
PageRuler™ Unstained Protein Ladder Fermentas Inc., Hanover, MD, USA 
RiboRuler™ RNA Ladder, High Range Fermentas Inc., Hanover, MD, USA 
2x RNA Loading Dye Fermentas Inc., Hanover, MD, USA 
Spectra™ Multicolor Broad Range Protein Ladder Fermentas Inc., Hanover, MD, USA 
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Ethanol absolute AustrAlco Österreichische Alkoholhandels GmbH, 
Spillern, Austria 
Ethidium bromide (EtBr) Fluka Chemie AG, Buchs, Switzerland 
Ethylenediamine-tetraaceticacid (EDTA) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Ferrous ammonium sulfate hexahydrate Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Ficoll® 400 Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Formaldehyde (37% (w/w)) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Glucose Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Glycogen Applied Biosystems/Ambion, Austin, TX, USA 
Glycerol (87% (w/v))  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Glycine  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
HEPES Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Hydrochloric acid (HCl) (37% (w/w)) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Hydrogen peroxide (H2O2), 30% Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Imidazol Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Iodacetamide GE Healthcare Bio-Sciences AB, Uppsala, Sweden 
Isopropanol (2-propanol) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Isopropyl-β-D-thiogalactopyranoside (IPTG) Sigma-Aldrich Chemie GmbH, Steinhausen, Germany 
Kanamycin Sigma-Aldrich Chemie GmbH, Steinhausen, Germany 
Magnesium chloride hexahydrate Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Magnesium sulfate heptahydrate Merck GmbH, Vienna, Austria 
Methanol Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Milk powder Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Mowiol 4-88 Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
N,N,N´,N´-tetramethylethane-1,2-diamine (TEMED)  Fluka Chemie AG, Buchs, Switzerland 
Potassium chloride (KCl) Merck GmbH, Vienna, Austria 
Paraformaldehyde (PFA) Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Proteose peptone Oxoid Ltd., Hampshire, England 
Roti®-Chloroform/I Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Rotiphorese® NF-Acrylamide/ Bisacrylamide-solution 
30 % (29:1) 
Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Sodium chloride (NaCl) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Sodium dihydrogen phosphate Mallinckrodt Baker B.V., Deventer, Holland 
Sodium dodecly sulfate (SDS)  Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Sucrose Merck GmbH, Vienna, Austria 
SYBR® Green II Nucleic Acid Gel Stain Lonza Rockland, Inc., Rockland, ME, USA 
Trifluoretic acid Fluka Chemie AG, Buchs, Switzerland 
Trishydroxymethylaminomethane (Tris-HCl) Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Trizol Invitrogen, Lofer, Austria 
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Trypticase Soy Broth Oxoid Ltd., Hampshire, England 
Trypsin gold powder Promega Corporation, Madison, USA 
TweenTM 20 Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Urea USB Corp., Cleveland, USA 
Xylene cyanole FF Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Yeast extract Oxoid Ltd., Hampshire, England 
 
 
 
2.6 Enzymes 
 
Table 7. Restriction enzymes used in this study 
 
Restriction Enzyme Restriction site Company 
BamHI 5'-G^G A T C C-3' Fermentas Inc., Hanover, MD, USA 
EcoRI 5'-G^A A T T C-3' Fermentas Inc., Hanover, MD, USA 
KpnI 5'-G G T A C^C-3' Fermentas Inc., Hanover, MD, USA 
NdeI 5'-C A^T A T G-3' Fermentas Inc., Hanover, MD, USA 
NotI 5'-G C^G G C C G C-3' Fermentas Inc., Hanover, MD, USA 
PstI 5'-C T G C A^G-3' Fermentas Inc., Hanover, MD, USA 
SalI 5'-G^T C G A C-3' Fermentas Inc., Hanover, MD, USA 
SmaI 5'-C C C^G G G-3' Fermentas Inc., Hanover, MD, USA 
XhoI 5'-C^T C G A G-3' Fermentas Inc., Hanover, MD, USA 
^…cleavage site 
5´, 3´…5’ end, 3’ end of DNA sequence 
 
 
 
Table 8. Restriction enzyme buffers 
 
Buffer Company 
Buffer O Fermentas Inc., Hanover, MD, USA 
Buffer Red Fermentas Inc., Hanover, MD, USA 
Buffer Tango Fermentas Inc., Hanover, MD, USA 
10x Ex Taq polymerase Buffer Fermentas Inc., Hanover, MD, USA 
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Table 9. Enzymes, except restriction enzymes, used in this study 
 
 
 
 
2.7 Organisms 
 
Table 10. Amoeba strains and endosymbionts used in this study 
 
Both Acanthamoeba sp. and P. amoebophila are classified as L2 organisms and were handled 
according to L2 laboratory guidelines. 
To provide sterility of the cultures and experiments, all vessels and flasks containing L2 
organsims were only opened within a class II safety cabinet, and multi-well plates containing 
these organisms were sealed with parafilm before removing them from the safety cabinet. Fluid 
waste containing these organisms was disposed according to the biosafety guidelines for L2 
laboratories. 
 
 
 
 
 
Enzyme/Enzyme inhibitor Company 
Benzonase Novagen, Darmstadt, Germany 
Complete EDTA free Protease Inhibitor Cocktail Roche Diagnostics GmbH, Mannheim, Germany 
DNaseI Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
High Fidelity PCR Enzyme Mix Fermentas Inc., Hanover, MD, USA 
Lysozyme (human) Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
Ribo Lock™ RNase Inhibitor Fermentas Inc., Hanover, MD, USA 
Taq DNA Polymerase (5U/µl)  Fermentas Inc., Hanover, MD, USA 
Trypsin gold (mass spectrometry grade) Promega Corporation, Madison, WI, USA 
T4 DNA Ligase Fermentas Inc., Hanover, MD, USA 
M-MuLV Reverse Transcriptase Fermentas Inc., Hanover, MD, USA 
Host Endosymbiont Source Reference 
Acanthamoeba castellanii 
Neff 
none 
American Type Culture 
Collection (ATCC), 
Manassas, VA, USA 
(Neff, 1957) 
Acanthamoeba castellanii 
Neff 
Protochlamydia 
amoebophila UWE25 
Universitiy of Washington, 
Seattle, USA 
(Fritsche et al., 1998; 
Collingro et al., 2005) 
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2.8 General primers for polymerase chain reaction (PCR) 
 
Primers were produced by Thermo Fisher Scientific GmbH (Ulm, Germany). Stock solutions 
were diluted with Aquabidest. (Mayrhofer Pharmazeutika GmbH & Co. KG, Leonding, Austria) 
and solutions were stored at -20°C until use. 
 
 
Table 11. General primers used in this study 
 
Primer name Target gene/site 
Primer sequence** 
(5´-3´ end) 
Annealing 
temperature 
Reference/ 
Company 
M13 R M13 binding site in 
lacZ gene of the 
vector pCR® II 
TOPO®  
CAG GAA ACA GCT ATG AC 
60°C 
TOPO® XL 
cloning kit, 
Invitrogen, 
Carlsbad, CA, 
USA 
M13 F GTA AAA CGA CGG CCA G 
pgEX R 3' end of MCS* in pGEX vectors 
CCG GGA GCT GCA TGT GTC 
AGA GG 
50°C 
GE Healthcare 
Bio-Sciences 
AB, Uppsala, 
Sweden pgEX F 
3' end of 
glutathione-S-
transferase 
GGG CTG GCA AGC CAC GTT 
TGG TG 
pQE R 3' end of MCS in pQE vectors GTT CTG AGG TCA TTA CTG 
50°C 
QIAgen, 
Hilden, 
Germany (pQE 
sequencing-
primer set) 
pQE F 5' end of MCS in pQE vectors CCC GAA AAG TGC CAC CTG 
T7 R T7 terminator of pet vectors GCT AGT TAT TGC TCA GCG G 58°C 
New England 
Biolabs GmbH, 
Frankfurt, 
Germany. T7 F 
T7 promoter of pet 
vectors 
TAA TAC GAC TCA CTA TAG 
GG 
PcR 16S rRNA gene of 
Parachla- 
mydiaceae, 
Waddliaceae 
GTC ATC RGC CYY ACC TTV 
SRC RYY TCT 
58°C (Horn and Wagner, 2001) PcF TCA GAT TGA ATG CTG AC 
PanR 16S rRNA gene of 
Chlamydiales 
GTC ATC RGC CYY ACC TTV 
SRC RYY TCT 65°C (Corsaro et al., 2002) PanF CGT GGA TGA GGC ATG CRA GTC G 
1492R 16S rRNA gene of 
Bacteria, but not 
Chlamydiales 
GGY TAC CTT GTT ACG ACT T 
52°C (Lane, 1991) 27F AGA GTT TGA TYM TGG C 
 
*MCS: multiple cloning site 
**According to the Nomenclature Committee of the International Union of Biochemistry (NC-IUB) the unspecified 
bases are represented as follows: R=G or A, Y=T or C, M=A or C, V=Gor C or A, S=G or C, N=G or C or A or T 
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2.9 General media, buffers and solutions 
 
Buffers, media and solutions were produced using double distilled and filtered water (H2Odd). For 
adjustment of the pH sodium hydroxide (NaOH) and hydrochloric acid (HCl) were used. 
 
All media and buffers described here were sterilized for 20 min at 121°C and 1013 x 105 Pa 
using a watervapour-high pressure autoclave. Substances and solutions that are unstable at high 
temperatures like antibiotics were filter-sterilized (0.22 μm pore size) and added after 
autoclaving. 
If not stated otherwise, media and buffers were stored at room temperature until further usage. 
 
2.9.1 Media for cultivation of organisms 
 
 
2.9.1.1 Media for cultivation of amoebae 
 
• Trypticase Soy Broth with Yeast Extract (TSY) 
Trypticase Soy Broth 30 g 
Yeast extract 10 g 
H2Odd ad 1000 ml 
pH 7.3 
 
• Peptone-Yeast-Glucose-medium (PYG) 
Peptone 20 g 
Glucose 18 g 
Yeast extract 2 g 
Sodiumcitrate 1 g 
MgSO4 x 7 H2O 980 mg 
Na2HPO4 x 7 H2O 355 mg 
KH2PO4 340 mg 
Fe(NH4)2(SO4)2 x 6 H2O 20 mg 
H2Odd ad 1000 ml 
pH 6.5 
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2.9.1.2 Media for cultivation of Escherichia coli (E. coli) 
 
• Luria Bertani medium (LB medium) 
Tryptone  10 g 
Yeast extract  5 g 
NaCl  5 g 
H2Odd  ad 1000 ml 
pH 7.0-7.5 
 
• Terrific Broth medium (TB medium) 
Solution A 
Tryptone 12 g 
Yeast extract 24 g 
Glycerol 4 ml 
H2Odd  ad 1000 ml 
 
Solution B 
KH2PO4 2.31 g 
K2HPO4 12.54 g 
H2Odd  ad 1000 ml 
 
Before use 1 volume of solution B was added to 9 volumes of solution A. 
 
• dYT - medium 
Tryptone 16 g 
Yeast extract 10 g 
NaCl l5 g 
H2Odd  ad 1000 ml 
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• SOC medium 
Tryptone 20 g 
Yeast extract 0.5 g 
NaCl 0.58 g 
KCl 0.19 g 
MgCl2 0.95 g 
MgSO4 1.20 g 
Glucose 3.60 g 
H2Odd  ad 1000 ml 
 
For solid media 15 g/l agar were added before autoclaving. 
 
 
2.9.2 Antibiotic solutions and solution for induction of heterologous expression 
 
For solid media antibiotic stock solutions were added to the autoclaved media at ~50°C. Solid 
media containing antibiotics were stored at 4°C until further use. 
Antibiotics were added to liquid media right before usage. 
 
• Ampicillin stock solution (Amp)  100 mg/ml 
Amp was dissolved in 50% EtOH and stored at -20°C. 
Amp was added to media to reach a final concentration of 100 µg/ml. 
 
• Kanamycin stock solution (Kan) 100 mg/ml 
Kan was dissolved in H2Odd and stored at -20°C. 
Kan was added to media to reach a final concentration of 100 µg/ml. 
 
• Chloramphenicol stock solution (Cam) 25 mg/ml 
Cam was dissolved in 100% EtOHabs and stored at -20°C. 
Cam was added to media to reach a final concentration of 125 μg/mL 
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• 1M IPTG stock solution 
Isopropyl-β-D-thiogalactopyranosid (IPTG)  238.3 mg/ml 
IPTG was dissolved in H2Odd, filter-sterilized by passing through a 0.2 µm filter and stored 
at -20°C. 
 
The IPTG stock solution was added to an actively growing E. coli culture to reach a final 
concentration of 1mM. 
 
 
2.9.3 General buffers and solutions 
 
• 10x Page’s Amoebic Saline (PAS) 
NaCl 1.20 g 
MgSO4 x 7H20 0.04 g 
CaCl2 x H20 0.04 g 
NaH2PO4 x 2H20 1.78 g 
KH2PO4 1.36 g 
H2Odd ad 1000 ml 
 
• PBS stock solution 
Solution 1:  35.6 g/l Na2HPO4   
Solution 2: 27.6 g/l NaH2PO4  
pH of solution 1 was adjusted to 7.2-7.4 by adding solution 2. 
 
• 10x PBS 
Na2HPO4 26.8 g 
NaH2PO4 13.8 g 
NaCl 81.6 g 
H2Odd  ad 1000 ml 
 
• 1x PBS 
PBS stock solution 50 ml 
NaCl 7.6 g 
H2Odd ad 1000 ml 
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• Sucrose-Phosphate-Glutamate (SPG) buffer 
Sucrose 75 g 
KH2PO4 0.52 g 
Na2HPO4 x 2 H20 2.30 g 
Glutamc acid 0.75 g 
H2Odd ad l000 ml 
 
• 4% paraformaldehyde (PFA) solution 
1x PBS 25 ml 
Paraformaldehyd (37% w/v) 2.7 ml 
 
 
2.9.4 Buffers and solutions for gel electrophoresis 
 
• 10x TBE 
Tris-HCl 162 g 
Boric acid 27.5 g 
EDTA 9.3 g 
H2Odd ad 1000 ml 
pH 8.3 – 8.7 
 
• 1x TBE 
10 x TBE 100 ml 
H2Odd ad 1000 ml 
 
• Loading buffer 
Ficoll 2.5 g 
Bromphenol blue 0.05 g 
Xylencyanol 0.05 g 
EDTA 0.15 g 
H2Odd ad 10 ml 
 
  2 Material and Methods 
  29 
2.9.5 Ethidium bromide solution 
 
• Ethidium bromide stock solution: 
10 mg/ml Ethidium bromide (EtBr) in H2Odd 
 
• Ethidium bromide staining solution: 
Ethidium bromide stock solution diluted 1:10000 in H2Odd 
 
 
 
2.10 Cultivation and maintenance of amoeba cultures 
 
Solutions 
PYG medium 
TSY medium 
 
Procedure 
Acanthamoeba castellanii Neff, either harboring P. amoebophila or without endosymbionts, 
were grown axenically in liquid TSY or PYG medium in 10 ml and 150 ml flasks at 20°C. 
Amoebic growth was observed by using an inverse microscope, screening for potential 
contaminations in parallel. 
 
Medium was exchanged if high rates of encystation or detachment of the trophozoites from the 
culture flasks got visible. Also well grown cultures with densely attached trophozoites were 
subjected to shaking off and subsequent medium exchange in order to maintain amoebae at the 
stage of growing. Medium was replaced by pouring the old medium out into a glass bottle, 
followed by adding the same standardized volume of fresh medium. The remaining amoebae 
were allowed to recover and grow again to a stage of densely attachement. 
 
New or poorly grown cultures were inoculated with respective cells from well-grown cultures. 
For this purpose, a 10 ml culture flask was shaken vigorously and 1-2 ml of the cell suspension 
were transferred to the target culture flasks by disposable single-use pipettes. 
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2.11 Harvesting and quantification of amoebae 
 
Depending on the number of amoebae needed for an experiment, the number of culture flasks to 
be harvested was estimated. One small well-grown culture yielded about 1.5 x 106 cells whereas 
a large one resulted in a yield of about 1 x 107 amoebae. 
 
Culture flasks were shaken rigorously in order to detach amoebae from the surface, suspensions 
were poured out into 50 ml Greiner tubes and cultures were supplied with fresh medium. The cell 
suspension was centrifuged at 7323x g for 5 minutes and the supernatants were discarded. Pellets 
were resuspended in 1 ml 1x PAS, pooled and another centrifugation step (7323x g, 5 min) was 
carried out. 
 
Cell concentrations of harvested amoebae were determined using a Neubauer counting chamber. 
For this purpose amoebal suspensions were diluted in 1x PAS either 1:10 or 1:100, depending on 
the harvested culture. These dilutions were subsequently pipetted into the two chambers of the 
Neubauer counting chamber. Cells were immediately subjected to counting with the help of an 
inverse phase contrast microscope. 
 
The cell concentration per ml was calculated as follows:  
 
Dilution factor (D) = 100 
Depth of chamber = 0.1 mm 
 
 
2.12 Screening of Acanthamoeba castellanii Neff cultures by 4', 6-
Diamidino-2-phenylindol (DAPI) staining 
 
Regularly, the amoeba cultures had to be screened for contaminations. One possibility to detect 
extracellular bacteria or other chlamydiae was DAPI staining. 
 
Solutions 
DAPI 
1x PAS 
4% PFA 
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Procedure  
DAPI was prepared at a dilution of 1:10000 and stored at 4°C in the dark until further use. 1 ml 
of an amoeba culture was harvested by centrifugation and the resulting pellet was washed once 
with 1x PAS. Subsequently, the pellet was resuspended in 200 μl 1x PAS and 20 μl of this 
suspension were applied to one well of a microscope slide. Amoebae were allowed to attach for 
30 min, afterwards the liquid was removed carefully and 10 μl of 4 % PFA were added for the 
fixation of the cells. After incubation for 10 min at RT, the fixative was removed and the wells 
were washed with 10 μl H20dd. Then, 10 μl of the DAPI-solution were added onto each well and 
slides were incubated for 7 min in the dark. The DAPI-solution was removed and wells were 
washed with 20 μl H20dd. Slides were dried at RT in the dark and prepared for microscopic 
analysis by embedding them in Citifluor. 
 
 
2.13 Partial purification of EBs 
 
Pellets after partial purification were expected to contain mostly elementary bodies of P. 
amoebophila, since reticulate bodies are thought to get destroyed during the procedure of partial 
purification. 
 
Solutions 
SPG-Buffer 
1x PAS 
 
Procedure 
Well grown amoebae cultures infected with P. amoebophila were harvested (2.11). The pellets 
were washed once with 1x PAS, subsequently resuspended in 1x PAS and finally pooled. To 
disrupt cell membranes of amoebae, they were first frozen at -20°C followed by thawing at 45°C. 
This freeze-and-thaw step was repeated once leading to a release of intracellular bacteria. For 
further lysis of the cells, 5 ml glass beads were added to the suspension and vortexed for 3 min to 
achieve a mechanical lysis of amoebae cells and RBs. 
The suspension was centrifuged at 300x g for 10 min at 4°C in order to get rid of the glass beads 
and amoebal cell debris. The supernatant was then transferred through a 1.2 µm filter to an 
ultracentrifuge tube and 1x PAS was added to a final volume of 10 ml.  
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After centrifugation at 35700x g for 40 min at 4°C, the pellet was resuspended in about 10 ml 
precooled SPG buffer, followed by a final ultracentrifugation step (35700x g, 40 min, 4°C). The 
pellet containing partial-purified bacteria was resuspended in 3 ml SPG and the suspension was 
passaged through a 0.45 mm needle several times in order to break up clusters of bacteria.  
Finally, SPG buffer was added to the P. amoebophila suspension to a total volume of 7 ml and 1 
ml aliquots were stored at -80°C. 
 
 
 
2.14 Quantification of purified P. amoebophila cells 
 
Solutions  
1x PBS (filter-sterilized) 
DAPI 
 
Procedure 
After partial purification P. amoebophila suspensions were quantified by filtration of particles 
(>0.22 μm diameter) onto a membrane, followed by DAPI staining. 
 
After thawing at 37°C, 1 μl of purified P. amoebophila EBs was diluted with 5 ml 1x PBS and 
suspensions were stored on ice until use. In the meantime, the filter device was flame-sterilized 
and assembled using a black 0.22 μm polycarbonate membrane filter and a 0.45 μm cellulose 
acetate membrane support underneath the filter. To rinse the funnel 5 ml filter-sterilized 1x PBS 
were filtered by applying a vacuum pump running at 250 millimeter of mercury. Next, the 
bacterial suspension was filtered, followed by another rinsing step to remove all bacteria from the 
funnel. Subsequently, 150 μl of DAPI solution were added on top of the filter and the filter was 
incubated for 5 min in the dark. By applying the vaccum pump, the DAPI solution was removed 
and the filter was washed with 1x PBS. 
Finally, the membrane was placed on a microscope slide and embedded in Citifluor for further 
analysis with an epifluorescence microscope.  
 
The number of DAPI signals within a 10 x 10 grid was counted using the 100x objective. Only 
clearly coccoid DAPI signals were considered to be P. amoebophila cells. 
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The cell number/ml was calculated as follows:  
 
M…Microscope factor = 11264 
DF… Dilution factor = 1000 
 
 
2.15 Infectious cycle of P. amoebophila in A. castellanii Neff 
 
Solutions 
TSY 
1x PAS (filter-sterilized) 
1x PBS (filter-sterilized) 
4% PFA 
Methanol 
 
Procedure 
A 150 ml culture of A. castellanii Neff was harvested and amoebae were counted using a 
Neubauer counting chamber (2.11). The suspension was pelleted by centrifugation and 
resuspended in the volume of TSY needed to obtain the required number of cells/ml. 
 
The following steps were performed in duplicates. 106 amoebae in 3 ml TSY were seeded in each 
well of a 6-well plate and samples were incubated for 1 or 2 hours at 20°C to allow attachment of 
amoebae. Partially purified P. amoebophila EBs were thawed at 37°C and directly placed on ice. 
Amoebae were infected with EBs at a theoretical multiplicity of infection (MOI) of 10 by adding 
a defined amount of EB suspension to each well. Amoebae from one well were not infected and 
used as a negative control. The plates were put on a shaking platform in order to equally 
distribute the EBs, then, plates were centrifuged at 600x g for 15 min at 20°C to stimulate the 
uptake of bacteria. The end of centrifugation was regarded as time point 0 hours post infection (h 
p.i.). Immediately afterwards, amoebae from time point 0 h p.i. were harvested by resuspension 
and centrifugation in a Greiner tube at 3900x g for 10 min at 20°C. In parallel, 15 µl of amoeba 
suspension from 0 h p.i. were incubated on one well of a 10-well microscopic slide for 20 min 
and finally fixed with methanol for 10 min at RT. 
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The medium from the other wells was exchanged to remove excess EBs that were not attached to 
amoebae and the infected cultures and the negative control were grown at 20°C. Ameobae were 
harvested 24, 48 and 96 h p.i., whereby the uninfected control was harvested at the last time point 
96 h p.i.. Again, 15 µl aliquots of each time point were incubated on 10-well microscopic slides 
and fixed with methanol for further analysis. 
Cell pellets from each time point were stored at -20°C. 
 
 
2.16 Cultivation and maintenance of recombinant E. coli strains 
 
Solutions 
LB medium 
LB agar plates 
Amp stock solution 
Kan stock solution 
Cam stock solution 
 
Procedure 
For culturing recombinant E. coli cells either liquid medium or plates with solid medium were 
used. To avoid the growth of cells without plasmid the appropriate antibiotic stock solution was 
added, depending on the resistance gene on the vector. 
Cells subjected for cultivation in liquid media were picked under sterile conditions from a single 
colony, inoculated in 5 ml of LB + antibiotics and incubated at 37°C on an orbital shaker over 
night (o/n) at 200 rpm. The E. coli cultures were used for isolation of plasmid DNA or for further 
overexpression experminents. 
 
Larger cell volumes were cultured in Erlenmeyer flasks containing the designated volume of 
medium. The medium was inoculated with an o/n culture of the desired E. coli strain at a ratio of 
1:20 and incubated at 37°C on an orbital shaker until the desired cell density was reached. 
 
Short time maintenance was achieved by transferring single clones to a masterplate. This plate 
was incubated o/n at 37°C and stored at 4°C until further use. For long time maintenance 
cryostocks of single clones were prepared according to the following procedure:  
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800 μl of o/n culture were transferred into 2 ml screw caps containing a special cryostock 
solution and hollow plastic spheres for the attachment of the cells. The caps were inverted about 
10 times, the supernatant was removed and the caps were frozen at -80°C. To grow cells from 
this stock one sphere could be removed from the cap and placed into fresh LB medium. 
 
 
2.17 Measurements of the optical density (OD) of E. coli cell cultures 
 
The growth of E. coli cultures was tracked by measurements of the optical density. Cultures were 
removed from the rocking platform and 500 µl were filled into a cuvette for photometric 
measurements at a wavelength of 600 nm using a spectral photometer. 
 
 
2.18 Sample preparation from E. coli cell cultures 
 
E. coli cell pellets were obtained by centrifugation of an E. coli culture at 7323x g for 10 min. 
The obtained pellet was resuspended in an appropriate amount of 4x SDS-PAGE loading buffer, 
depending on the size of the pellet. Samples were heated to 95°C for 5 min in order to break up 
the cells. 1 µl of Benzonase was added to the samples and digestion of nucleic acids was 
performed for 1 h at 4°C. Samples were stored at -20°C until further use. 
 
 
2.19 Preparation of electrocompetent E. coli strains 
 
Solutions 
dYT medium 
10% glycerine 
 
Procedure 
All solutions as well as the necessary instruments und tubes had to be precooled to 4°C in 
advance. All steps were carried out in the 4°C room and all centrifugation steps had to be 
conducted at 4°C. 
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750 ml dYT medium were inoculated with an over-night culture containing the desired E. coli 
strain at a ratio of 1:1000. Cells were grown at 37°C on a shaking platform and the optical 
density at a wavelength of 600 nm was measured in regular intervals until the cultures reached an 
OD600 of ~ 0.6. Cells were placed on ice to cool them and were harvested by centrifugation 
(7323x g, 15 min, 4°C).  
Each cell pellet was washed with 50 ml ice-cold H2Odd, resuspended in 50 ml 10% glycerine and 
again centrifuged. The supernatant was removed and the pellets were resuspended in an equal 
volume of 10% glycerine solution, aliquoted à 100 μl in screw  caps and immediately stored at     
-80°C until further use. 
 
 
2.20 Methods for DNA isolation 
 
2.20.1 Isolation of total DNA from amoeba cultures 
 
10 ml of an amoeba culture were harvested in order to isolate DNA from the resulting pellet. 
DNA isolation was accomplished by using the DNeasy Blood & Tissue Kit according to the 
manufacturer´s instructions following the protocol for Gram-negative bacteria.  
Finally, the concentration of isolated DNA dissolved in H2Odd was determined by using a Nano 
Drop® device (2.24.2) and could be subsequently used as template in PCR. 
 
 
2.20.2 Isolation of plasmid DNA from recombinant E. coli strains 
 
Solutions 
LB medium 
Kan/Amp/Cam stock-solution 
 
Procedure 
5 ml LB medium were mixed with 5µl antibiotic stock solution, and recombinant E. coli cells 
were inoculated and cultivated as described in 2.16. 
Finally, plasmids were isolated with the QIAprep® Spin Miniprep Kit following the 
manufacturer`s instructions and analyzed quantitatively by Nanodrop measurements. Plasmids 
were sequenced to verify correct inserts prior to restriction experiments. 
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2.21 Simultaneous isolation of RNA from amoebae and their bacterial 
endosymbionts 
 
Solutions 
H2Odd/DEPC 
0.1 Vol% Diethylpyrocarbonat (DEPC) was dissolved in 1 l H2Odd by stirring, incubated at RT 
o/n and finally autoclaved. 
In general all aqueous solutions used for RNA treatment were prepared with DEPC-treated H2Odd 
in order to inactivate RNases. 
 
Trizol 
Chloroform 
Isopropyl alcohol 
75% EtOHDEPC 
 
Procedure 
Phenol was used for the extraction of RNA, hence all steps including Phenol were carried out 
under the hood. 
 
For the isolation of RNA, 3 ml of amoebal culture were harvested at 7323x g for 10 min at 20°C. 
After removing the supernatant carefully, the pellet was resuspended in 750 µl Trizol by 
pipetting up and down about 30 times. The cells were disrupted using a bead beater at an 
intensity of 4.5 for 30 sec and the disrupted cell suspenison was then centrifuged at 12000x g for 
5 min. The supernatant was incubated at RT for 5 min followed by the addition of 200 µl 
chloroform per 750 µl Trizol. This solution was shaken vigorously by hand for 15 sec, incubated 
at RT for 5 min and finally centrifuged at 12000x g for 15 min at 4°C. The aqueous supernatant 
was taken off carefully, avoiding a carryover of chloroform. The supernatant was then mixed 
with 500 µl isopropyl alcohol per 750 µl volume and incubated at RT for 10 min.  
After another centrifugation step (12000x g, 10 min, 4°C) the resulting gel-like RNA-pellet was 
washed with 1 ml 75% EtOH and centrifuged once more for 5 min at 7000x g at 4°C. The RNA 
pellet was air-dried for 10 min, and finally dissolved in 30 µl RNase free H2Odd/DEPC. 
The isolated RNA was then quantified photometrically (2.24.2) and could either be stored at -
80°C or treated directly with DNase. 
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2.22 DNase treatment of isolated RNA 
 
In order to ensure that the isolated RNA was free of DNA, DNase digestion was carried out. 
 
Solutions 
Deoxyribonuclease I amplification grade 2 Units/µl 
10x DNase reaction buffer  
RNase inhibitor  
H2Odd/DEPC 
3M Natrium acetat, pH 5.2 
Glycogen 
70% EtOHDEPC 
100% EtOH 
 
Procedure 
The DNase digestion reaction had to be prepared according to the following standard procedure 
considering the use of 1 Unit DNase per 2µg RNA. As DNase is susceptible to any physical 
stress, the digestion reaction was never vortexed. 
 
DNase digestion mixture: 
RNA 30 µl 
10x reaction buffer 5 µl 
DNase x 
RNase inhibitor 2.5 µl 
H2Odd/DEPC ad 50 µl 
 
This reaction was incubated for 1 h at RT, then 5 µl stop solution were added and the reaction 
was heat inactivated for 10 min at 70°C. 
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2.23 Ethanol precipitation of isolated RNA 
 
After DNase digestion, RNA had to be precipitated by using Ethanol. H2Odd/DEPC was added to 
the reaction mix to a final volume of 200 µl, next 20 µl 3M sodium acetat were added and RNA 
samples were additionally treated with 20 µl glycogen. 600 µl 100% EtOH were used for 
precipitation at -20°C o/n. 
Finally, the reaction mixture was centrifuged at 12000x g for 15 min at 4°C. The resulting pellet 
was washed with 70% EtOHDEPC and once more centrifuged. RNA precipitation was completed 
by air-drying the pellet for 10 min and resolving in 30 µl H2Odd/DEPC. The RNA was measured 
photometrically and the quality of the RNA samples was checked as described in 2.28.1. 
 
 
2.24 Qualitative and quantitative analysis of nucleic acids 
 
2.24.1 Qualitative analysis of nucleic acids using agarose gel electrophoresis 
 
For qualitative analysis of nucleic acids, horizontal agarose gel electrophoresis was used. This 
technique offers the possibility to separate nucleic acids according to their size by migration 
through an agarose gel under the influence of an electric field. 
 
Solutions 
1x TBE 
Loading buffer 
DNA ladder 
EtBr staining solution 
 
Procedure 
Agarose gels with concentrations of 1-2.5 % were obtained by mixing 1.5 g – 3.75 g agarose 
with 150 ml of 1x TBE and melting it in a microwave. The solution was poured into a gel–tray 
with applied combs. After polymerization, the gel-carriage was inserted into an electrophoresis 
apparature filled with 1x TBE, the combs were removed and nucleic acid solutions, mixed 1:1 
with loading buffer, were pipetted into the pockets of the gel. By applying a voltage of 80 - 100 
V for 60 - 90 min, depending on the type of analysis, nucleic acids got separated according to 
their fragment size. 
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After separation the gels were incubated in ethidium bromide staining solution for 30 min and 
nucleic acids were visualized with UV-transillumination (λ = 312 nm). Band patterns were 
recorded and digitalised with a gel–documentation system. 
 
2.24.2 Quantitative, photometric analysis of nucleic acids 
 
Concentration and purity of nucleic acids were determined using a NanoDrop® ND-1000 
spectralphotometer. For this purpose 1.5 µl nucleic acid solution were pipetted onto the end of 
the fibre optic cable of the NanoDrop® device. Measurments were performed at λ = 260 nm 
according to the manufacturer’s instructions. 
 
 
 
2.25 In silico design of new PCR primers for the amplification of target 
genes 
 
Specific PCR primers targeting the respective start- and end-sequences of genes of P. 
amoebophila UWE25 were constructed by using the Clone Manager software. The primers 
inserted two different restriction sites at the 3’- and 5’-end of the PCR products (Table 13 and 
Table 14) for cloning of the amplified genes into an expression vector. If necessary, the reverse 
primers were designed to insert a 6x Histidine tag at the 5`end for purification. The used 
restriction sites were also present in the vector of choice for further cloning experiments. 
All primers described in this study were obtained from Thermo Electron GmbH (Ulm, Germany). 
All PCR amplifications were carried out using the iCycler or the Mastercycler gradient PCR 
cycler. 
 
2.25.1 Detection of the leader sequence of the porins of P. amoebophila 
 
For the in silico design of new PCR primers it was necessary to identify the leader sequence of 
the porins using the software SignalP3. These primers should amplify the porins without leader 
sequence during a PCR reaction; therefore the most probable cutting sites were identified by 
using the methods “neutral networks” and “hidden Markov models”. 
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Furthermore, the E. coli OmpT protease leader sequence was integrated during primer design: 
CGGGCGAAACTCCTAGGAATAGTCCTGACAACCCCTATCGCGATCAGCTCTTTTGCGTCGAC (Novagen, 
Darmstadt, Germany – pet12a) 
 
 
Table 12. SignalP3 prediction for the leader sequences of the 4 putative porins 
 
 
 
 
 
2.26 Primers used for amplification of target genes 
 
 
Table 13. Specific primers for the amplification of porins 
Porin cut between amino acid 
pc0870 21 + 22 
pc1077 20 + 21 
pc1489 20 + 21 
pc1860 22 + 23 
Primer 
name* 
Target 
molecule 
Primer sequence 
(5´-3´ end) Comments** 
Restriction 
site for 
For 
cloning 
into 
pet0870R 
pc0870 
CGG GTA CTC GAG AAT CCC 
AAA TCC AAT ATC 
HPLC 
Ta=58°C 
XhoI 
pet21b 
pet0870F CGG GTA GAA TTC ATG AAA 
AAA GTT TGT TGC GTT 
EcoRI 
pet1077R 
pc1077 
CGG GTA CTC GAG GAA TGC 
CAT TCC TAC ATC 
XhoI 
pet1077F CGG GTA GTC GAC ATG CGC 
AAA ATC CTT TTG ACA 
SalI 
pet1489R 
pc1489 
CGG GTA CTC GAG GAA TTG 
TTT TCC AAA TGT 
XhoI 
pet1489F CGG GTA GTC GAC ATG CGA 
AAG TTG ATA ACC TTC 
SalI 
pet1860R 
pc1860 
CGG GTA CTC GAG GAA AGA 
ATG GGA TAA TGC 
XhoI 
pet1860F CGG GTA GAA TTC ATG TTT 
AGA TCT CTG GTC GCT 
EcoRI 
pet0870R_2 
pc0870 
CGG GTA GGA TCC GTG GTG 
GTG GTG GTG GTG CCC AAA 
TCC AAT ATC 
PAGE 
Ta=58°C 
BamHI 
pet16b 
pet0870F_2 CGG GTA CAT ATG AAA AAA 
GTT TGT TGC GTT 
HPLC 
Ta=58°C 
NdeI 
pet1077R_2 
pc1077 
CGG GTA GGA TCC GTG GTG 
GTG GTG GTG GTG GAA TGC 
CAT TCC TAC ATC 
PAGE 
Ta=58°C 
BamHI 
pet1077F_2 CGG GTA CAT ATG CGC AAA 
ATC CTT TTG ACA ATT 
HPLC 
Ta=58°C 
NdeI 
pet1489R_2 
pc1489 
CGG GTA CTC GAG GTG GTG 
GTG GTG GTG GTG GAA TTG 
TTT TCC AAA TGT 
PAGE 
Ta=58°C 
XhoI 
pet1489F_2 CGG GTA CTC GAG CGA AAG 
TTG ATA ACC TTC 
HPLC 
Ta=58°C 
XhoI 
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*noL: resulting amplicon without leader sequence 
omp: resulting amplicon with OmpT leader sequence 
**Ta: annealing temperature 
HPLC: High Performance Liquid Chromatography, technique for primer purification, purity of the 
oligonucleotide >80% 
PAGE: Polyacrylamid gel electrophoresis, technique for primer purification, suitable for the purification of very 
long oligonucleotides 
 
 
pet1860R_2 
pc1860 
CGG GTA GGA TCC GTG GTG 
GTG GTG GTG GTG GAA AGA 
ATG GGA TAA TGC 
PAGE 
Ta=58°C 
BamHI 
pet16b 
pet1860F_2 CGG GTA CAT ATG TTT AGA 
TCT CTG GTC GCT 
HPLC 
Ta=58°C 
NdeI 
qe0870R 
pc0870 
CGG GTA CTG CAG GTG GTG 
GTG GTG GTG GTG TAC CCG 
AAT CCC AAA TCC AAT ATC 
PAGE 
Ta=58°C 
PstI 
pQE-30 
qe0870F CGG GTA GGT ACC AAA AAA 
GTT TGT TGC GTT 
HPLC 
Ta=58°C 
KpnI 
qe1077R 
pc1077 
CGG GTA CTG CAG GTG GTG 
GTG GTG GTG GTG TAC CCG 
GAA TGC CAT TCC TAC ATC 
PAGE 
Ta=58°C 
PstI 
qe1077F CGG GTA GGT ACC CGC AAA 
ATC CTT TTG ACA 
HPLC 
Ta=58°C 
KpnI 
qe1489R 
pc1489 
CGG GTA CTG CAG GTG GTG 
GTG GTG GTG GTG TAC CCG 
GAA TTG TTT TCC AAA TGT 
PAGE 
Ta=58°C 
PstI 
qe1489F CGG GTA GGT ACC CGA AAG 
TTG ATA ACC TTC 
HPLC 
Ta=58°C 
KpnI 
qe1860R 
pc1860 
CGG GTA CTG CAG GTG GTG 
GTG GTG GTG GTG TAC CCG 
GAA AGA ATG GGA TAA TGC 
PAGE 
Ta=58°C 
PstI 
qe1860F CGG GTA GGT ACC TTT AGA 
TCT CTG GTC GCT 
HPLC 
Ta=58°C 
KpnI 
gx0870F pc0870 CGG GTA GAA TTC A AAA 
AAA GTT TGT TGC GTT 
HPLC 
Ta=58°C 
EcoRI 
pgEX-4T-3 
gx1077R pc1077 CGG GTA GC GGCC GC  GAA 
TGC CAT TCC TAC ATC 
NotI 
gx1489F pc1489 CGG GTA CCC GGG AA CGA 
AAG TTG ATA ACC TTC 
SmaI 
gx1860F pc1860 CGG GTA GAA TTC A TTT 
AGA TCT CTG GTC GCT 
EcoRI 
noL0870R 
pc0870 
CGG GTA CTG CAG AAT CCC 
AAA TCC AAT ATC 
PstI 
pQE-30 
noL0870F CGG GTA GGT ACC GAA CTA 
TTA AGT TTT GAT 
KpnI 
noL1077R 
pc1077 
CGG GTA CTG CAG GAA TGC 
CAT TCC TAC ATC 
PstI 
noL1077F CGG GTA GGT ACC TTT TGG 
CCT GAA GCA ACA 
KpnI 
omp1860R 
pc1860 
CGG GTA CTG CAG GTG GTG 
GTG GTG GTG GTG TAC CCG 
GAA AGA ATG GGA TAA TGC 
PAGE 
Ta=58°C 
PstI 
omp1860F 
CGG GTA GGT ACC CGG GCG 
AAA CTC CTA GGA ATA GTC 
CTG ACA ACC CCT ATC GCG 
ATC AGC TCT TTT GCG TCG 
AC AAG TTG TCA ACA AAG 
TGT GGA 
KpnI 
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Table 14. Specific primers for the amplification of cytoplasmic proteins 
*Ta: annealing temperature 
HPLC: High Performance Liquid Chromatography, technique for primer purification, purity of the 
oligonucleotide >80% 
 
2.27 In vitro amplification of DNA fragments via PCR 
 
DNA fragments of interest were amplified by PCR using specifically designed primers. 
Every PCR reaction starts with a denaturation step to separate the double strands of the DNA 
from each other, followed by an annealing step, where the primers bind to the DNA template. An 
ultimate step results in elongation of the primers by a DNA polymerase (Taq). By repeating this 
cycle several times, millions of copies of one gene can be amplified in a short time. 
 
Table 15. Components for a standard reaction mixture for PCR 
 
Component Volume/ 
50 μl reaction 
MgCl2 (25 mM) (Fermentas Inc., Hanover, MD, USA) 4 µl 
10 x Taq buffer (with KCl) 5 µl 
dNTP – Mix (2 mM each) (Fermentas Inc., Hanover, MD, USA) 5 µl 
Forward primer (50 pmol/µl) 1 µl 
Reverse primer (50 pmol/µl) 1 µl 
Taq DNA Polymerase (5 u/μl) 0.2 µl 
Aquabidest. (Mayrhofer Pharmazeutika GmbH & CoKG, Leonding, Austria) ad 50 µl 
Template ~100 ng 
Primer 
name 
Target 
molecule 
Primer sequence 
(5´-3´ end) Comments* 
Restriction 
site for 
For 
cloning 
into 
qe0595R 
pc0595 
CGG GTA CTG CAG TTT AAG 
GAT TTC GGA AAC 
HPLC 
Ta=58°C 
PstI 
pQE-30 
qe0595F CGG GTA CCC GGG A GCT AAA GAA ACT TTT CAG SmaI 
qe1499R 
pc1499 
CGG GTA CTG CAG TGG TTT 
TTT ATC ATC CAA PstI 
qe1499F CGG GTA CCC GGG A AGC CAA AGT CAA ACA AAA SmaI 
gx0595R 
pc0595 
CGG GTA CTC GAG TTT AAG 
GAT TTC GGA AAC XhoI 
pgEX-4T-3 
gx0595F CGG GTA CCC GGG AA GCT AAA GAA ACT TTT CAG SmaI 
gx1499R 
pc1499 
CGG GTA CTC GAG TGG TTT 
TTT ATC ATC CAA XhoI 
gx1499F CGG GTA CCC GGG AA AGC CAA AGT CAA ACA AAA SmaI 
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Procedure  
H2Odd., MgCl2, 10x Taq polymerase buffer and tubes needed for PCR were exposed to UV-light 
for 15 min before preparing the standard reaction mixture in order to avoid contaminations. All 
pipetting steps, except for the addition of the positive control, were carried out in a UV sterilizing 
PCR hood. 
For easier handling a mastermix for the standard reaction mixture was prepared. Furthermore, 
each PCR contained a positive and a negative control. 
 
Standard PCR reaction: 
PCR step Temp. (°C) Time Number of cycles 
Denaturation 95 3 min 1 
Denaturation 95 30 sec 
35 
Annealing * 30 sec 
Elongation 72 
30 sec/ 500 
basepairs 
Final elongation 72 7 min 1 
*Annealing temperature see Table 13 and Table 14 
 
 
2.27.1 Gradient PCR 
 
In order to determine the optimal annealing temperatures of the newly designed primer pairs a 
gradient PCR was performed. Denaturation, elongation and final elongation were conducted as in 
the standard PCR approach (2.27). A negative control containing no template DNA was run at 
the lowest annealing temperature in order to check for PCR contaminations.  
100 ng DNA were used as template for the amplification. 
 
Temperature gradient of the thermocycler 
Row A B C D E F G H 
Temperature (°C) 65 64 62.3 59.5 55.7 53 51.1 50 
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2.27.2 High Fidelity PCR 
 
This PCR approach used the Hi-Fidelity PCR Enzyme Mix for the amplification of genes. This 
DNA polymerase features proof reading activity for correct copying of the amplified sequence. 
Thus, frameshifts were minimized and correct expression was expected. 
 
Components and volumes were the same as for standard reactions (Table 15), except using the 
Hi-Fidelity polymerase. DNA isolated from E25 elementary bodies (2.14) was used as template. 
The same amplification conditions as for standard PCR were used. 
 
 
2.28 Reverse Transcription PCR (RT-PCR) 
 
To exclude degradation effects of RNA and contaminations with DNA should, only RNA 
samples of approved quality were used in RT-PCR. 
 
2.28.1 Methods for testing RNA quality 
 
A 2% agarose gel was prepared using TAEDEPC and gel electrophoresis was performed (2.24.1) in 
order to separate RNA by size. The samples for electrophoresis were prepared by mixing 1 µl of 
each isolated RNA sample with 2 µl of RNA loading dye. 
Furthermore, the isolated RNA was used as template in PCR in combination with specific 
primers, designed for quantitative PCR (qPCR) (Table 16). Since no DNA should be contained in 
the RNA samples, no amplification of gene fragments was expected. PCR products were 
controlled on a 2% agarose gel.  
 
2.28.2 Reverse transcription 
 
Reverse transcription was performed by using the RevertAidTM First Strand cDNA Kit according 
to the manufacturer’s instructions. 1 μg RNA was applied per reaction and random hexamer 
primers were used for reverse transcription. A negative control was performed in parallel where 
no reverse transcriptase was added. During this reaction no creation of cDNA was expected. 
The obtained cDNA was stored at -20°C until further use in qPCR as described in the next 
chapter. 
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2.29 Quantitative polymerase chain reaction (qPCR) 
 
qPCR was used as a method for transcriptional analysis of the porin pc1489 in comparison to the 
16S rRNA gene of P. amoebophila during an infectious cycle. Three independent biological 
replicates of isolated RNA were analyzed (2.15). The third replicate, which was kindly provided 
by Albert Müller, did not comprise a RNA sample from a non-infected culture. 
 
The Platinum® SYBR® Green qPCR SuperMix-UDG Kit was used for amplification following 
the manufacturer`s instructions by applying cDNA to the reaction mixture. 
 
Table 16. Specific primers for qPCR were designed using the online tool Primer3plus 
 
 
*Ta: annealing temperature 
HPLC: High Performance Liquid Chromatography, technique for primer purification, purity of the 
oligonucleotide >80% 
 
 
2.29.1 Preparation and calculation of qPCR standards by TOPOTM XL cloning 
 
All qPCR runs had to include internal standards for the quantification of unknown samples. As 
the 16S rRNA gene and the gene for pc1489 were subjected to detailed transcriptional analysis, 
standards for these genes had to be included in the whole process. 
 
Plasmids for each involved gene were prepared by TOPOTM XL cloning following the 
manufacturer`s instructions, and the plasmid copy number was calculated according to the 
molecular weight (Table 17). A dilution series was produced and the most appropriate dilutions, 
ranging from 109 to 102, were chosen as standard in qPCR. 
 
 
Primer 
name 
Target molecule 
Size of 
amplicon 
Primer sequence (5´-3´ end) Comments* 
q16S_R 16S rRNA gene of 
P. amoebophila 
88 bp TTC CAA CCG TTA TCC CAG AG 
HPLC 
Ta=60°C 
q16S_F GCA AGT CGA ACG AAA CCT C 
q1489_R pc1489 gene of P. 
amoebophila 
143 bp CAG CCC CAA TTT ACA GAA GC 
q1489_F TGG AAC CAA AAA GCT CCA TC 
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Table 17. Calculation of plasmid copies of the 16S and pc1489 standard plasmids 
 
Gene fragment 
Concentration of isolated 
recombinant TOPO XL 
Molecular weight in 
kilo Daltons (kDa) 
TOPO XL plasmid 
copies per µl 
16 S rRNA 451 ng /µl 2988 9.1 E+13 
pc1489 323 ng/µl 2952 6.6 E+13 
 
 
 
2.29.2 Plate setup for qPCR 
 
All standards for the 16S rRNA gene, the pc1489 gene as well as the unknown cDNA samples 
from the infectious cycle had to be analyzed on one plate during a single run in order to produce 
comparable results. Each reaction was performed in duplicates. 
 
 
 
            
 16S 1 109 
16S 1 
109  
1489 1 
109 
1489 1 
109  
16S 1 
0 hpi 
16S1 
0 hpi 
1489 1 
0 hpi 
1489 1 
0 hpi  
 16S 2 108 
16S 2 
108  
1489 2 
108 
1489 2 
108  
16S 2 
24 hpi 
16S 2 
24 hpi 
1489 2 
24 hpi 
1489 2 
24 hpi  
 16S 3 107 
16S 3 
107  
1489 3 
107 
1489 3 
107  
16S 3 
48 hpi 
16S 3 
48 hpi 
1489 3 
48 hpi 
1489 3 
48 hpi  
 16S 4 106 
16S 4 
106  
1489 4 
106 
1489 4 
106  
16S 4 
96 hpi 
16S 4 
96 hpi 
1489 4 
96 hpi 
1489 4 
96 hpi  
 16S 5 105 
16S 5 
105  
1489 5 
105 
1489 5 
105  
16S 5 
neg 
16S 5 
neg 
1489 5 
neg 
1489 5 
neg  
 16S neg1 
16S 
neg2  
1489 
neg1 
1489 
neg2  
16S 6 
-RT 
16S 6 
-RT 
1489 6 
-RT 
1489 6 
-RT  
 
            
 
Figure 5. Plate setup for qPCR used in this study 
 
    primers q16S R+F 
    primers q1489 R+F 
    no template 
109 – 105: dilution series of standards, 0 h p.i. – 96 h p.i.: unknown samples of infectious cycle 
 
 
 
 
 
2 Material and Methods 
48 
2.29.3 qPCR program 
 
Since primer concentrations and annealing temperatures had to be optimized first, a gradient 
PCR was performed as described in 2.27.1. Further, the optimal template concentration had to be 
tested in a qPCR pre-run. 
The following qPCR program was designed for transcription analysis, including a melt curve 
after amplification of the gene fragments. Camera recording and data collection took place during 
cycle 2. 
 
qPCR program for the primer pairs q16S R+F and q1489 R+F 
Cycle Temperature (°C) Time Repeats 
1 95 3 min 1 
2 
95 40 sec 
35 60 30 sec 
72 30 sec 
3 72 1 min 1 
4 95 30 sec 1 
5 55 30 sec 1 
6 55-95 10 sec 80 
 
 
Each run included a negative control (NTC) containing H2Odd as template in the reaction mix. In 
order to create an additional negative control, single-stranded RNA was used as template in one 
qPCR reaction. Since this RNA sample has not been treated with reverse transcriptase during 
RT-PCR, no amplicons were expected after qPCR. 
For interpretation and further analysis of the qPCR results the iCycler software was used. 
 
 
 
2.30 Purification of PCR products 
 
PCR products were purified in order to remove reaction mix components that could disrupt 
subsequent DNA measurements, cloning and sequencing. Purification was achieved by using the 
QIAquick PCR purification Kit according to the manufacturer´s instructions. Elution of DNA 
was carried out by placing the spin column into a clean reaction tube, adding 30 μl H2Odd to the 
center of the membrane and centrifugation for 1 min at maximum speed. 
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2.31 DNA Sequencing 
 
PCR products were sequenced by Christian Baranyi using an ABI 3130xl DNA sequencer and 
the BigDye Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems). This kit is based on 
Sanger’s chain-termination dideoxynucleotide method for sequencing, leading to termination of 
DNA synthesis after incorporation of a di-deoxynucleotide (ddNTP). The mix contains 
deoxynucleotides (dNTPs) as well as ddNTPs linked to different fluorescent dyes. Incorporation 
of a ddNTP results in termination of DNA synthesis, caused by lacking of the 3’OH-group which 
is necessary for elongation of the strand by DNA polymerase. DNA-fragments of different sizes 
are separated electrophoretically and recognized by a laser. The same primers as for standard 
PCR analysis were used at a concentration of 10 pmol/µl. Proof-reading of the sequences had to 
be done manually using the FinchTV software and subjected to BLAST search 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
The porin sequences analyzed during this work all consist of a length of about 1000 bp, thus, 
they all required sequencing from both directions to finally obtain a reliable sequence. After 
proof-reading of the output data of DNA sequencing the corresponding forward and reverse 
sequences were put together and translated into the amino acid sequence. The obtained sequence 
was compared to the original genomic data of the analyzed gene. 
 
 
2.32 2-Step-Cloning of gene amplificates 
 
2.32.1 Vectors and vector maps 
 
Table 18. Vectors used in this study 
Plasmid Manufacturer Size Characteristics Antibiotic resistance 
Addition of 
bases for 
primer desgin 
pet21b Novagen 
5442 
basepairs 
(bp) 
10x His-Tag at C-terminus 
T7 promoter 
Ampicillin +1 
pet16b Novagen 5711 bp 
10x His-Tag at N-terminus 
T7 promoter 
Ampicillin - 
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*Gene expression using the vector pgEX-4T-3 leads to a fusion of the N-terminus of the expressed gene with the 
GST-tag. This GST-tag has a molecular weight of 26 kDa, therefore a band of higher molecular weight had to be 
expected for the fusion protein (Table 20). 
 
 
 
 
All vetor maps (Figure 6 - Figure 9) were produced by using the software “Clone Manager”. The 
Ampicillin-resistance gene and the tag are marked with red arrows, the multiple cloning site 
(MCS) with a blue square. Not all restriction sites were included in the vectors maps. 
 
 
 
 
 
Figure 6. Vector map of the empty expression vector pet21b 
 
 
 
pQE-30 Qiagen 3461 bp 
6x His-Tag at N-terminus 
T5 promoter 
E. coli M15 for 
overexpression 
Ampicillin +1 
pgEX-4T-3* Amersham 4968 bp 
Glutathion-S-Transferase 
(GST)-Tag at N-terminus 
tac promoter 
Ampicillin +2 
TOPO XL Invitrogen 3519 bp M13 binding sites Kanamycin - 
pet21b 
5442 bps 
1000 
2000 
3000 
4000 
5000 
StyI 
AvaI 
XhoI 
NotI 
Eco52I 
HindIII 
SalI 
Ecl136II 
SacI 
EcoRI 
BamHI 
EcoNI 
BclI 
ApaI 
EcoRV 
SapI 
AhdI 
BsaI 
PstI 
ScaI 
6x His 
MCS 
Ampicillin 
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Figure 7. Vector map of the empty expression vetor pet16b 
 
 
 
 
 
 
 
Figure 8. Vector map of the empty expression vector pQE-30 
 
 
 
pQE 
3461 bps 
500 
100 
150 200 
250 
300 
Xho EcoR 
BamHI 
Sph BanII 
Ecl136II 
Sac Acc65I 
Kpn SmaI 
XmaI 
HincI Sal BspMI 
Pst HindII Bpu1102I 
Nhe 
Msc 
Xba 
BsaA Nde Sap 
BsaI 
Vsp 
Fsp 
Pvu 
Xmn 6xHis 
MCS 
Ampicillin 
pet16b 
5711 bps 
1000 
2000 
3000 
4000 
5000 
HindIII 
BamHI 
XhoI 
NdeI 
XbaI 
SphI 
MluI 
ApaI 
HpaI 
NruI 
MscI 
AccI 
SapI 
AhdI BsaI 
PstI 
ScaI 
EcoRI 
MCS 
6x His 
Ampicillin 
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Figure 9. Vector map of the empty expression vector pgEX-4T-3 
 
 
2.32.2 E. coli strains 
 
Table 19. Competent E. coli strains used in this study 
*electrocompetent E. coli strain 
Strain Source Genotype 
Reference/ 
Source 
Comment 
TOP10 Invitrogen 
F- mcrA _(mrrhsdRMS-mcrBC) 
Φ80lacZ_M15_lacX74 recA, ara139 
_(araleu), 7697 galU galK rpsL 
(StrR) endA1 nupG 
TOPO® XL 
cloning kit  chemical competent 
BL21 (DE3) Stratagene 
F– ompT hsdSB(rB– mB–) gal dcm 
(DE3) 
(Studier and 
Moffatt, 
1986) 
* 
C43 (DE3) Avidis 
F- dcm ompT gal hsdSB (rB- mB-) 
lon _DE3 
(Miroux and 
Walker, 
1996) 
for overexpression of 
outer membrane 
proteins * 
M15 [pREP4] Qiagen 
derived from E. coli K12 - NaIS, 
StrS, RifS, Thi–,Lac–, Ara+, Gal+, 
Mtl–, F–, RecA+, Uvr+, Lon+. 
(Blattner et 
al., 1997) 
for overexpression of 
proteins cloned into the 
vector pQE-30 * 
Rosetta (DE3) 
pLysS 
Novagen 
F– ompT hsdSB(rB– mB–) gal dcm 
(DE3) pLysSRARE2 (CamR) 
(Kane, 1995) encodes rare codons * 
XL1blue Stratagene 
recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)] 
(Bullock, 
1987) 
for maintenance of 
recombinant plasmids* 
pGEX-4T-3 
4968 bps 
1000 
2000 3000 
4000 
BspMI 
EcoNI 
MscI 
SwaI 
BamHI 
EcoRI 
SmaI 
XmaI 
AccI 
SalI 
XhoI 
NotI 
Eco52I BsaAI 
PstI 
MluI 
ApaI 
EcoRV 
NarI 
Bsu36I DsaI 
GST 
MCS 
Ampicillin 
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All E. coli strains described in Table 19, except E. coli TOP10, were available as 
electrocompetent cells (Miller and Nickoloff, 1995). The strain XL1blue was used for 
amplification, preparation and maintenance of vectors and recombinant plasmids. The other 
strains are common expression strains suitable for heterologous expression of proteins. 
All used expression strains feature a protease-deficiency in order to prevent degradation of the 
heterologously produced proteins. The E. coli strain C43 features a dampened overexpression 
rate favorable for expressing outer membrane proteins.  
 
 
2.32.3 Preparation of PCR-products 
 
After amplification of the genes of interest using the High Fidelity polymerase and the specific 
primers (Table 13 and Table 14), reactions were controlled on an agarose gel, pooled and finally 
purified using the QIAquick PCR Purification Kit. 
 
Table 20. Sequence length and molecular weight of the four members of the putative porin family 
 
 
2.32.4 TOPOTM XL cloning 
 
The purified PCR products were cloned using the TOPO® XL Cloning Kit following the 
manufacturer`s instructions. Transformed E. coli TOP10 cells were grown on LB+Kan plates at 
37°C o/n. 
 
2.32.5 Screening for recombinant clones – Insert screening via M13 PCR 
 
The recombinant cells, grown on LB+Kan cells, were screened for the presence of a plasmid 
containing the desired PCR-product as insert.  
Porin Sequence length (bp) 
Protein size 
(kDa) 
Protein fused with 
GST-tag (kDa) 
Leader 
sequence (bp) 
cut between 
amino acid 
pc0870 891 34 60 60 21 + 22 
pc1077 1038 39 65 66 20 + 21 
pc1489 945 36 62 63 21 + 22 
pc1860 978 37 63 60 22 + 23 
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For M13-screening 10 to 20 clones of each E. coli transformation were picked and screened with 
the primer pair M13 R+F (Table 11). The primers bind to the flanking regions of the insert site 
on the vector, therefore allowing amplification of the insert and finally an estimation of the insert 
size. The reaction mix and the conditions were the same as for standard PCR except the volume 
of Aquabidest.. Recombinant E. coli cells were used as template. Therefore, a colony was picked 
using a sterile toothpick, stroke out on a masterplate and suspended in 25 µl of PCR water. After 
adding the PCR reaction mixture the microtiterplate was sealed with a thermostable foil and PCR 
was started. 
PCR products were analyzed on a 1% agarose gel to detected clones with an insert of correct size 
for further analyses. Selected PCR products were sequenced as described in 2.31. 
 
2.32.6 Double digestion of recombinant plasmids 
 
Plasmids containing a validated insert were digested using the according restriction enzymes and 
buffers (see Table 7 and Table 8).  
 
Digestion reaction mixture 
Vector 2 µg 
Buffer, see Table 8 2.5 µl 
Enzyme, see Table 7 0.5 µl 
H2Odd up to 25 µl 
 
The reaction mixture was incubated for 3 hours in a water bath at the appropriate temperature. 
Afterwards the temperature was shifted to 65°C for 20 min leading to inactivation of the 
restriction enzyme. Next, the second enzyme was added following the same procedure, including 
an incubation and an inactivation step. 
 
2.32.7 Double digestion of empty vectors 
 
The empty expression vector was isolated as described in 2.20.2 and digested with the same 
restriction enzymes as the corresponding PCR product. The same digestion procedure was 
conducted as for double digestion of recombinant plasmids. 
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2.32.8 Ligation of empty vectors and target gene amplificates 
 
The PCR-products as well as the vectors were cut with the according restriction enzymes 
resulting in complementary ends of the vector and the PCR-product. This complementary ends 
were necessary for ligation and correct insertion direction of the PCR-product into the vector. 
 
Since double digestion produced sticky ends, a ligation reaction using T4-DNA-ligase could be 
performed. In order to ensure an excess of PCR products compared to the vector, a ratio of 3:1 
(insert:vector) was used. 
 
Ligation reaction mixture (20 μl) 
5x Ligase Buffer  4 µl 
ATP 1 µl 
Vector, double digested x µl 
Insert, double digested x µl 
T4 DNA Ligase  1 µl 
H2Odd up to 20 µl 
The reaction was incubated at 4°C o/n. 
 
In order to stop ligation and to get rid of ions, dialysis against H2Odd was performed for 20 min 
by using a nitrocellulose filter (pore size 0.025 μm). 
 
 
 
2.33 Transformation of electrocompetent E. coli cells 
 
One common method for the transformation of plasmid DNA into bacterial cells is 
electroporation. The bacterial cell membrane gets permeable for charged molecules by a short 
electric impulse.  
 
Solutions 
SOC medium 
electrocompetent E. coli cells (Table 19) 
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Procedure 
The dialyzed ligation reaction was used for transformation of electrocompetent E. coli XL1blue 
cells. Cells were thawed on ice for 10 min and then 5 µl of the ligation reaction were added. 
After stiring carefully, the cells were incubated on ice for 30 min, followed by electroporation. 
The electrical impulse was carried out at the following parameters: voltage of 2.5 kV, capacity of 
25 mF, resistance of 200 Ω, with a time for the electric discharge of 4.5 to 5 msec.  
 
After electroporation, 250 μl of SOC medium were added and the suspension was incubated for 1 
h at 37°C on an orbital shaker. Finally, 100 and 150 μl of the suspension were plated on LB 
plates containing the appropriate antibiotics depending on the vector and the E. coli strain. The 
plates were incubated at 37°C o/n. 
 
 
2.34 Identification of positive clones – Insert screening via T7/ pQE/ pgEX 
PCR 
 
Screening for positive clones was done as described in 2.32.5, except of using the primer pairs 
T7/ pQE/ pgEX R+F (Table 11) instead of the M13 primers. 
 
 
2.35 Heterologous expression of proteins in different E. coli strains 
 
Extraction of sufficient amounts of protein from a homologous system is difficult in general. To 
address this problem, proteins are expressed in a heterologous expression system, like E. coli. 
Vectors and E. coli strains used for the heterologous expression of target genes are listed in Table 
18 and Table 19.  
 
 
 
Table 21. Optimal conditions for successful porin overexpression in the vectors pQE-30 and pgEX-4T-3 
 
pc0870 
Vector  E. coli strain  Leader sequence  Tag  
pQE 30  M15  no  His  
pgEX  C43  yes  GST  
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pc1077 
Vector  E. coli strain  Leader sequence  Tag  
pQE 30  M15  no  His  
pgEX  C43  yes  GST  
 
pc1489 
Vector  E. coli strain  Leader sequence  Tag  
pgEX  C43  yes  GST  
 
pc1860 
Vector  E. coli strain  Leader sequence  Tag  
pQE 30  M15  OmpT  His  
pgEX  C43  yes  GST  
 
 
Solutions 
LB medium 
TB medium 
IPTG stock solution 
 
Procedure 
For protein overexpression, 5 ml of LB medium containing the suitable antibiotics were 
inoculated with an o/n culture of an E. coli expression strain containing the recombinant plasmid. 
Cells were grown at 37°C on an orbital shaker for 2 hours or until an OD of 0.5-0.6 was reached. 
Protein expression was induced by adding IPTG to a final concentration of 1 mM in the medium. 
A negative control without IPTG induction was prepared in parallel and both approaches were 
incubated on an orbital shaker for 2, 4 or 6 hours at 37°C or 20°C. 
1.5 ml of cell suspension were harvested by centrifugation (7323x g, 10 min, 4°C). The cell 
pellet was either stored at -20°C until further analysis or directly resuspended in 4x SDS-PAGE 
loading buffer for loading on an SDS-PAGE gel. 
For protein purification (2.36) larger amounts of induced cell culture were required. Therefore, 
cells were grown in 300 ml or 1 l of liquid medium, depending on the rate of the overexpression 
at small scale. 
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2.36 Purification of His-tagged proteins 
 
The 6x histidine tag (His-tag) encoded on the vector or the primer and located at the N-terminal 
part or C-terminus of the expressed protein allows the purification of the expressed protein via 
immobilized metalaffinity chromatography. 
 
Solutions 
Binding buffer (20 mM Imidazol) 
25x Protease Inhibitor  
Benzonase 
Elution buffers A/B/C/D (60 /100/300/500 mM Imidazol) 
20% Ethanol 
8M Urea 
 
2.36.1 Sample preparation from E. coli cell cultures for purification of His-tagged 
proteins 
Protein overexpression in E. coli might result in aggregation of inclusion bodies containing the 
desired protein. Hence pre-experiments with and without urea had to be done prior to the final 
purification in order to determine if urea had to be included in all the buffers for purification. 
 
For protein purification larger amounts of cell cultures (up to 1 l) were required. Cells were 
grown in liquid media and overexpression was induced as described above (2.35).  
After harvesting of the cells pellets were resuspended in 5-10 ml binding buffer per 1g cell pellet 
and treated with protease inhibitor to prevent protein degradation. The suspensions were pooled 
in a 50 ml Greiner tube and sonicated 5 times for 1 min with 0.9 sec pulse and 60-70% power. 
During sonication, the cell suspension was kept on ice. Volume was adjusted to 10 ml by adding 
binding buffer and additionally 100 µl protease inhibitor. After centrifugation (7323x g, 30 min, 
4°C) the supernatant was used for further analysis. 
 
2.36.2 Purification of His-tagged proteins using Amersham HisTrap HP Columns 
This protocol is based on protein binding to a Ni2+ matrix via the His-tag of the overexpressed 
proteins. The Amersham HisTrapHP column was used according to the manufacturer`s 
instructions.  
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Protein elution was achieved by the addition of increasing concentrations of imidazole, which 
features a strong chelating nature and therefore competes with the proteins for binding to the 
matrix. 
Protein purification was performed following the instructions of the manufacturer using 8 M urea 
if necessary. 
Collected fractions were controlled on a SDS-PAGE gel and the fraction containing the highest 
amount of protein according to the band intensities was chosen. 
 
 
2.37 Dialysis and precipitation of purified protein fractions 
 
As 8M urea and imidazol could be harmful for animals during antibody generation, the selected 
protein fractions were dialyzed and finally precipitated. 
 
Solutions 
1x PBS 
ice-cold acetone 
 
Procedure 
Fractions of eluted proteins that had been collected during protein purification were transferred to 
a dialysis tube for dialysis against 1x PBS. The first 30 min of dialysis were carried out at room 
temperature on a magnetic stirrer, followed by buffer change and continuing dialysis at 4°C o/n. 
Ice-cold acetone was added at a ratio of 4:1 to the dialyzed fractions and proteins were 
precipitated for at least 6 hours or o/n at -20°C.  
Finally, the precipitated proteins were harvested by centrifugation (10621x g for 15 min at 4°C), 
resuspended in an appropriate amount of 1x PBS and stored at 4°C. 
 
 
2.38 Quantification of purified proteins with the BCATM Protein Assay Kit 
 
Protein concentrations were measured using the BCATM Protein Assay Kit following the 
manufacturer`s instructions. This Kit is based on the use of bicinchoninic acid (BCA) for the 
colorimetric detection and quantification of total protein.  
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It combines the reduction of Cu2+ to Cu1+ by proteins in an alkaline medium with the colorimetric 
detection of the cuprous cation (Cu1+). The purple-colored reaction product of this assay is 
formed by the chelation of two molecules of BCA with one Cu1+. 
 
Procedure 
Standards were prepared as suggested by the manufacturer. The protein content of different 
fractions was determined using the enhanced protocol, implying incubation of protein samples 
and reagent for 30 min at 60°C according to the manufacturer’s instructions. All standards as 
well as the samples were measured at a wavelength of 562 nm with a spectral photometer. After 
plotting a standard curve of known protein concentrations, this curve was used to determine the 
unknown protein concentration of the samples.  
All measurements were performed in duplicates using the mean absorbance for the determination 
of protein concentrations. 
 
 
2.39 Sample preparation for the identification of proteins by mass 
spectrometry 
 
In order to guarantee the identity of proteins which were present in the bands of SDS-PAGE gels 
after His-trap purification, bands of interest were excised from the gel. The samples were 
prepared and analyzed by linear quadrupole ion trap mass spectrometry (LTQ). 
 
Solutions (all buffers and solutions were prepared right before use) 
10% (v/v) and 0.1% (v/v) trifluoroacetic acid (TFA) 
50 mM ammonium bicarbonate (ABC) 
Acetonitrile (ACN) 
Alkylation buffer (10 mg/ml iodacetamide in 50 mM ABC) 
Destaining solution (100 µl 50 mM ABC + 80 µl ACN) 
Reduction buffer (10 mM DTT in 50 mM ABC) 
Trypsin gold working solution: 
Trypsin gold was dissolved in 50 mM acetic acid to yield a concentration of 100 ng/µl 
and aliquots were stored at -80°C. Immediately before use, one aliquot of 10 µl was 
thawn and diluted by addition of 70 µl ABC-buffer leading to a final concentration of 
12.5 ng/µl. 
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Procedure  
All incubation steps were performed on a rocking platform at room temperature (RT), if not 
stated otherwise. 
 
Bands of interest were excised from Coomassie stained SDS-PAGE gels, transferred to screw 
caps and either stored at -80°C until further use or processed immediately for mass spectrometry. 
Gel bands were cut into small pieces, washed three times in 200 µl H20dd and destained by 
adding 100 µl destaining solution. This solution was replaced every 15 min, resulting in a 
completely destained gel. Thereafter, the gel pieces were incubated for 5 min in acetonitrile. 
ACN was removed and bands were vacuum-dried for 5-10 min at room temperature. 
 
The disulfide bonds of the proteins were reduced by using 200 µl reduction buffer for 30 min at 
56°C, followed by incubation in 160 µl ACN for 5 min. ACN was removed and 100 µl 
iodacetamide were added causing alkylation of the proteins. After 20 min incubation in the dark 
the samples were washed 3 times with 200 µl ABC, gel bands were dehydrated with 160 µl ACN 
and vacuum-dried. 
 
20 µl trypsin gold working solution were added to each dried sample and rehydration was carried 
out for 10 min at 4°C. Afterwards, residual trypsin solution was removed, samples were covered 
with ABC-buffer and tryptic digestion was performed overnight at 37°C (12-16 h). The reaction 
was stopped by addition of 2 µl 10% TFA resulting in 1% final TFA concentration.  
Peptides were extracted by sonication for 10 min in a cooled sonication waterbath. The peptide 
solution was transferred to a clean tube and the sonication step was repeated by adding 10 µl 
0.1% TFA to the sample. The peptide extracts were pooled and stored at -80°C prior to nano-
liquid chromatography matrix-assisted laser desorption-ionization (MALDI) - time of flight 
(TOF)/TOF (nanoLC-MS/MS) analysis. 
 
 
2.40 Protein analysis by nanoLC-MS/MS 
 
Chromatographic separation of peptides and measurements were carried out at the Institut für 
Biochemie und molekulare Zellbiologie der Universität Wien at the Vienna Biocenter by Dr. 
Dorothea Anrather. 
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For protein identification MS/MS spectra were matched against a custom designed database with 
Mascot version 2.2 (Matrix Science, London, UK). This database contained the protein 
sequences of P. amoebophila UWE25 and protein sequences availabe for other environmental 
chlamydiae. Since protein sequences of the host should also be considered, all availabe protein 
sequences for E. coli were included. Additionally a list of sequences of frequently found 
contaminants in MS samples, like trypsin, keratins and BSA, was included. 
 
 
2.41 Lipid bilayer measurements 
 
Lipid-bilayer measurments were performed at the laboratory of Prof. Roland Benz (Germany) 
according to previous studies (Hunten et al., 2005). After overexpression, purification and 
precipitation, the samples containing pc1077 and pc0870 were diluted 1:100 in 1 % Genapol. 
 
 
Figure 10. Principle of lipid bilayer measurements. This technique is based on measurements of conductance, 
which increases if a channel-forming protein is incorporated in an aritificial lipid-bilayer (Fig.9, B and C). The used 
apparature consists of two chambers (cis- and trans-chamber) which are connected by a small circular hole (Fig.9, 
A). Across this hole an artificial lipid-bilayer is formed, the protein to be investigated is added and pore-formation in 
the membrane is measured. Modified from (Benz, 2004). 
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2.42 Antibody generation against purified proteins 
 
Antibodies were produced by Eurogentec (Seraing, Belgium). Depending on the immunization 
program and the included animal different amounts of protein were needed for the immunization, 
including a first immunization and three additional boosts. 
 
Primary antibodies against the protein DnaK were raised in both chicken and guinea pig. 
Approximately 400 µg of the purified protein were used for the immunization of a chicken and 
300 µg for 2 guinea pigs. Primary antibodies against the porin pc1077 were obtained from an 
immunization program containing 2 rabbits. For this purpose, 800 µg of purified and dialyzed 
protein were needed in total. 
 
Pre-immune sera and pre-immune egg yolks obtained before the first antigen boost were 
provided as negative controls. Rabbit and guinea pig sera as well as egg-yolks were collected 
throughout the program. After the immunization program for the chicken and the rabbits had 
officially finished, an additional boost was ordered to improve the specificity and concentration 
of the generated antibodies. 
 
 
 
2.43 Purification of antibodies using a HiTrap™ IgY Purification HP column 
 
 
Solutions 
• Binding Buffer 
NaH2PO4 3.12 g 
K2SO4  87.13 g 
H2Odd ad 1000 ml 
pH 7.5  
 
• Elution Buffer 
NaH2PO4 3.12 g 
H2Odd ad 1000 ml 
pH 7.5  
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• Cleaning Buffer 
NaH2PO4 3.12 g 
Isopropanol 300 ml 
H2Odd ad 1000 ml 
pH 7.5  
 
Procedure 
IgY antibodies from the pre-immune egg yolks as well as from the consecutive egg yolk 
collections were purified with the help of a HiTrap™ IgY Purification HP column according to 
the manufacturer´s instructions except that just 6 column volumes instead of 10 were used as 
elution volume in order to get a higher concentration of antibodies in the eluat. 
According to the protocol using a pump and 50 ml syringes, the required buffer volumes were 
filled into a syringe, which was then inserted into a pump and fixed. With the help of a flexible 
tube and adaptors, the respective buffers were passed through a 1.2 µm and a 0.45 µm filter and 
loaded onto the column. The adjustments of the pump had to be set according the following 
parameters: rate: 5 ml/min, diameter of the 50 ml syringe: 27.8 mm. 
 
 
2.44 Inactivation of antibodies targeting amoeba proteins 
 
Amoebae are ubiquituous, hence a contamination of the sera with antibodies against amoebal 
proteins was considered. To avoid unspecific background in immunofluorescence experiments 
due to amoeba antibodies, all obtained sera were inactivated first against amoeba proteins. 
 
 
2.44.1 Preparation of amoeba lysate 
 
Solutions 
FA-block solution 
10x PBS 100 ml 
Bovine Serum Albumine (BSA)  20 g 
H2Odd  ad 1000 ml 
Aliquots can be stored at -20°C until further use. Upon thawing aliquots were stored at 4°C. 
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Procedure 
An A. castellanii Neff culture containing no endosymbiont was harvested by centrifugation (5 
min, 7323x g) and the pellet was resuspended in 500 μl – 1 ml FA-block solution, depending on 
the size of the pellet. In order to break up amoeba cells, the suspension was either sonicated 4 
times for 30 seconds or treated with two freeze-and-thaw steps (freezing at -20°C/ thawing at 
42°C in a water bath). The resulting lysate was stored at -20°C and when needed, thawed at 37°C 
in a water bath. 
 
2.44.2 Blocking of antibodies 
Antibody sera were mixed 1:1 with amoeba cell lysates, vortexed briefly and incubated at 4°C 
o/n. On the following day the solution was mixed again and incubated for another 30 min at 4°C. 
Amoeba cell debris which had bound the host-reactive antibodies was removed by centrifugation 
for 2 min at 6797x g. The supernatant containing the unbound protein-specific antibodies was 
transferred to a new tube and used for further analysis. 
 
 
2.45 Fixation of cells 
 
Fixation of the samples is an essential step to preserve the morphology of cells for microscopic 
examination. The fixative to be used depends on the cell type that should be analyzed. 
In this study, cells were fixed either with PFA, which cross-links cell constituents, thereby 
stabilizing the cells, or with Methanol. 
 
2.45.1 Cell fixation with 4% PFA 
 
Solutions 
4% PFA 
1x PBS 
 
Procedure 
A 24-well plate was prepared by placing round steril cover slips into each well. A well grown 10 
ml amoeba culture, either uninfected or harboring chlamydial endosymbionts, was harvested by 
shaking.  
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1 ml of cell suspension was pipetted into each well of the 24-well plate and the amoeba cells 
were allowed to attach to the surface of the cover slip o/n. 
On the next day, the medium was aspirated off and each well was washed with 500µl 1x PBS. 
Then 500 µl 4% PFA were added and cells were fixed for 1 h at RT. After this incubation the 
fixative was removed, each well was washed once with 1x PBS and fixed cells were stored in 1x 
PBS up to 2 weeks at 4°C. 
 
2.45.2 Cell fixation with Methanol 
 
Solutions 
Methanol 
1x PBS 
 
Procedure 
The amoebal cells were prepared in the same way as for cell fixation with 4% PFA, with the 
exception that the cells were fixed for 10 min with methanol. 
 
 
2.46 Primary and secondary antibodies 
 
The immunofluorescence (IF) technique used is an indirect assay. The antigen-specific primary 
antibody is not fluorescently labeled but the secondary antibody, which binds to the primary 
antibody, is conjugated to a fluorescent dye.  
The optimal dilutions of the primary antibodies were determined empirically using several 
dilutions. 
 
 
Table 22. Primary antibodies used in this study 
 
Primary 
antibody 
Antigen Source of 
antibody 
Dilution Reference/ 
Manufacturer 
anti -Pam P. amoebophila elementary bodies rabbit 1 : 2000 (Heinz, 2008) 
anti -Pam P. amoebophila elementary bodies chicken 1 : 2000 (Heinz, 2008) 
anti- DnaK pc1499, overexpressed in E. coli guinea pig 1 : 2000 
this study 
anti- DnaK pc1499, overexpressed in E. coli  chicken 1 : 1000 
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preI DnaK 
(pre-immune 
serum) 
none guinea pig 1 : 2000 
this study 
preI DnaK 
(pre-immune 
serum) 
none chicken 1 : 1000 
anti- pc1077 pc1077 without leader sequence rabbit immunization program not 
fnished at the end of this work preI pc1077 none rabbit 
anti- GST 
Glutathion-S-Transferase rabbit 1:10000 Sigma-Aldrich 
Chemie GmbH, 
Steinheim, 
Germany 
anti- His 
Histidine mouse 1 : 1000 Novagen, 
Darmstadt, 
Germany 
anti- Hsp60 
Hsp60 of Chlamydophila caviae 
GPIC 
guinea pig 1 : 2000 (Yuan et al., 1992) 
anti- pc1489 pc1489 purified from EBs chicken 1 : 2000 (Aistleitner, 2009) 
 
 
 
Table 23. Secondary antibodies used in this study 
 
Secondary 
antibody 
Antigen Modification 
Source of 
antibody 
Dilution Manufacturer 
anti- chicken chicken IgY Cy3 donkey 1 : 1000 
Dianova GmbH, 
Hamburg, 
Germany 
anti- chicken chicken IgY Cy2 donkey 1 : 1000 
anti- chicken chicken IgY HRP goat 1 : 10000 
anti- guinea pig 
guinea pig IgG 
(heavy chains) 
Cy3 
goat 1 : 1000 
anti- guinea pig 
guinea pig IgG 
(heavy chains) 
Cy2 
goat 1 : 1000 
anti- guinea pig 
guinea pig IgG 
(heavy chains) 
HRP 
goat 1 : 10000 
anti- rabbit rabbit IgG FITC goat 1 : 1000 
anti- rabbit rabbit IgG Cy5 goat 1 : 10000 
anti- rabbit rabbit IgG Cy3 goat 1 : 1000 
anti- rabbit rabbit IgG 
Cy2 
goat 1 : 1000 
GE Healthcare 
Bio-Sciences 
AB, Uppsala, 
Sweden 
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anti- rabbit rabbit IgG HRP goat 1 : 500000 Sigma-Aldrich 
Chemie GmbH, 
Steinheim, 
Germany 
anti- mouse mouse IgG Fc 
fragment 
HRP 
goat 1 : 10000 
 
Cy3: Indocarbocyanine 
Cy2: Carbocyanine 
Cy5: Indocarbocyanine 
FITC: Fluorescein 
HRP: Horseraddish-Peroxidase 
 
 
 
2.47 Indirect immunofluorescence assay 
 
The assay was performed with amoebal cultures containing chlamydial endosymbionts. 
Amoebae, devoid of endosymbionts, were used as negative controls. 
Pre-immune sera, which were obtained prior to immunization of the respective animal, were 
tested to verify the specificity of the antibodies. 
 
Solutions 
1x PBS 
10 mM Tris-HCl (pH 6.5) 
0.05% TweenTM 20 in 1 x PBS  
4% PFA 
FA-block solution 
Mowiol: 
2.4 g Mowiol 4-88 were mixed with 6 g glycerine and 6 ml H2Odd. After adding 12 ml 0.2 M 
Tris-HCl (pH 8.5) the solution was stirred at 50-60°C until the Mowiol had dissolved 
completely. The solution was centrifuged at 7700x g for 15 min to remove air bubbles and 
the supernatant was collected and stored in aliquots at -20°C until further use. 
 
Procedure 
The following steps were performed at RT and all incubation steps were carried out on a shaking 
platform. 
Already fixed cells were used for immunofluorescence analysis. Using methanol as a fixative, the 
cells could be directly incubated with 500 µl FA-block solution, whereas PFA fixed cells had to 
undergo a pre-treatment to permeabilice the cells.  
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1x PBS was removed and cells were incubated in 300 µl 0.05% TweenTM 20 in 1x PBS for 25 
min. After removing Tween from each well, 300 µl 10 mM Tris-HCl containing 5 µg/ml 
lysozyme were added and cells were incubated for 1 h. The permeabilized PFA fixed cells as 
well as the methanol fixed cells were covered with 500 µl FA-block solution in order to block 
unspecific binding sites. The blocking solution was initially replaced by the primary antibody 
(Table 22), appropriately diluted in FA-block solution, and incubated for 1 h to allow specific 
binding of the antibody. Cells were washed 3 times with 500 µl 1x PBS, followed by addition of 
the secondary antibody (Table 23), diluted in FA-block solution. After another hour of incubation 
in the dark, the secondary antibody was finally removed and the cells were again washed with 1x 
PBS as before. The cover slips were embedded in 1.5 µl Mowiol, placing the cover slips face-
down on a glass slide, and stored in the dark at RT until further analysis by epifluorescence 
microscopy. 
 
 
2.47.1 Immunofluorescence analysis of E. coli cells 
 
Solutions 
Methanol 
4% PFA 
FA-block solution 
1x PBS 
Citifluor 
 
Procedure 
Fixation of E. coli cells was carried out as described in 2.45 using a multiwell microscopic slide 
for fixation. 15 µl aliquots of E. coli cultures were pipetted onto one well, incubated for 20 min 
and finally fixed with the desired fixative. 
The procedure for immunofluorescence was carried out as already depicted in 2.47, with the 
slight modification that incubation steps were not performed on a shaking platform but in a 
humid chamber. Furthermore, washing steps were reduced to one time washing with 1x PBS. 
Antibodies against the GST tag of overexpressed proteins and against general outer membrane 
structures of P. amoebophila are listed in Table 22. 
Finally, slides were dried and stored in the dark until further analysis by epifluorescence 
microscopy. Slides were embedded in Citifluor and then stored at 4 °C. 
2 Material and Methods 
70 
2.48 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS – 
PAGE) 
 
Solutions 
• Lower buffer 
Tris – HCl   90.8 g 
10% (m/v) Sodium dodecyl Sulfate (SDS)  20 ml 
H2Odd  ad 500 ml 
pH 8.8 
 
• Upper buffer 
Tris - HCl   30.3 g 
10% SDS   20 ml 
H2Odd  ad 500 ml 
pH 6.8 
 
• 10 x SDS-PAGE running buffer 
Tris - HCl  30.2 g 
Glycine   144 g 
SDS  10 g 
H2Odd   ad 1000 ml 
 
• 4 x SDS - PAGE loading buffer  
Tris-HCl pH 6.8  2.42 g 
SDS  8 g 
Bromphenolblue  0.02 g 
Glycerol  40 µl 
Dithiothreitol (DTT)   6.2 g 
H2Odd   ad 100 ml 
 
 
Procedure 
First, a 12.5% polyacrylamid gel was prepared according to the following standard protocol for 2 
small gels: 
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Separating gel 
Lower buffer 
H2Odd 
Rotiphorese®NF-30%(w/v) Acrylamide/Bisacrylamide-solution 
10% (w/v) Ammoniumpersulfat (APS) 
N,N,N´,N´-tetramethylethane-1,2-diamine (TEMED) 
 
2 ml 
2.66 ml 
3.33 ml 
40 µl 
8 µl 
Stacking gel 
Upper buffer 
H2Odd 
Acrylamid/bisacrylamid solution 
10% APS 
TEMED 
 
0.63 ml 
1.63 ml 
0.38 ml 
17.5 µl 
10 µl 
 
 
For gel preparation four glass plates were set up in a BioRad Mini-PROTEAN casting stand. 
First, the separating gel was prepared. APS and TEMED were added at last to initiate 
polymerization. The solution was poured between two glass plates to about 3 cm below the rim 
and gels were overlayed with isopropanol to produce a smooth surface of the separating gel. 
After polymerization of the gel layer, the isopropanol was poured off and the stacking gel was 
prepared according to the standard reaction mixture. A layer of this solution was then applied on 
top of the separating gel and the combs were applied. Polymerized gels could either be wrapped 
in wet paper towels and saran wrap and stored at 4°C for a few days or used directly for SDS-
PAGE. 
 
For the separation of proteins, gels were inserted into a Mini-PROTEAN gel electrophoresis 
chamber filled with 1x SDS-PAGE running buffer. Pockets of the gel had to be rinsed shortly 
prior to application of the marker and the samples. Samples were heated to 95°C for 5 min before 
loading. Proteins were separated by applying a voltage of 60 – 110 V for 1.5 hours and the run 
was stopped when the marker front reached the bottom of the gel. The gel apparature was then 
dissembled and the stacking gel was removed from the separating gel. 
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2.48.1 Staining and destaining of SDS-PAGE gels using Coomassie brilliant blue 
staining solution  
 
Solutions 
• Coomassie brilliant blue staining solution  
Methanol 500 ml 
Acetic acid 100 ml 
Coomassie Brilliant Blue G-250 2.76 g 
H2Odd ad 1000 ml 
 
• Destaining solution  
Acetic acid 50 ml 
Ethanol  200 ml 
H2Odd ad 1000 ml 
 
Procedure 
After electrophoresis the separating gels were incubated in Coomassie brilliant blue staining 
solution for about 45 min on a rocking platform. Afterwards, the gels were transferred into 
destaining solution and destained on a rocking platform o/n. The gels were rinsed with H2Odd and 
digitalized by scanning. 
 
 
 
2.48.2 Fixation, staining and destaining of SDS-PAGE gels using colloidal Coomassie 
staining solution 
 
Solutions 
• Colloidal Coomassie solution 
(NH4)2SO4 100 g 
Orthophosphoric acid 20 g 
Methanol 250 ml 
Coomassie Brilliant Blue G-250 0.625 g 
H2Odd ad 1000 ml 
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• Fixing solution 
Ethanol 800 ml 
Acetic acid 200 ml 
H2Odd ad 2000 ml 
 
Procedure 
All following steps were carried out on a rocking platform.  
The separating gels were first rinsed with H2Odd for 5 min, followed by incubation in fixing 
solution for about 20 min. Gels were rinsed 2 times for 10 min in H2Odd and stained with 
colloidal Coomassie o/n. Gels were destained by rinsing them 2 times for 30 min in H2Odd and 
finally scanned.  
 
 
 
2.49 Western Blot analysis 
 
Solutions 
• Transfer buffer 
Glycine  2.9 g 
Tris-HCl  5.8 g  
Methanol 200 ml 
H2Odd ad 1000 ml 
 
• 10x TBS 
Tris-HCl  12.1 g 
NaCl 43.8 g 
H2Odd  ad 500 ml 
pH 7.5; store at 4°C 
 
• 1x TBS 
10 x TBS 100 ml 
H2Odd ad 1000 ml 
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• TBS-T 
10x TBS 50 ml 
Tween 20  0.5 ml 
H2Odd ad 500 ml 
store at 4°C 
 
• Developer and Fixer solution 
SIGMA Kodak GBX Developer 
SIGMA Kodak GBX Fixer 
Developer and Fixer were diluted as recommended by the manufacturer 
 
Procedure 
Proteins were separated according to 2.48. Separating gels were equilibrated in transfer buffer for 
about 15 min. In the meantime a polyvinylidene fluoride (PVDF) membrane and 2 pieces of 
extra thick Whatman paper were cut to a size corresponding to the seperating gel. Since the 
PVDF membrane had to be activated, it was shaken in methanol for 5 min, followed by rinsing 
with H2Odd for 5 min. The membrane and the Whatman paper had to be equilibrated in transfer 
buffer for 5 min prior to building up the “blotting sandwich” (consisting of one piece of 
Whatman paper – membrane – gel – Whatman paper). 
Transfer onto the membrane was performed by semi-dry blotting in a Trans-Blot® SD Semi-Dry 
Electrophoretic Transfer Cell, using settings as recommended by the manufacturer. 
 
To prevent unspecific binding of antibodies, the membrane was incubated in 5% non-fat dry milk 
in 1x TBS on a rocking platform o/n. Blocking of the membrane was followed by incubation in 
10 ml TBS-T containing the primary antibody (Table 22) for 1 hour. To remove excess primary 
antibody the membrane was washed 3 times in TBS-T for 15 min, followed by incubation in 
TBS-T with the corresponding HRP-labeled secondary antibody (Table 23) for 1 hour. After 3 
additional washing steps for 10 min the membrane was treated with the Western Lightning 
Chemiluminesence Plus kit as recommended by the manufacturer. The membrane was exposed 
to a photographic film in the dark. The film was then developed with Developer Solution, fixed 
with Fixer Solution and washed in H2O. Finally films were digitalized by scanning. 
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3 Results 
 
3.1 Characterization of novel porins from P. amoebophila 
 
3.1.1 Amplification of the genes encoding the putative porins pc0870, pc1077, pc1489 
and pc1860, including changes in the leader sequence 
 
After the design of specific primers (Table 13) for the genes of interest of P. amoebophila, a 
high-fidelity PCR was performed. Amplicons of the expected length were obtained for all genes, 
as listed in Table 20. 
 
3.1.2 2-step cloning and clone screening 
 
The four putative porins were cloned by following a 2-step cloning protocol (2.32). As a result, 
different constructs for overexpression experiments were obtained. Despite of low transformation 
efficiency, it was possible to verify at least two inserts with correct sequence and direction for 
each construct by several rounds of screening colonies from LB plates. 
 
Figure 11 shows an example of pairwise alignment of the obtained sequence of pc1077 without 
leader sequence in comparison to the original sequence of pc1077 from the online environmental 
chlamydia genome database (http://mips.helmholtz-muenchen.de/genre/proj/uwe25/). All 
constructs used for further overexpression experiments showed at least 99.6 % amino acid 
sequence similarity. 
 
 
 
                         10        20        30        40        50 
Seq1             MRKILLTIMASLLSCSAAQAFWPEATDSSLEVGFGYRRDELKWKTRTGLD 
                                     :::::::::::::::::::::::::::::: 
Seq2   FHTEFIKEEKLTMRGSHHHHHHGSACELGTFWPEATDSSLEVGFGYRRDELKWKTRTGLD 
               50        60        70        80        90       100 
 
               60        70        80        90       100       110 
Seq1   SSDSGYSAASPFGAQSTLKWKNLNIWQIEARGEYVTCDNVYLRASGDYGWIVSGKNRDSD 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Seq2   SSDSGYSAASPFGAQSTLKWKNLNIWQIEARGEYVTCDNVYLRASGDYGWIVSGKNRDSD 
              110       120       130       140       150       160 
 
              120       130       140       150       160       170 
Seq1   YINAGEESQLEISRTHAKTRGHVYDVDVALGYQFKLCDDSFSVTPVVGYSWKGQHLKDRH 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Seq2   YINAGEESQLEISRTHAKTRGHVYDVDVALGYQFKLCDDSFSVTPVVGYSWKGQHLKDRH 
              170       180       190       200       210       220 
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              180       190       200       210       220       230 
Seq1   LRFATSPIGESSSSSGLLRASSDYYDYSSSSSSSSSSNFHNRYNTRWNGPFVGVDFDYRI 
       : :::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Seq2   LGFATSPIGESSSSSGLLRASSDYYDYSSSSSSSSSSNFHNRYNTRWNGPFVGVDFDYRI 
              230       240       250       260       270       280 
 
              240       250       260       270       280       290 
Seq1   SCDLELFLDYEFHFAKYHAKADWKLRNDLPNGFHHRSKSSQGHVLDFGVKWDLDECWTLA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Seq2   SCDLELFLDYEFHFAKYHAKADWKLRNDLPNGFHHRSKSSQGHVLDFGVKWDLDECWTLA 
              290       300       310       320       330       340 
 
              300       310       320       330       340           
Seq1   LKGGIQYFHARRGHDRSLVTKTEVGNVDTKCFVSIPLRDVKWCSGSVTFDVGMAF      
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::      
Seq2   LKGGIQYFHARRGHDRSLVTKTEVGNVDTKCFVSIPLRDVKWCSGSVTFDVGMAFLQPSSTP 
              350       360       370       380       390       400 
 
 
Figure 11. Output from PIR- protein pairwise alignment, checking similarity of a sequence obtained after 2-step 
cloning of pc1077 to the original sequence of pc1077.  
The Alignment shows 99.692% (= 1 mismatch, shown in red) identity (99.692% ungapped) in 325 aa overlap. 
 
Seq1: pc1077, amino acid sequence obtained from the environmental chlamydia genome database 
Seq2: obtained sequence for pc1077 without leader sequence in the vector pQE, translated into amino acids using the 
Expasy Proteomic Tools (http://www.expasy.ch/tools/dna.html) 
 
M: Start-codon, HHHHHH: 6xHis-tag at N-terminus, derived from the vector, : start of sequence identity at amino 
acid 21, R-G: mismatch, STP Stop-codon 
Abbreviations for amino acids are used according to the NC-IUB 
 
 
 
3.1.3 Porin overexpression using different constructs in various E. coli strains 
 
Vectors containing the correct porin sequence in-frame with the tag for purification were used for 
heterologous expression. 
Different E. coli expression strains, temperatures, IPTG concentrations and media were used to 
create the optimal conditions for overexpression. 
 
3.1.3.1 Overexpression in the vectors pet21b, pQE-30 and pet16b 
 
The vector pet21b was first used for heterologous expression of the four porin candidates using 
different induction conditions, E. coli strains and media. Since this approach failed (Figure 12A), 
we used the vectors pQE-30 and pet16b for overexpression, again varying in the conditions for 
each approach (Table 24). 
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Table 24. Conditions used for overexpression of pc0870, pc1077, pc1489 and pc1860 in different expression 
vectors 
 
Vector 
Expression- 
culture 
media 
IPTG 
concentration 
Growing 
temperature of 
the expression 
culture 
Harvest 
point 
Pre-
culture 
duration 
E. coli 
strain 
pet21b LB 1 mM 37°C 6h 15 h o/n BL21 (DE3) 
 TB 0.5 mM RT 4h 9 h o/n C43 
  0.1 mM    
Rosetta 
(DE3)- 
pLysS 
pQE-30 LB 1 mM 37°C 6 h 15 h o/n M15 
   37°C - RT* 3 h, 6 h   
   37°C - 20°C 3 h, 6 h   
pet16b LB 1 mM 37°C - 37°C/20°C** 6 h 15 h o/n BL21 (DE3) 
  0.5 mM 37°C - 37°C/20°C 3h/6h**   
  0.2 mM 37°C - 37°C/20°C 3h/6h   
*37°C - RT: The E. coli culture was grown for 2 h at 37°C. Then expression was induced and the culture was grown 
at RT for 3 h or 6 h. 
**37°C/20°C: After induction the expression culture was either grown at 37°C for 3 h or at 20°C for 6 h. 
 
 
 
Although a lot of different constructs and conditions were tested, none of the four putative porins 
could be successfully overexpressed in these constructs. No difference between induced and non-
induced cultures was detectable after IPTG induction and no band at the correct size (Table 20) 
could be obtained. 
 
Some of the obtained negative results with the respective SDS-PAGE gels and Western blots are 
shown in Figure 12. 
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A. Porin overexpression of pc1489 in pet21b using E. coli Rosetta 
M: prestained protein ladder (kDa), 1: empty, 2: E. coli protein lysate 4 h after induction of overexpression of 
pc1489 (pc1489 i.), 3: pc1489 i. for 6h, 4: E. coli protein lysate after 4 h of growing without induction of 
overexpression of pc1489 (pc1489 n.i.), 5: E. coli Rosetta without vector i. for 4h, 6: E. coli Rosetta without vector i. 
for 6h, 7: E. coli Rosetta without vector n.i. 
 
 
 
 
B. Porin overexpression of different constructs in pQE-30 using E. coli M15 comparing E. coli lysates 3h (B.1) 
and 6h (B.2) after induction 
M: prestained protein ladder (kDa), 1: pc1860 i., 2: pc1860 n.i., 3: pc1077 i., 4: pc1077 n.i., 5: pc0870 i., 6: pc0870 
n.i., 7: E. coli M15 without vector i. 
 
 
 
          
C. Porin overexpression of different constructs in pet16b using E. coli Bl21(DE3) comparing E. coli lysates 3h 
at 37°C (C.1) and 6h at 19°C (C.2) after induction 
1: pc1077 i., M: prestained protein ladder (kDa), 2: pc1077 n.i., 3: pc1860 i., 4: pc1860 n.i., 5: pc0870 i., 6: pc0870 
n.i., 7: E. coli BL21 (DE3) without vector i., 8: E. coli BL21 (DE3) without vector n.i. 
 
 
 
D. Verifying results of C.1 by Western blot analysis using anti-His antibodies. The film was exposed for 10 min. 
No bands of correct size were detected. 
M: prestained protein ladder (kDa), 1: pc1077 i., 2: pc1077 n.i., 3: pc1860 i., 4: pc1860 n.i., 5: pc0870 i., 6: pc0870 
n.i., 7: E. coli BL21 (DE3) without vector i., 8: E. coli BL21 (DE3) without vector n.i. 
 
 
Figure 12. No detectable changes of expression levels after overexpression of the four 
putative porins in various E. coli strains (A, B, C, D). 
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3.1.3.2 Overexpression in the vector pgEX-4T-3 and effects of changes in the leader sequences of 
pc0870, pc1077 and pc1860 
 
For further expression studies the vector pgEX was used, since this vector features a GST-tag 
with a molecular weight of 26 kDa suitable for masking toxic proteins in E. coli. 
Gene expression form the vector pgEX-4T-3 results in a fusion of the GST-tag with the N-
terminus of the porin. This fusion protein showed a higher molecular weight than the porin itself 
(Table 20).  
 
Based on other studies (Findlay et al., 2005), also changes in the leader sequence could have 
positive effects on the overexpression of porins. Special constructs were designed as described in 
2.32 and used for additional expression experiments. 
Heterologous expression was performed with constructs including or lacking a leader sequence 
and expression results were analyzed by SDS-PAGE and Western blot analysis. 
 
Bands of the desired molecular weight could be observed on SDS-PAGE gels for pc0870 (Figure 
13) and pc1077 (Figure 14) in both approaches and for pc1489 and pc1860 at least when using 
the vector pgEX (Figure 15 and Figure 16). For an additional identification of each porin fused to 
its tag, Western Blot analysis was performed detecting either the His-tag of the fusion-protein or 
the GST-tag with the help of HRP labeled antibodies. Since specific antibodies against pc1489 
were available, they were also applied during Western blot analysis (Figure 15c). 
 
Interestingly, results of Western blotting showed a possible processing of the porins, since 
additional bands at a molecular weight of ~26 kDa were detected, maybe displaying the cleavage 
of the leader sequence fused to the GST-tag at the N-terminus (Figure 13c and d, indicated by an 
arrow head). 
Strong degradation effects were observed for pc1860 overexpressed in the vector pgEX (Figure 
16c). 
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Figure 13. Overexpression of pc0870 checked by colloidal Coomassie staining and Western 
blot analysis 
Bands of the correct and expected size are indicated by an arrow. Arrow heads indicate the possibly cut off leader 
sequence with the GST-tag. 
 
a. Overexpression of pc0870 in pQE-30 
M: prestained protein ladder (kDa), 1: E. coli protein lysate 4 h after induction of overexpression of pc0870 (pc0870 
i)., 2: E. coli protein lysate after 4 h of growing without induction of overexpression of pc0870 (pc 0870 n.i.), 3: E. 
coli M15 without vector i. 
b. Western blot analysis to verify overexpression of pc0870 in pQE-30 using anti-His antibodies. Film was 
exposed for 1 min. 
M: prestained protein ladder (kDa), 1: pc0870 n.i., 2: pc0870 i., 3: E. coli M15 without vector i. 
c. Overexpression of pc0870 in pgEX-4T-3 
M: prestained protein ladder (kDa), 1: E. coli C43 without vector i., 2: pc0870 n.i., 3: pc0870 i 
?: Coomassie staining did not show a clearly visible band of expected size, as indicated by the arrow. 
d. Western blot analysis to verify overexpression of pc0870 in pgEX-4T-3 using anti-GST antibodies. Film was 
exposed for 10 min. Contrast was enhanced. 
M: prestained protein ladder (kDa), 1: pc0870 n.i., 2: pc0870 i., 3: E. coli C43 without vector i. 
 
 
 
 
        
 
Figure 14. Overexpression of pc1077 checked by colloidal Coomassie staining and Western 
blot analysis 
Bands of the correct and expected size are indicated by an arrow. 
 
a. Overexpression of pc1077 in pQE-30 
M: prestained protein ladder (kDa), 1: E. coli protein lysate 4 h after induction of overexpression of pc1077 (pc1077 
i.), 2: E. coli protein lysate after 4 h of growing without induction of overexpression of pc1077 (pc1077 n.i.), 3: E. 
coli M15 without vector i. 
b. Western blot analysis to verify overexpression of pc1077 in pQE-30 using anti-His antibodies. Film was 
exposed for 5 min. 
M: prestained protein ladder (kDa), 1: pc1077 n.i., 2: pc1077 i., 3: E. coli M15 without vector i. 
c. Overexpression of pc1077 in pgEX-4T-3 
M: prestained protein ladder (kDa), 1: pc1077 i., 2: pc1077 n.i., 3: E. coli C43 without vector i. 
d. Western blot analysis to verify overexpression of pc1077 in pgEX-4T-3 using anti-GST antibodies. The film 
was exposed for 2 sec. 
M: prestained protein ladder (kDa), 1: pc1077 n.i., 2: pc1077 i., 3: E. coli C43 without vector i. 
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Figure 15. Overexpression of pc1489 checked by colloidal Coomassie staining and Western 
blot analysis 
Bands of the correct and expected size are indicated by an arrow. 
a. Overexpression of pc1489 in pgEX-4T-3 
M: prestained protein ladder (kDa), 1: E. coli protein lysate 4 h after induction of overexpression of pc1489 
(pc1489i.), 2: E. coli protein lysate after 4 h of growing without induction of overexpression of pc1489 (pc1489 n.i.), 
3: E. coli C43 without vector i. 
b.+c. Western blot analysis to verify overexpression of pc1489 in pgEX-4T-3 using anti-GST antibodies (b) and 
anti-pc1489-antibodies (c). The film was exposed for 1 min (b) and 5 min (c, contrast was enhanced). 
M: prestained protein ladder (kDa), 1: pc1489 n.i., 2: pc1489 i., 3: E. coli C43 without vector i. 
 
 
 
 
 
       
 
Figure 16. Overexpression of pc1860 checked by colloidal Coomassie staining and Western 
blot analysis 
Bands of the correct and expected size are indicated by an arrow. 
a. Overexpression of pc1860 in pQE-30 
M: prestained protein ladder (kDa), 1: E. coli protein lysate 4 h after induction of overexpression of pc1860 (pc1860 
i.), 2: E. coli protein lysate after 4 h of growing without induction of overexpression of pc1860 (pc1860 n.i.), 3: E. 
coli M15 without vector i. 
b. Western blot analysis to verify overexpression of pc1860 in pQE-30 using anti-His antibodies. The film was 
exposed for 1 min. 
M: prestained protein ladder (kDa), 1: pc1860 n.i., 2: pc1860 i., 3: E. coli M15 without vector i. 
c. Western blot analysis to verify the overexpression of pc1860 in pgEX-4T-3 using anti-GST antibodies. The 
film was exposed for 10 sec. Contrast was enhanced. 
M: prestained protein ladder (kDa), 1: pc1860 n.i., 2: pc1860 i., 3: E. coli M15 without vector i. 
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3.1.4 Hints for the formation of inclusion bodies and toxicity during porin 
overexpression in E. coli 
 
If looking at the cell pellets after an overexpression of E. coli cells containing the expression 
construct or control cells without any vector, a remarkable difference could be observed. After 
harvesting, the transformed and consecutively induced cells resulted in smaller amounts of cells 
of white color, suggesting the formation of inclusion bodies. In contrast, cells without vector 
resulted in bigger brownish pellets. 
 
During the process of 2-step cloning and subsequent overexpression of the porins pc1077 and 
pc0870, a reduced cell growth could be observed maybe due to the pore-forming characteristic of 
porins. Already after transformation of E. coli XL1blue with the overexpression constructs, some 
colonies did not grow well on the agar plates, probably displaying porin expression and 
incorporation into the outer membrane. 
 
Badly grown colonies on a masterplate from screening for recombinant clones were compared 
with the respective screening results. Some clones regarded as positive in respect of containing 
pc1077 (Figure 17A, clones 1 and 11) or pc0870 (Figure 17A, clones 22 and 30) as insert, could 
be directly linked to bad growing on the masterplates as shown in Figure 17B (positive clones 
marked in red). However, some clones giving positive results for pc1077 in PCR (Figure 17A, 
clone 8) did not show bad growth on the masterplate (Figure 17B, clone 8). Since pgEX-specific 
primers were used for screening for recombinant clones, the true identity of the amplified 
fragment after PCR is not affirmed. 
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Figure 17. Linking weak growth of transformed E. coli cells to the results of the screening for recombinant 
clones. 
A. Screening for recombinant clones of E. coli XL1blue containing pc1077 and pc0870 in the vector pgEX-4T-3. 
Clones 1 and 11 could be confirmed by sequencing to contain pc1077 as an insert. The clones 22 and 30 contain the 
correct sequence of pc0870as insert, according to sequencing results. M: DNA ladder 1kb 
B. Masterplate from a screening for recombinant clones of pc1077 and pc0870. 
 
 
3.1.5 Measurements of the optical density of E. coli C43 expression cultures 
 
Taking a closer look at the cell growth during an overexpression, the optical density of induced 
and non-induced cells was measured at defined time-points to get some hints for pore-forming 
activity caused by porin expression. For this purpose, the construct pc1077 in the vector pgEX 
was used. 
 
It could be shown in duplicates that the non-induced cells had grown to a much higher density 
than the induced cells four hours after induction (Figure 18A). Repetition of OD measurements 
starting directly after inoculation of the E. coli expression culture did not show drastic 
differences between the growths of induced and non-induced cells (Figure 18B).  
Non-induced cells grew slightly better than the induced ones. However, results were not 
reproducible and effects of the inoculum size were considered. 
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Figure 18. OD measurments during porin overexpression, concentrating on the construct pc1077 in 
the vector pgEX-4T-3 overexpressed in E. coli C43. Cultures overexpressing pc1077 showed a reduced cell density 
4 h after induction of overexpression in comparison to a control culture, where overexpression was not induced (A). 
Differences in culture growth between induced and non-induced E. coli cultures were not always significant (B). 
 
0,695
1,678
0,65
1,661
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
OD 600 nm
Optical density 4 h after induction of overexpression 1 of pc1077 in the vector pgEX-4T-3
Optical density after 4 h without induction of overexpression 1 of pc1077 in the vector pgEX-4T-3
Optical density 4 h after induction of overexpression 2 of pc1077 in the vector pgEX-4T-3
Optical density after 4 h without induction of overexpression 1 of pc1077 in the vector pgEX-4T-3
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
0 1 2 3 4 5 6 7
OD 600 nm
time (h)
Overexpression 1 of pc1077 in the vector pgEX-4T-3
Culture growth 1  without induction of overexpression of pc1077 in the vector pgEX-4T-3
Overexpression 2 of pc1077 in the vector pgEX-4T-3
Culture growth 2  without induction of overexpression of pc1077 in the vector pgEX-4T-3
Overexpression of DnaK in the vector pQE-30
Culture growth  without induction of overexpression of DnaK in the vector pQE-30
A 
B 
induction of overexpression 
  3 Results 
  85 
 
As a negative control the optical density of an E. coli culture expressing the cytoplasmic protein 
DnaK was tracked throughout the whole process (Figure 18B, red). No differences in the 
growing potential between induced and non-induced cultures were observed. Additionally, the 
inclusion membrane protein of P. amoebophila pc1111 in the vector pet16b (kindly provided by 
Eva Heinz) was overexpressed to get an idea of the growing behavior of an E. coli culture 
expressing non-toxic proteins. Again, no reduction in cell growth of the induced E. coli 
expression culture was observed (results not shown). 
 
 
 
3.1.6 Indirect immunofluorescence experiments with E. coli cells after overexpression 
of pc1860 in the vector pgEX 
 
In order to get more information about the localization of overexpressed porins in E. coli, 
immunofluorescence experiments with E. coli cells fixed after heterologous expression of 
pc1860 containing the leader sequence (2.47.1) were carried out.  
 
Different antibodies were used for immunofluorescent staining of the cells, either targeting the 
GST-tag at the N-terminus of the porin or general outer membrane structures of P. amoebophila. 
Apparently, GST antibodies could bind in the induced E. coli C43 cells, whereas no cell staining 
got visible in the induced control cells without a vector if the same microscopic settings were 
used (Figure 19). However, despite of several tries, it was not possible to obtain reproducible 
results. 
 
Looking at E. coli cells after induction in general, their morphology had changed evidently in 
comparison to non-induced cells. Due to the stress caused by protein overexpression the cells 
were elongated, whereas control cells without induction of overexpression showed coccoid 
morphology (results not shown). 
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Figure 19. Immunofluorescence analysis for the visualization of expressed pc1860. The construct pc1860 in 
pgEX-4T-3 was overexpressed in E. coli C43 and detected by anti-GST-antibodies in green. Anti-Pam antibodies 
against general outer membrane components of P. amoebophila only show background signals (red). As a negative 
control empty E. coli C43 cells, equally induced, were investigated (A). Pictures were taken with exactly the same 
software and microscope settings. 
 
 
 
 
3.1.7 Protein purification of pc1077 without leader sequence (noL1077) 
 
The construct noL1077 could be successfully overexpressed (Figure 14). Thus, it was chosen for 
protein expression of pc1077 at large scale and consecutive purification via the His-tag. 
 
As the harvested cells showed white color, indicating the possible formation of inclusion bodies, 
urea was used as a detergent during protein purification. Additionally, the whole approach was 
repeated using TB medium instead of LB medium and a growing temperature of 20°C after 
induction of overexpression. Interestingly, the pellet of an induced culture grown in TB showed 
hardly any differences in comparison to the non-induced cells after harvesting. The pellets had 
nearly the same appearance according to size and color, though the pellets of induced cells were 
a little bit brighter. Induced cells grown in LB resulted in small and white pellets, whereas the 
non-induced cells of the LB-approach looked similar to the pellets of TB-cultures. According to 
these findings, TB medium and a growing temperature of 20°C was chosen for an optimal yield 
during overexpression. 
 
The collected fractions were analyzed by SDS-PAGE in order to detect the fraction containing 
the highest amount of purified protein (Figure 20). noL1077 was marginally eluted in the 60 mM 
to 100 mM imidazole fractions, while prominent bands for noL1077 were seen in the last 100 
mM and first 300 mM imidazole fraction.  
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Figure 21. SDS-PAGE gel showing the 
purified pc1077 fractions B3 and C1. 
Arrows 1, 2 and 3 are pointing at the 
extracted bands 
These eluates contained also some minimal amounts of other proteins (Figure 20, B3 and C1). In 
order to identify the purified protein as well as the additional bands, selected bands were 
analyzed by mass spectrometry. 
 
 
 
Figure 20. His-trap purification of noL1077 overexpressed in E. coli M15. Each imidazole concentration was 
applied three times, starting with 60 mM. The fractions B3 and C1 were containing the highest amount of purified 
protein. 
M: prestained protein ladder, 1: pellet after sample preparation, 2: filtrate subjected to the column, 3: flow through 
during loading of the sample, 4: washing fraction, 5: flow through, collected while loading the first imidazole 
fraction 
60-500 mM: used imidazole concentrations 
 
 
 
3.1.8 Identification of protein bands by mass spectrometry 
 
Proteins from fraction B3 and C1 were separated by SDS-PAGE. Three 
clearly visible protein bands (Figure 21) were chosen and subjected to 
analysis by nanoLC-MS/MS. 
Interpretation of the output data of mass spectrometry showed that the 
dominant band 1 mostly contained the porin pc1077 as expected. All 
samples showed contamination with keratin, most likely introduced 
during sample preparation. 
 
Band 2 and band 3 mainly showed hits for keratin, whereas 
results for band 3 reported an additional hit for pc1077. The 
appearance of the porin in this band of a lower molecular 
weight as expected (Table 20) could be due to degradation of the porin during the process of 
overexpression. 
Additionally, all results were matched against an E. coli database to exclude the presence of E. 
coli porins in further functional analyses, but no significant hits were obtained. 
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Table 25. Hits for band 1, 2 and 3 for pc1077 based on the output data from mass spectrometry 
 
 Band 1 Band 2 Band 3 
Hit 1 
Keratin, type II cytoskeletal 
2 epidermal (Cytokeratin-2e) 
PREDICTED: similar to 
Keratin, type I cytoskeletal 
14 (Cytokeratin-14) 
keratin 1 [Homo sapiens] 
Hit 2 
PREDICTED: similar to 
Keratin, type I cytoskeletal 
14 (Cytokeratin-14) 
keratin 1 [Homo sapiens] 
epidermal cytokeratin 2 
[Homo sapiens] 
Hit 3 
pc1077 Candidatus 
Protochlamydia 
amoebophila UWE25 
epidermal cytokeratin 2 
[Homo sapiens] 
keratin 1 [Pan 
troglodytes] 
Hit 4 
PREDICTED: similar to 
keratin 1 isoform 7 
type I keratin 16 [Homo 
sapiens] 
PREDICTED: similar to 
Keratin, type I 
cytoskeletal 14 
(Cytokeratin-14) 
Detection of pc1077 Hit 3 no Hit 14 
Total number of hits 24 58 28 
 
 
 
3.1.9 Immunofluorescence with A. castellanii Neff harboring P. amoebophila 
endosymbionts using anti-pc1077 antibodies 
 
Antibodies against pc1077 were produced by Eurogentec (Seraing, Belgium) according to 2.42. 
 
Applying pre-immune sera and subsequent bleeds in immunofluorescence (IF) experiments with 
uninfected A. castellanii Neff no signals could be detected, excluding the possible detection of 
amoeba proteins (results not shown). 
 
Tests with the pre-immune sera were performed in the same dilutions as with the small, large and 
final bleeds. Unexpectedly, pre-immune sera of both rabbits showed signals if tested in IF 
experiments with E25-infected amoebae either due to unspecific binding of the antibodies or to a 
former chlamydial-infection of the rabbits. Results from Western Blot analysis (next chapter) 
promised insights into the unspecific binding capacities of the pre-immune sera. 
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The large bleed used in IF could not come up to expectations either, as testing the pre-immune 
serum in the same dilution as the antibody led to even stronger signals as obtained from the large 
bleed (Figure 22). No specific signals from the anti-pc1077 antibodies could be observed. 
 
Also the overlay of signals from anti-pc1077 antibodies and the positive control against the 
cytoplasmic protein DnaK of P. amoebophila did not show overlapping signals (Figure 22B). 
This observation implied the detection of only unspecifically bound anti-pc1077 antibodies, since 
no halo-shaped signal from the outer membrane, surrounding the signals of anti-DnaK antibodies 
in the cytoplasm, was detectable. 
 
 
 
        
 
        
 
Figure 22. Specificity of the anti-pc1077 antibody was tested by immunofluorescence analysis. 
B. The large bleed (green) was applied in a dilution of 1:100 and tested in E25-infected A. castellanii Neff. 
Antibodies against the cytoplasmic protein DnaK were used as a positive control, shown in red. No clearly 
overlapping signals could be observed. 
A. In order to test the pre-immune serum for former chlamydial infections a dilution of 1:100 was applied in a 
parallel experiment, showing some strong unexpected signals (green). 
Exactly the same microscopic settings were used for recording the pictures of A and B. 
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3.1.10 Western blot analysis with anti-pc1077 antibodies 
 
For further investigation of the unexpected signals from the pre-immune sera in IF, Western blot 
analysis was performed with the large bleed as well as with the pre-immune serum of the rabbit. 
 
Different dilutions of the large bleed and of the pre-immune serum were tested on the protein 
lysate after an overexpression of pc1077 in E. coli M15, resulting in a difference of the band 
pattern. Results for the pre-immune serum at low dilutions revealed a high unspecific 
background (results not shown). But Western blot using the large bleed at a dilution of 1:2000 
demonstrated the specificity of the antibody by displaying an additional band at the expected size 
of about 37 kDa. The actual band of interest appeared as a strong white band in front of a high 
background, an indication for chosing a too low dilution of the respective antibody (Figure 23B, 
arrow). In comparison, the pre-immune serum applied in the same high dilution did not show any 
specific bands (Figure 23A). 
 
For creating an even higher specificity of the anti-pc1077 antibody, suitable for its usage in IF 
experiments, an additional boost was considered. 
 
 
 
 
 
 
Figure 23. Western blot analysis to show specific binding of antibodies in the large bleed. Both the pre-immune 
serum (A) and the large bleed (B) were tested in a dilution of 1:2000 on a protein lysate after overexpression of 
pc1077 in E. coli M15. The secondary antibody was used 1:20000. The pre-immune serum just showed some weak 
unspecific bands at this high dilution, whereas the large bleed visualized a band of the expected size, indicated by an 
arrow. A higher dilution of the anti-pc1077 antibodies would reduce the high unspecific background. 
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3.1.11 Functional analysis of pc1077 
 
In order to get an idea of the actual function of pc1077, lipid-bilayer measurements were 
performed to investigate the proposed pore-forming activity of this protein. The construct of 
pc1077 without leader sequence in the vector pQE-30 was overexpressed, purified and subjected 
to further analyses by lipid-bilayer measurements by Roland Benz.  
 
A negative control of purified proteins of an overexpressed E. coli M15 culture containing only 
the empty pQE-30 vector was measured in parallel. Purification of this overexpression via a His-
trap column resulted in hardly any detection of proteins by colloidal Coomassie staining, as 
expected. 
 
Unfortunately, the measurements detected pores in the negative control due to the presence of the 
E. coli porin OmpF. Therefore, the measurements of the sample of purified pc1077 could not be 
considered as significant, since pore-forming activity could either be linked to a contamination 
with OmpF or as originally proposed linked to the porin of P. amoebophila. As a conclusion, no 
ascertained hint for the pore-forming activity of pc1077 was observed. 
 
 
 
3.2 Transcription analysis 
 
3.2.1 Defining the optimal settings for qPCR primers 
 
Optimal conditions for the primer pairs q16S R+F and q1489 R+F (Table 16) were highly 
important, therefore different primer concentrations (15 pmol, 25pmol, 50 pmol and 75 pmol) 
were tested in each possible combination as well as various annealing temperatures. The optimal 
conditions for 16S R+F were set to a concentration of 25 pmol, whereas for 1489 R+F a 
concentration of 15 pmol was used. In both cases the annealing temperature was set to 60°C. 
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3.2.2 RNA isolation and control of RNA quality 
 
Three independent biological replicates of RNA isolated at defined time points throughout an 
infectious cycle (0 h p.i., 24 h p.i., 48 h p.i. and 96h p.i.) were analyzed. RNA quality was tested 
in order to detect degradation effects resulting from the isolation procedure, but bands for 16S 
rRNA and 23S rRNA were obtained for all three replicates if loaded onto an agarose gel (Figure 
24A). 
 
The sample isolated 24h p.i. and the non-infected negative control, both descending from 
replicate 2, contained very low amounts of RNA, therefore no bands could be detected on the 
RNA gel (Figure 24A, replicate 2, lane 2 (24 h p.i.) and lane 5 (non-infected)). 
 
 
 
       
Figure 24. Testing the quality of isolated RNA 
A. Bands for the 16S rRNA gene and the 23S rRNA gene could be detected on a 2% TAE-agarose gel as clearly 
defined bands, indicated by the arrows. 1, 2, 3 represent the 3 replicates, samples applied from 0 h to 96 h p.i. and 
non-infected sample (n.-i.). M: RNA ladder. Contrast was enhanced. 
B. After the second DNase digestion co-extracted DNA of some samples was still amplified in PCR, visualized on a 
2% TBE-agarose gel. DNA contaminations were detected using q1489 R+F. A positive (+) and a negative control (-) 
were included. M: 100 bp ladder 
 
 
 
DNase digestion had to be performed three times in order to get rid of DNA, co-extracted during 
RNA isolation (Figure 24B). Finally, the primer pair q1489 R+F did not amplify the fragment of 
pc1489 in general PCR any more, approving the digestion of co-extracted DNA. The RNA 
sample which originated from the isolation 48 h p.i. still contained some DNA contamination 
after three times of DNase digestion. Hence, this sample was treated with and without reverse 
transcriptase in parallel during RT-PCR to get an idea of the effects of the remaining DNA in 
subsequent qPCR. 
 
 
M 
1 3 2 
M    0h  24h  48h   96h   n.-i.   +      -      M 
2000 
1500 
200 
100 
A B 
  3 Results 
  93 
3.2.3 Optimization and quality control of the data output of qPCR using the iCycler 
software 
 
First, the negative controls of the qPCR data had to be inspected to estimate reliability of the 
output data. Results from a qPCR run are shown in Figure 25. All three negative controls did not 
reach the treshhold for significant signals. 
 
 
 
Figure 25. Amplification graph for the fragment of pc1489 recorded during a qPCR run at cycle 2. The orange 
line, representing the treshhold value, was not reached by the negative controls. 
CF RFU: curve fit relative fluorescent units 
 
 
The slope value of the standard curve of each qPCR run was inspected. If this value ranged from 
-3 to -3.6, the standard curve was used for further analysis (Figure 26, arrow). In all runs the 
slope value came up to this precondition by excluding standards which obviously deviated from 
the expected value. 
 
Furthermore, PCR efficiency was expected to come up to 100% or even slightly more (Figure 26, 
arrow). Values much higher than 100% were due to the possible formation of primer dimers. 
 
 
 
 
 
 
Negative controls: 
• no template 
• RNA as template 
• not infected 
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Figure 26. Standard curve for the amplicons of pc1489 calculated with the help of the pc1489 standards (blue), 
unknowns were plotted in red, arrows were pointing out the important values. (Slope:-3.28, PCR efficiency: 101.6%, 
correlation coefficient: 0.998) 
 
 
 
 
After each qPCR run, results were analyzed by agarose gel electrophoresis to check specific 
binding of the primer pairs (Figure 27). 16S R+F amplified a sequence of 88 bp, whereas the 
resulting amplicon using 1489 R+F consisted of 143 bp. As an additional proof of primer 
specificity, a melting curve was recorded at the end of each run, displaying the melting 
temperature (Tm) for each amplicon. Thus, if only one amplicon was produced during the run, as 
expected in the best case, just one Tm dominated throughout the melt curve data. Tm for the 
amplicon of pc1489 was set to 79°C (Figure 28, vertical orange line) and the amplicon of 16S 
separated at a Tm of 80°C. Melting curves of the negative control, containing no template, and 
the non-infected samples did not show a prominent Tm peak. The negative control –RT was 
characterized by a slightly shifted peak (Figure 28, red arrows), implying unspecific binding of 
the primer pairs with another amplification result. 
 
 
 
      
Figure 27. 2% agarose gel for showing the amplification results of a qPCR run. 16S standards were applied in 
duplicates from 109 to 105, 1489 standards were applied once with exception of 109. NTCs were represented by -1 
for 16S and -2 for 1489. Unknowns were applied in duplicates starting with 0h, except the following: non-infected 
(n.i.) and without reverse transcription (–RT) samples of 16S and 1489 and 96h p.i of pc1489 were only applied 
once. 
M: 100 bp ladder 
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Figure 28. Melting curve for the pc1489 amplicons after a qPCR run. For each reaction one specific melting 
temperature was figured out. Production of always the same amplicon should end up in only one common Tm. Red 
arrows are indicating different Tms for the negative controls. 
-d(RFU)/dT: change of fluoresecent units with time 
 
 
3.2.4 Summary of all qPCR runs 
 
qPCR was performed in duplicates with three biological replicates, finally producing data from 6 
different runs: 
• Run 1 and Run 2: RNA kindly provided by Albert, but data from Run 1 were not included 
in further analyses, as standard curve data were not reliable 
• Run 3 and Run 4: RNA isolated from infectious cycle 1 
• Run 5 and Run 6: RNA isolated from infectious cycle 2 
 
An overview of all runs, except Run 1, is shown in Figure 29. No outstanding differences could 
be observed between the single runs, displaying about 10000 times less transcripts of pc1489 
than transcripts of the 16S rRNA at 0 h p.i..  
 
The mean values for each time point were calculated for further investigation and the lowest 
value at 24 h p.i. was used as starting-point for subsequent calculations. 
 
Temperature, Celsius 
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Figure 29. Results of 5 qPCR runs. Red colored lines are displaying values for pc1489, lines in green are 
representing values for the 16S rrNA. Templates were diluted 1:10. The first run was excluded from analyses. 
 
 
 
 
Changes in the transcription level got visible by comparing the copy numbers of pc1489 and the 
16S rRNA at different time points. The increase of both was set in relation to the respective 
lowest value at 24 h p.i..  
The copy numbers of the 16S rRNA showed an increase of more than 10 times from 24 h p.i. to 
96 h p.i., reflecting the expected growth of the bacterial community. The increase of copy 
numbers of pc1489 from 24 h p.i. to 96 h p.i. was more evident, since a 100 fold rise was 
observed (Figure 30A). 
 
The copy numbers of pc1489 were normalized to those of the 16S rRNA in order to produce 
representative values displaying the actual changes of transcription throughout an infectious 
cycle not due to expected bacterial replication. Normalized copy numbers of pc1489 
demonstrated a 10 fold increase from 24 h p.i. to 96 h p.i. (Figure 30B).  
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Figure 30. Different transcription levels of the 16S rRNA and pc1489 during an infectious cycle (displaying the 
mean values). 
A. Increase of both copy numbers of the 16S rRNA and copy numbers of pc1489 in relation to the lowest copy 
number at 24 h p.i. 
B. Copy numbers of pc1489 normalized with the help of the corresponding values for the 16S rRNA. 
 
 
1,00
10,00
100,00
1000,00
0h p.i. 24h p.i. 48h p.i. 96h p.i.
xf
ol
d 
 in
cr
ea
se
Changes of copy numbers in comparison to 24 h p.i.
16S
1489
1,00E+05
1,00E+06
1,00E+07
1,00E+08
0h p.i. 24h p.i. 48h p.i. 96h p.i.
Normalized copy numbers of pc1489
copy numbers of 
pc1489 normalized 
to 16S
A 
B 
copy numbers 
3 Results 
98 
3.3 Generation of polyclonal antibodies against cytoplasmic proteins 
 
3.3.1 Amplification of pc1499 (DnaK) and pc0595 (EF-TU), 2-step cloning and clone 
screening 
 
Specific primers (Table 14) for pc1499 and pc0595 of P. amoebophila UWE25 were designed 
and amplificates from a high-fidelity PCR showed the expected length of 1965 bp for pc1499 and 
1185 bp for pc0595. 
 
Cloning was performed following a 2-step cloning protocol. It required several rounds of 
screening to finally detect amplicons with the correct and expected sequence length. For each 
construct two clones with correct inserts were verified by pQE/pgEX screening and sequencing. 
 
Sequencing of the clones of DnaK was linked to some problems due to the length of its sequence. 
Despite of forward and reverse sequencing, it was not possible to obtain the whole length 
sequence of 1965 bp. Hence, pc1499 clones were only identified by their start- and end-
sequences, thereby showing up to 100% similarity to the original sequence part.  
 
 
3.3.2 Overexpression of DnaK in the vector pQE-30 and EF-TU in the vector pgEX-
4T-3 
 
After heterologous expression in an adequate E. coli strain, the expression level was inspected by 
colloidal Coomassie staining and Western blot analysis. Based on the amount of overexpressed 
protein the constructs pc1499 (DnaK) in the vector pQE-30 and pc0595 (EF-TU) in the vector 
pgEX-4T-3 were used for further investigations. 
 
Bands of the expected molecular weight of 71 kDa could be observed for DnaK (Figure 31, 
arrows). According to colloidal Coomassie staining, the overexpression of DnaK resulted in a 
very strong signal. This high amount of detectable DnaK led to high background signals in 
Western blot analysis with anti-His antibodies (Figure 31B). The signals from DnaK visually 
intensified the additional bands, resulting from other proteins containing histidines. 
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Figure 31. Overexpression of pc1499 (DnaK) in pQE-30 using E. coli M15 and different IPTG concentrations 
for induction. Results shown with colloidal Coomassie stainig (A) and Western blot using anti-His antibodies (B) 
and anti-DnaJ antibodies (C). Films were exposed for 30 sec. 
A. M: multicolor protein ladder (kDa), 1: E. coli protein lysate 4 h after induction of overexpression of pc1499 
(pc1499 i.) with 1mM IPTG, 2: pc1499 i., 0.5 mM IPTG, 3: pc1499 i., 0.1 mM IPTG, 4: E. coli protein lysate after 4 
h of growing without induction of overexpression of pc1499 (pc1499 n.i.), 5: E. coli M15 without vector i., 1mM 
IPTG 
B.+C. M: multicolor protein ladder (kDa), 1: E. coli M15 without vector i., 1mM IPTG, 2: pc1499 i., 0.5 mM IPTG, 
3: pc1499 i., 1 mM IPTG, 4: pc1499 n.i. 
 
 
 
The expected molecular weight of EF-TU was calculated by adding 26 kDa for the GST-tag to 
the original weight of 43 kDa, resulting in a weight of 69 kDa. This GST-fusion protein was 
detected as an additional band at ~70 kDa after induction of overexpression of EF-TU (Figure 32, 
arrows). 
 
 
                                
 
Figure 32. Overexpression of pc0595 (EF-TU) in pgEX-4T-3 using E. coli BL21 (DE3) shown by colloidal 
Coomassie staining (a) and Western blot analysis (b) usind anti GST-antibodies (1:5000). The film was exposed for 
20 sec. 
A. M: prestained protein ladder (improved), 1: E. coli protein lysate 4 h after induction of overexpression of pc0595 
(pc0595 i.), 2: E. coli protein lysate after 4 h of growing without induction of overexpression of pc0595 (pc0595 
n.i.), 3: E. coli BL21 (DE3) without vector i. 
B. M prestained protein ladder, 1: E. coli BL21 (DE3) without vector i., 2: pc0595 i., 3: pc0595 n.i. 
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3.3.3 Purification of pc1499 (DnaK) 
 
DnaK in the vector pQE-30 was chosen for further protein expression at large scale followed by 
purification via the His-tag using an imidazole gradient (60 mM – 100 mM- 300 mM- 500 mM). 
SDS-PAGE analyses showed elution of the protein at nearly all imidazole concentrations and 
many additional protein bands. Thus, additional imidazole steps (30 mM, 40 mM, 50 mM, 55 
mM, 70 mM, 80 mM) were included in order to improve the purity of the overexpressed protein. 
After this optimization process, fractions were collected again and analyzed with SDS-PAGE 
(Figure 33) in order to detect the fraction containing the highest amount of purified protein. 
 
 
 
                
 
 
     
 
Figure 33. Protein fractions after purification of DnaK using a His-trap column to identify the fraction 
containing the highest and purest amount of desired protein. Results are visualized by colloidal Coomassie staining 
of SDS-PAGE gels. a and b show the first and second eluat-fractions, in c the third fraction of each imidazole step 
was applied. 
a. M: prestained protein ladder (kDa), 1: filtrate after sample preparation, 30-70 mM: applied imidazole 
concentrations 
b. M: prestained protein ladder (kDa), 7: pellet after sample preparation, 80-300 mM: applied imidazole 
concentrations 
c. M: prestained protein ladder (kDa), 30-300 mM: applied imidazole concentrations 
 
 
 
DnaK was still - but most of the time marginally - eluted in all imidazole fractions. The most 
prominent band for DnaK was seen in the first 300 mM imidazole fraction (Figure 33b, arrow). 
Also the last 100 mM fraction yielded a notable amount of protein.  
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3.3.4 Identification of protein bands by mass spectrometry 
 
The selected eluates from purification of DnaK still contained some minimal amounts of other 
proteins (Figure 33b+c), which could disrupt antibody generation. Therefore, two of these 
additional bands as well as the dominant band were extracted and subjected to nanoLC-MS/MS 
in order to ensure purity of purified DnaK for the following antibody generation. Additionally, 
bands obtained after overexpression of the protein EF-TU were analyzed. 
 
Mass spectrometry approved high purity of DnaK. The dominant band featuring the expected 
weight of 71 kDa as well as the other bands, considered as possible contaminations, could be 
identified as DnaK (Table 26). Moreover, a contamination with keratin was detected in all 
samples most probably arising from the process of sample preparation. 
 
Also EF-TU was identified by mass spectrometry, since the analyzed band contained a hit for 
pc0595 (EF-TU) beside some additional hits for keratin. 
 
 
Table 26. Hits for bands 1, 2 and 3 for DnaK and the band for EF-TU based on the output data of mass 
spectrometry 
 
 Band 1 DnaK Band 2 DnaK Band 3 DnaK EF-TU 
Hit 1 
pc1499 Candidatus 
Protochlamydia 
amoebophila UWE25 
pc1499 Candidatus 
Protochlamydia 
amoebophila UWE25 
pc1499 Candidatus 
Protochlamydia 
amoebophila UWE25 
pc0595 
Candidatus 
Protochlamydia 
amoebophila 
UWE25 
Hit 2 keratin 1 [Homo sapiens] 
keratin 1 [Homo 
sapiens] 
Keratin, type II 
cytoskeletal 2 
epidermal 
(Cytokeratin-2e) 
ECOLI 60 kDa 
chaperonin 
(Protein Cpn60) 
Hit 3 
Keratin, type II 
cytoskeletal 2 epidermal 
(Cytokeratin-2e) 
PREDICTED: similar to 
Keratin, type I 
cytoskeletal 14 
(Cytokeratin-14) 
keratin 1 [Homo 
sapiens] 
HUMAN 
Keratin, type II 
cytoskeletal 1 
(Cytokeratin 1) 
Hit 4 
PREDICTED: similar to 
Keratin, type I 
cytoskeletal 14 
(Cytokeratin-14) 
PREDICTED: similar to 
keratin 2a [Macaca 
mulatta] 
PREDICTED: similar 
to Keratin, type I 
cytoskeletal 14 
(Cytokeratin-14) 
EFTU_ECOLI 
Elongation 
factor Tu 
Total number of 
hits 13 35 20 19 
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3.3.5 Immunofluorescence experiments and Western blot analysis showing the 
specificity of anti-DnaK antibodies 
 
Antibodies against DnaK were raised in both guinea pig and chicken by Eurogentec (Seraing, 
Belgium) and localization of DnaK was studied by immunofluorescence analysis using A. 
castellanii Neff harboring P. amoebophila endosymbionts. Pre-immune sera from the respective 
animal were used as negative control. 
 
 
3.3.5.1 Immunofluorescence analysis with antibodies against DnaK obtained by the immunization 
of two guinea pigs (anti-DnaK gp) 
 
Initial tests with the pre-immune serum in IF showed no signals when using an appropriate 
dilution of 1:1000 after inactivation (data not shown). 
 
To visualize the localization of DnaK in P. amoebophila anti-DnaK antibodies were used 
simultaneously with anti-Pam antibodies, targeting the immunodominant components of the 
outer membrane of P. amoebophila, and anti-pc1489 antibodies, targeting the porin pc1489 in 
the outer membrane of P. amoebophila (kindly provided by Karin Aistleitner). 
The first bleed already showed knob-shaped signals located in the cytoplasm of P. amoebophila, 
suggesting detection of DnaK. In support of this, the overlay of signals showed that the red signal 
for DnaK was surrounded by signals for the outer membrane originating from anti-Pam (blue) as 
well as from anti-pc1489 (green) antibodies (Figure 34B). 
 
In parallel, the first bleed was used in amoeba cells without endosymbionts (Figure 34A). 
Antibodies from one guinea pig showed signals, suggesting unspecific binding to the 
mitochondria of amoebae. While testing the second and the final bleed from this guinea pig 
under the same conditions, the detection of mitochondria was reduced (results not shown). 
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Figure 34. Immunofluorescence analysis using anti-DnaK gp antibodies. No signals were observed in uninfected 
amoebal cells (A) whereas P. amoebophila-infected amoebal cells showed signals detecting the endosymbionts (B). 
The overlay of signals visualizes localization of the signals for DnaK (red) in the cytoplasm of P. amoebophila, 
surrounded by signals for the outer membrane (blue, green). The four pictures of both A and B represent identical 
microscopic fields. Pictures of A and B were taken with the same microscope settings. Bars 5µm. 
 
 
 
Additional assays were performed using the second and the final bleed, including PFA fixed cells 
as well as methanol fixed cells. No differences in the location of signals could be observed. The 
expected intracellular localization was clearly visualized (Figure 35) and this newly generated 
antibody can be used as an intracellular standard in future immunofluorescence experiments. 
 
 
Figure 35. Showing the intracellular localization of anti-DnaK 
antibodies by immunofluorescence analysis. Antibodies used for 
visualizing the outer membrane (anti-Pam) are shown in green whereas 
anti-DnaK appears in red. Bar 2 µm. 
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3.3.5.2 Cross-reactivity of anti-DnaK antibodies in other chlamydia-like bacteria 
 
The anti-DnaK antibody was considered to be used as a standard antibody in 
immunofluorescence experiments. Thus, some additional experiments were performed to detect 
Waddlia chondrophila by these newly generated antibodies in IF. 
Signals indicating a Waddlia chondrophila infection of amoebae could be observed as shown in 
Figure 36 (pictures taken by Karin Aistleitner), offering a new method for detecting these 
chlamydia-like bacteria besides of DAPI staining and fluorescent-in-situ-hybridization. 
 
           
Figure 36. Detection of a homologue of DnaK by anti-DnaK antibody in Waddlia chondrophila. Bacteria are 
blue due to DAPI staining. The antibody against DnaK shows red signals. Bar 5 µm. 
 
 
 
 
 
3.3.5.3 Western blot analysis with anti-DnaK gp antibody 
 
Specificity of anti-DnaK gp was tested by Western blot analysis. For this purpose, either E. coli 
M15 cells, harvested after an overexpression of DnaK, or amoebae harboring P. amoebophila 
were applied. Specific detection of DnaK could be shown in both approaches, since distinct 
bands at a molecular weight of 71 kDa were present (Figure 37). The overexpression of DnaK 
has always yielded high amounts of protein, explaining the strong signal (Figure 37, lane 2) 
resulting from this approach. 
 
Moreover, no unspecific binding to amoeba proteins was detectable in Western blot (Figure 
37B). 
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Figure 37. Western blot analysis to show specificity of anti-DnaK gp.  
A. Antibodies were tested at a dilution of 1:2000 to detect a specific signal after overexpression or DnaK in amoebae 
infected with P. amoebophila. Film was exposed for 10 sec. 
M: prestained protein ladder (kDa), 1: E. coli protein lysate after 4 h of growing without induction of overexpression 
of DnaK (DnaK n.i.), 2: E. coli protein lysate 4 h after induction of overexpression of DnaK (DnaK i.), 3: E. coli 
M15 without vector i., 4: uninfected A. castellanii Neff, 5: E25-infected A. castellanii Neff 
 
B. Anti-DnaK gp was tested in various dilutions to demonstrate detection of P. amoebophila-infected amoebae by 
Western blot. 
+: P. amoebophila-infected A. castellanii Neff, -: uninfected A. castellanii Neff 
1:10000, 1:20000: applied dilutions of the anti-DnaK antibody 
 
 
 
 
 
3.3.5.4 Immunofluorescence analysis with antibodies against DnaK obtained by the immunization 
of one chicken (anti-DnaK chick) 
 
After purification of the specific antibodies out of egg-yolks, they were applied in 
immunofluorescence analysis for visualization of DnaK in P. amoebophila.  
IF with the purified pre-immune yolks, diluted 1:100 after inactivation of antibodies, showed no 
signals in A. castellanii Neff harboring P. amoebophilus endosymbionts (data not shown). 
 
The concentration of antibodies was really low in all three egg-yolk collections, thus dilutions up 
to 1:1 were used for indirect immunofluorescence to observe signals. The pre-immune yolk 
always had to be tested in parallel in the same dilution, leading to detection of unspecifically 
bound antibodies at this low dilution. Consequentially, the anti-DnaK chick antibody was 
regarded as too weak for usage in IF experiments and an additional antigen boost was ordered 
after the end of the immunization program in order to stimulate a stronger immune response. 
 
Repeating the assay with this additional egg-yolk collection in a 1:100 dilution after antibody 
inactivation, signals could be observed resembling those for anti-DnaK gp antibodies (Figure 
38B).  
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The specific antibody was used simultaneously with anti-Pam antibodies for the detection of 
outer membrane structures of P. amoebophila. Again, knob-shaped signals for DnaK (shown in 
red) were observed and in an overlay of signals the intracellular localization of DnaK could be 
clearly visualized (Figure 38B, overlay). Already inactivated antibodies could be applied in a 
dilution of up to 1:1000. No signals were detected when applying the same antibody on non-
infected amoeba cells (Figure 38A) as a negative control, resembling the results of the pre-
immune yolk tested in a dilution of 1:1000 in P. amoebophila-infected amoebae (data not 
shown). 
 
 
 
         
          
Figure 38. Localization of DnaK visualized by immunofluorescence analysis. Knob-shaped signales of DnaK can 
be seen in red surrounded by the green signals of anti-Pam (B). 
No signals were observed in empty Neff if using anti-DnaK chick in the same dilution of 1:1000 (A). Bars 5 µm. 
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3.3.5.5 Western blot analysis with anti-DnaK chick antibody 
 
Western blot using anti-DnaK chick was performed in the same way as done before with anti-
DnaK gp. The tested ratio of inactivated antibody was 1:500, applying the pre-immune yolk in 
the same dilution in a parallel experiment. 
Results resembled those of anti-DnaK gp shown in Figure 37A. A strong signal emerging from 
the overexpression of DnaK in E. coli was observed. As expected, the pre-immune serum showed 
no specific signals at all (results not shown). 
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4 Discussion 
 
4.1 Towards the characterization of novel porins from P. amoebophila 
 
The major aim of this study was to illuminate the nature and function of the four members of a 
recently discovered putative porin family. Heterologous expression followed by antibody 
production and lipid-bilayer measurements were performed to investigate the localization and 
function of the porin candidates. 
 
Our knowledge about the outer membrane of environmental chlamydiae is still limited. No 
homologue of the major outer membrane protein (MOMP), the most dominant component of the 
outer membrane in the Chlamydiaceae, could be identified (Caldwell et al., 1981), thus great 
differences in comparison to the clinical chlamydiae are assumed.  
 
Recent studies provided first insights into the outer membrane composition of this novel 
chlamydial lineage by combining 1D and 2D gel electrophoresis with mass spectrometry (Heinz, 
2008). Heinz et al. suggested a novel porin family that could be responsible for the functional 
substitution of MOMP (Heinz, 2008). 
In silico analysis predicted a beta-barrel structure for two of these putative porins, namely 
pc1489 and pc1077, a characteristic feature of porins in general (Nikaido, 2003). The high 
abundance of pc1489 and pc1077 in outer membrane fractions additionally contributes to 
speculations about the importance of these potential porins (Heinz, 2008). As a result, the 
localization of pc1489 to the outer membrane and its function as a porin have already been 
shown in a previous study (Aistleitner, 2009). 
 
4.1.1 Overexpression of outer membrane proteins – problems and solutions 
 
Gene sequences are characterized by unique and subtle structural features, which may complicate 
gene expression as well as translational efficiency of mRNA, individual protein folding and 
degradation effects. Being aware of this, only some empirical “rules” but no standard procedure 
for protein overexpression exist (Makrides, 1996). Even though standing out due to extensive 
knowledge on its genetics and molecular biology, E. coli must not be seen as the answer for an 
efficient overexpression for every gene.  
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Even 30% of proteins from E. coli itself cannot be successfully overexpressed in the E. coli 
expression system (Vincentelli et al., 2003). 
 
 
4.1.1.1 Effects of different E. coli strains for the overexpression of the four porin candidates 
 
Studies have shown that especially overexpression of outer membrane proteins is problematic, 
often achieving no efficient overexpression, since toxicity to the host is a common phenomenon 
observed during heterologous expression (Wagner et al., 2006). In the present study various E. 
coli strains were tested in combination with different expression vectors for heterologous 
expression of the four putative porins, expecting improvement of the expression levels.  
 
This work included experiments using the E. coli strain C43, a member of the so-called “Walker 
strains” derived from E. coli BL21 (DE3) (Miroux and Walker, 1996). Various studies could 
show that the use of E. coli C43 as an expression host correlates with successful overexpression 
of membrane components (Miroux and Walker, 1996; Rogl et al., 1998; Korepanova et al., 
2001). 
 
In most E. coli strains used for heterologous expression of proteins transcription is conducted at a 
very high speed, leading to high amounts of protein, which cannot be processed that quickly. 
Therefore, the process of insertion into the outer membrane is inhibited (Iost et al., 1992). The 
Walker strains feature mutations in the lacUV5 promoter region, which exclusively controls the 
T7 RNA polymerase that is used to drive recombinant protein production in E. coli (Miroux and 
Walker, 1996). As the high transcription level can be reduced by these mutations, the Walker 
strain C43 was used for overexpression of the four putative porins. A low transcriptional rate 
would contribute to correct folding and processing of these outer membrane components without 
aggregation and further formation of inclusion bodies. 
 
However, the use of E. coli C43 did not lead to a successful overexpression of the constructs 
based on the vectors pet21b and pet16b.  
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4.1.1.2 Effects of different vectors and tags for purification of overexpressed porin candidates 
 
Different constructs were designed for an optimized heterologous expression of the four putative 
porins in E. coli. 
 
Porins feature a leader sequence at the N-terminus, necessary for directing the nascent 
polypeptide to the outer membrane, where this “leader” gets finally cleaved (Mizuno et al., 
1983). Therefore, we focused on the vector pet 21b, featuring a 6x His at the C-terminus, which 
would not be affected by the cleavage of the N-terminal leader sequence of porins. This vector 
was successfully applied during overexpression of outer membrane proteins of E. coli (Shin et 
al., 2005) and Rickettsia japonica (Uchiyama et al., 2006), but no detectable overexpression of 
the porin candidates was achieved in the present study. 
In addition, the vector pet16b was used, which has been successfully applied for the 
overexpression of inclusion membrane proteins of P.amoebophila (Heinz, 2004) and membrane 
proteins from Mycobacterium tuberculosis (Korepanova et al., 2005). Also this attempt of 
heterologous expression of the porins failed during our work. 
 
The vector pQE-30, based on the T5 promoter transcription–translation system (Bujard et al., 
1987), was further chosen for overexpression. Efficient repression of the powerful T5 promoter is 
ensured by the presence of high levels of the lac repressor protein. Therefore, an E. coli strain 
featuring the plasmid pREP4 is required for overexpression, since this plasmid constitutively 
expresses the lac repressor (Farabaugh et al., 1978). As a result, our constructs based on the 
vector pQE-30 could not be overexpressed in E. coli C43 due to the requirement of the E. coli 
M15 host strain (Quiagen, The QIAexpressionist). Using this strain and the vector pQE-30 did 
not lead to a successful overexpression of native-leadered porin candidates, either.  
 
There is an ongoing discussion in the literature about the effects of different fusion tags, since in 
general they are thought to have little influence on protein structure (Scholtz, 1995). However, it 
has been demonstrated that terminal extensions may change protein stability and folding 
properties (Korepanova et al., 2001). A study by Alam et al. showed that some proteins are 
completely insoluble with an N-terminal histidine tag, whereas a C-terminal tag contributes to 
solubility in a favourable way (Alam et al., 2002). 
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To date, polyhistidine tags (His-tags) are considered to be most effective for the expression of 
soluble proteins (Edwards et al., 2000). Considering this and standing out due to it easy handling, 
this work focused on using the His-tag (Porath, 1992) as well as the GST-tag, encoding the 
glutathione-S-transferase (Smith and Johnson, 1988). The latter tag is characterized by the GST 
molecule featuring a molecular weight of 26 kDa, providing a possibility for masking a toxic 
protein (Terpe, 2003).  
 
We used the vector pgEX-4T-3, which leads to an N-terminal fusion of the expressed protein 
with GST. The putative porins are considered to be problematic during overexpression due to 
their lethal effects, hence, the GST-tag may hide the original function from the E. coli host to 
finally get expressed and even processed without being recognized as harmful for the host cell. In 
addition, all pgEX vectors are engineered with an internal lacIq gene which contributes to 
repression of the tac promoter, thus maintaining tight control over expression of the insert (GST 
Gene Fusion System, Amersham Biosciences). 
 
Constructs based on the vector pgEX-4T-3 were overexpressed in E. coli C43 for low expression 
rates as well as in E. coli BL21(DE3), both strains deficient in known cytoplasmic protease gene 
products, as OmpT, DegP or HtpR. This special feature may assist in the expression of fusion 
proteins by minimizing the effects of proteolytic degradation by the host (Grodberg and Dunn, 
1988; Strauch and Beckwith, 1988; Sugimura and Higashi, 1988).  
 
Interestingly, the vector pgEX-4T-3 turned out to feature optimal conditions for heterologous 
expression of each of the four porins. We assumed that Western blot analysis showed processing 
of the proteins, since an additional band at about the expected molecular weight of the GST-tag 
(26 kDa), which was originally fused to the N-terminus of the leader sequence, got visible after 
overexpression. However, GST-fusion proteins are supposed to be quite unstable and 
spontaneous cleavage events of the GST-tag appear frequently (GST Gene Fusion System, 
Amersham Biosciences). Therefore, detection of a separated GST-tag by Western blot analysis 
does not directly imply correct processing and cleavage of the leader sequence. 
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4.1.1.3 Effects of changes in the leader sequence and the formation of inclusion bodies 
 
Frequently, overexpression of membrane proteins can be achieved, though only in connection 
with the formation of inclusion bodies and no successful way of refolding into functional 
proteins (Drew et al., 2003). Studies dealing with MOMP of clinical chlamydiae demonstrated 
the effects of changes in the leader sequence by comparing the expression levels of various 
constructs (Findlay et al., 2005). Findlay et al. could show that overexpression of leaderless 
MOMP is connected to protein misfolding and aggregation, contributing to the formation of 
inclusion bodies and requiring refolding of the protein. Heterologous expression of MOMP was 
improved by using either the native leader or the E. coli OmpT leader under slow induction 
conditions (Findlay et al., 2005).  
 
These studies have clearly demonstrated that successful expression and processing apparently 
depend on the precise leader sequence (Findlay et al., 2005). Based on these findings, our 
additional approach for porin overexpression contained a total cut-off of the signal sequence as 
well as its substitution with the E. coli leader sequence of the ompT gene (Baneyx, 1999). Using 
an E. coli leader sequence is supposed to affect correct processing in a favorable way (Baneyx, 
1999). Correct incorporation into the outer membrane of E. coli would further offer the 
opportunity for functional analysis in vivo, testing transportation behavior in respect of nutrients 
or antibiotics, further illuminating the nature of the putative porins. Unfortunately, heterologous 
expression of pc1860, after substitution of its native leader sequence with the E. coli OmpT 
leader sequence, did not lead to detectable amounts of overexpressed protein. 
 
During this work we had to cope with inclusion bodies, especially when using leaderless porins 
for overexpression experiments, being consistent with the findings for leaderless MOMP 
(Findlay et al., 2005) and other leaderless outer membrane proteins (Bannwarth and Schulz, 
2003). Inclusion bodies were visible as white colonies and pellets during and after 
overexpression experiments, implying problems for the E. coli host while dealing with this 
foreign protein. 
 
Using the online tool “Recombinant protein solubility prediction” (www.biotech.ou.edu) we 
inspected the probability of inclusion body formation after overexpression of the porins. This 
method is based on six parameters only derived from the protein´s amino acid composition 
(Wilkinson and Harrison, 1991).  
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We compared the values for the four porin candidates with the cytoplasmic protein DnaK in 
Table 27, showing that the formation of inclusion bodies during overexpression of the porins was 
highly likely. 
 
Table 27. Probability of the formation of inclusion bodies after overexpression of the porins using the online tool 
“Recombinant protein solubility prediction” (www.biotech.ou.edu) 
 
Protein Solubility prediction 
Hints for inclusion bodies after 
overexpression 
pc0870 85 % insoluble yes 
pc1077 80 % insoluble yes 
pc1489 79 % insoluble yes 
pc1860 88 % insoluble yes 
DnaK 58 % soluble no 
 
 
The aggregation of toxic proteins in inclusion bodies is an advantage if high amounts of pure 
protein are needed, as it contributes to suppression of the lethal effect on the host cells 
(Makrides, 1996). Since antibody production requires proteins of high purity and high 
concentration, the present study used the overexpression approach of the porin pc1077 without 
leader sequence for the generation of antibodies despite of the formation of inclusion bodies. 
 
Inside inclusion bodies the overexpressed proteins are typically found in an insoluble and 
biologically inactive form. To address the problem of correct refolding chromatography or 
refolding in solution are proposed (Swietnicki, 2006). In addition, Singh et al. could show that 
mild solubilization contributes to high recovery of the bioactive native confirmation of proteins 
(Singh and Panda, 2005). 
 
 
4.1.2 Hints for toxicity 
 
The toxic effect of porins is derived from pore-forming activities by building holes in the outer 
membrane of E. coli cells with lethal effects (Koehler et al., 1992; Findlay et al., 2005). As 
different studies have already shown, the maintenance of a stable clone for MOMP turned out to 
be problematic (Pickett et al., 1988; Koehler et al., 1992) and this was also true in the present 
study during overexpression of the porins from P. amoebophila. 
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Studies by Koehler et al. visualized the lethal effects of MOMP for a foreign host by comparing 
induced and non-induced cells. Colony-forming-units were plotted over time, resulting in a 
dramatic drop already 10 min after induction, which was not as obvious in the actual cell culture 
(Koehler et al., 1992). Notable hints for toxicity could hardly be observed in our studies of the 
four putative porins, since OD measurements at 600 nm revealed only slight differences between 
induced and non-induced E. coli cultures. In fact, differences in the cell density could only be 
observed for the induced culture expressing the porin pc1077 in the vector pgEX, therefore 
giving considerable evidence for pore-forming activity and resulting in reduced growing 
potential of the E. coli expression culture. Thus, it can be assumed that pc1077 features 
functional characteristics of a porin, but OD measurements did not show the final proof. 
 
As a negative control, OD measurements during an overexpression of the cytoplasmic protein 
DnaK and the inclusion membrane protein pc1111 (kindly provided by Eva Heinz) were 
performed. The growth potential of E. coli cultures expressing the constructs for these two 
proteins did not show changes in comparison to E. coli cells without induction of overexpression, 
demonstrating that proteins of P. amoebophila are not per se toxic for E. coli. But effects of the 
tag or even the vector itself could contribute to wrong interpretations of the optical density of 
induced E. coli expression cultures. In fact, previous studies demonstrated that plasmids and 
associated tags even without any insert can have lethal effects on E. coli host cells (Miroux and 
Walker, 1996; Dumon-Seignovert et al., 2004; Wagner et al., 2007). 
Thus, it remains questionable to directly link reduced growing potential to lethal effects due to 
pore-forming activities of the porins. 
 
An observation after transformation of the respective E. coli cells with the construct for 
overexpression hints at toxic effects of the porin candidates pc1077 and pc0870, though. 
Reduced growing potential on agar plates could be directly linked to positive screening results, 
since badly grown clones were shown to carry a plasmid with the desired porin as insert.  
This observation gives an additional proof of correct processing, incorporation into the outer 
membrane and negative or even lethal effects for E. coli host cells. 
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4.1.3 Disulfide bridges of the putative porins in a reducing environment 
 
According to sequence analyses, the four putative porins of P. amoebophila contain a high 
number of cysteines, an unexpected feature of porins in general (Nikaido, 2003). Challenges of 
expressing disulfide-rich proteins arise from the reducing conditions of the cytoplasm of E. coli 
cells (Stewart et al., 1998). As disulfide formation requires cysteine oxidation, this process 
naturally takes place within the periplasmic space in E. coli.  
 
Heterologous expression of the porins in an E. coli host cell takes place in the cytoplasm of the 
cell, thereby exposing the newly processed protein to a more reducing potential (Baneyx and 
Mujacic, 2004). Little is known about the involvement of intramolecular disulfide bonds for 
correct structural folding of cysteine-rich proteins. Hence, an overexpression of these putative 
porins in a reducing environment would probably result in formation of aggregates and inclusion 
bodies.  
 
Considering these general findings, an explanation for the failure of different overexpression 
constructs of the putative porins during this work can be hypothesized. In many approaches no 
changes in the expression level could be detected possibly due to unfolding or aggregation of 
proteins. Therefore, an unexpected running behaviour on SDS-PAGE gels seems possible. 
 
 
4.1.4 Localization of pc1860 in the outer membrane of E. coli host cells 
 
After heterologous expression of MOMP in E. coli, immunofluorescence experiments with anti-
MOMP antibodies clearly visualized the localization either in the outer membrane of the E. coli 
host cells or in inclusion bodies if a construct without leader sequence was overexpressed 
(Findlay et al., 2005). 
 
We wanted to demonstrate incorporation of the porin pc1860 into the outer membrane, after 
correct processing and folding, by immunofluorescence analysis with E. coli cultures after an 
overxpression of native-leadered pc1860 in the vector pgEX. By comparing induced E. coli C43 
cells without a vector and an induced expression culture of the same strain, indications for 
incorporation into the outer membrane got visible. 
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Signals of the anti-GST antibody appeared in the induced expression culture, but not in the 
control cells, suggesting an expression of pc1860 as a fusion protein with GST. Detection of the 
N-terminal GST-tag in the outer membrane would reflect problems during processing (Mizuno et 
al., 1983). Cutting off the leader sequence, fused to GST, seemed to be disturbed leading to 
incorporation of the whole length protein into the outer membrane. Arguing against a proper 
incorporation, it could be hypothesized that the porin was just expressed as a fusion protein with 
GST, without processing and translocation to the correct place. 
 
Another theory suggests that the signal peptide, linked to the GST-tag, was cut off and the 
mature porin was exposed to the surface. Hence, staining with anti-GST antibodies would detect 
the signal peptides tagged with GST and not the actual porin of interest. 
 
 
4.1.5 Localization of the porin candidate pc1077 
 
Pc1077 and pc1489 are considered to be responsible for the substitution of MOMP of the 
Chlamydiaceae (Heinz, 2008), hence their localization in the outer membrane of P. amoebophila 
should get clearly visible by staining with specific antibodies. Previous studies using anti-pc1489 
antibodies showed a halo-shaped signal, consisting of single signals from incorporated pc1489 in 
the outer membrane (Aistleitner, 2009). Moreover, pc1489 was successfully visualized as a 
component of the outer membrane by transmission electron microscopy (pictures taken by 
Jacqueline Montanaro). 
 
As pc1077 and pc1489 could be equally detected in outer membrane fractions (Heinz, 2008), 
maybe due to their high occurrence, we suggested that pc1077 and pc1489 are functionally 
interacting or even linked to each other. Antibodies against pc1077 could be used for further 
analysis of interactions between pc1489 and pc1077, either during immunofluorescence 
experiments or for Western blot analysis, maybe contributing to our understanding of the 
unexpected running behavior of pc1489 on SDS-PAGE gels, since this phenomenon was 
observed in Western blots by Karin Aistleitner. 
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4.1.5.1 Unexpected signals from the pre-immune serum in immunofluorescence analysis 
 
Unexpected signals were observed when using the pre-immune serum on P. amoebophila-
infected amoebae. Since chlamydiae are ubiquitous (revisited by Horn, 2008), a former 
chlamydial infection of the rabbits is a possible explanation. In this case, chlamydia-specific 
antibodies would have already been present before the actually planned immunization. 
 
Notably, Western blot analysis confirmed that the large bleed contained pc1077-specific 
antibodies, visualized by an additional band at the expected molecular weight beside the 
unspecific background in E. coli. Evidence for specificity of the anti-pc1077 antibody is given, 
though a successful usage in IF was not realized. 
 
Recent studies on outer membrane fractions of P. amoebophila proved the fact of specific 
binding capacities of anti-pc1077 antibodies in comparison to the pre-immune serum. Detection 
of pc1077 (39 kDa) was clearly demonstrated in Western blot experiments beside the detection 
of bands of lower molecular weight than expected, when using anti-pc1077 antibodies (analysis 
done by Karin Aistleitner). These findings are in accordance with results of mass spectrometry 
performed with COMC, where pc1077 was also detected in bands of lower molecular weight 
than 39 kDa (Heinz, 2008). To date, further processing of pc1077 or degradation effects 
represent unknown issues and remain to be analyzed.  
 
 
  
Figure 39. Detection of pc1077 in the outer membrane fraction of P. amoebophila by anti-pc1077 antibodies 
(B, red arrow). In comparison, the pre-immune serum did not show any signals at all (A). Additional bands of lower 
molecular weight than expected were visualized by anti-pc1077 maybe due to degradation and further processing of 
the porin pc1077. Antibodies were applied 1:500. 
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4.1.5.2 Immunogenic potential of pc1077 
 
In contrast to naturally folded pc 1489 (Aistleitner, 2009), pc1077 without leader sequence 
cannot be considered as a highly immunogenic antigen, since the reaction of the immune system 
and the production of specific antibodies seems to be repressed. Even with the large bleed, no 
strong and specific signals for the outer membrane could be observed by IF. 
 
The weak specificity of anti-pc1077 antibodies in immunofluorescence experiments potentially 
reflects problems during the process of purification. The involvement of co-purified E. coli 
proteins has to be considered (Graslund et al., 2008), therefore triggering the antibodies against 
additional proteins of E. coli origin and leading into weak affinity to the original target pc1077. 
 
Low immunogenic reactions may correlate with the use of urea as a strong denaturing agent 
during protein purification (Brandts and Hunt, 1967). The application of urea got essential, since 
insoluble pc1077 aggregated in inclusion bodies during the process of overexpression, but maybe 
affected the potential of pc1077 as an antigen in a negative way. Defolding and denaturing of 
proteins are considered to have non-predictable consequences during immunogenic reactions of 
the host´s immune system. The major antigenic determinant could be lost after denaturation in 
8M urea (Ishizaka et al., 1975), contributing to reduced specificity of the antibody if 
encountering the mature and correctly folded protein in vivo or fixed. 
 
In an additional approach, purification without urea was performed. Although the amount of 
soluble protein was considerably low, one of the purified fractions appeared suitable for further 
analysis by showing an adequate amount of pc1077 and a high grade of purity. To date, the 
effects of using pc1077 in its natural folding for the production of specific antibodies were not 
known. 
 
4.1.6 Functional analysis of pc1077 
 
In general, lipid bilayer measurements provide the opportunity for an accurate determination of 
existing pore-forming proteins in a sample (Benz et al., 1988; Findlay et al., 2005). As the 
function of pc1489 as a porin was confirmed already with the help of this method (Aistleitner, 
2009), it was also applied to elucidate the functional nature of pc1077 in more detail. A 
functional similarity could be reasoned (Heinz, 2008).  
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The amino acid sequence similarity within the four members of the putative porin family of P. 
amoebophila was determined as 22-28% (Heinz, 2008), but a functional prediction based on 
similarities only is not possible. However, in the COMC of C. trachomatis a protein with about 
20% sequence identity to MOMP could be identified. This protein known as PorB was shown to 
have an even more specific porin function compared to MOMP (Kubo and Stephens, 2000). In 
contrast, the three dominant porins of E. coli, OmpC, OmpF and PhoE, share about 60 % 
sequence homology and just vary slightly in ion-selectivity and pore size (Mizuno et al., 1983).  
 
Also MOMPs of C. psittaci and C. trachomatis differ significantly in ion selectivity, suggesting 
that selectivity for cations or anions results from the variable domains exposed to the surface 
(Hughes et al., 2001). Referring to these findings, the putative porins of P. amoebophila could 
show functional differences, including different expression patterns during an infectious cycle or 
variations in the ion-selectivity. 
 
During lipid bilayer measurements, the sample which is supposed to contain a porin is added to 
artificial lipid bilayers followed by a stepwise increase in conductance. Each step indicates 
incorporation of one pore into the membrane (Benz et al., 1988). Unfortunately, lipid-bilayer 
measurements could not give the expected proof of the function of pc1077 as a porin, since we 
had to encounter some unexpected problems with the negative control. This negative control was 
created under exactly the same conditions as the actual sample after overexpression of pc1077. 
However, a contamination with the E. coli porin OmpF (Mizuno et al., 1983) was detectable in 
the negative control, making the data obtained by these lipid-bilayer measurements insignificant. 
Even though pores were detected in the sample, it remains questionable whether they actually 
originated from a contamination with E. coli porins or from the analyzed putative porin pc1077. 
 
This work did not concentrate on correct refolding of pc1077, thus its purification out of 
inclusion bodies may also have negative effects on functional analysis of pc1077 by lipid-bilayer 
measurements.  
 
 
4.1.6.1 Avoiding contaminations with the E. coli porin OmpF 
 
The co-purification of OmpF with a His-trap column cannot be explained easily (Graslund et al., 
2008). Interestingly, only one histidine resides in the amino acid sequence of OmpF, making the 
co-purification of this E. coli porin even more inexplicable (Klebba et al., 1990). 
4 Discussion 
120 
One single porin represents the detection limit of lipid-bilayer measurements, hence the use of 
other purification methods could ensure samples of high purity without E. coli contaminations. 
Separation of pc1077 from OmpF seems to be possible due to differently predicted isoelectric 
points (Tudor and Karp, 1994; environmental chlamydia genome database). Also anti-OmpF 
antibodies could be used to detect contaminations in future approaches (Fourel et al., 1992). 
 
Repetition of lipid-bilayer measurements is planned, analyzing purified pc1077 which was not 
exposed to the strong denaturing agent urea and did not undergo the process of precipitation after 
purification in order to maintain the natural secondary structure of pc1077. Additionally, 
unspecific binding of proteins with no His-tag, like E. coli porins, to a His-trap column may be 
reduced due to the natural folding of proteins, which have not been denatured by urea. 
 
The aggregation and binding of unspecific proteins to the matrix can be assumed if no His-tagged 
proteins are bound to the column (Waugh, 2005). But even in the presence of His-tagged pc1077, 
showing high affinity to the binding matrix, a co-purification cannot be excluded, since again E. 
coli proteins could stick unspecifically to the column followed by co-elution at a distinct 
imidazole concentration. Also the impact of urea has to be considered, as discussed above. 
 
Knock-out strains offer the perfect possibility to exclude a possible contamination with E. coli 
porins (Bannwarth and Schulz, 2003). As an example, E. coli BL21(DE3)omp8 is a porin-
deficient strain that lacks the outer membrane proteins OmpF, OmpC, OmpA, and LamB 
(Prilipov et al., 1998). Hence, successful overexpression of pc1077 in this strain seems to be 
possible followed by purification, where the co-purification of other E. coli porins can be 
reduced. Though the expression construct of pc1077 without leader sequence is based on the 
vector pQE-30, which requires the E. coli M15 strain, characterized by containing the plasmid 
pREP4, as host. The lac repressor encoded on this plasmid ensures a tightly regulated expression 
and the optimal conditions for the process of overexpression (The QIAexpressionist, Quiagen). 
Nevertheless, pQE-30 has been successfully tested in other E. coli expression strains during our 
work, leading to detectable levels of heterologously expressed porins. 
 
As a conclusion, these different methods provide the opportunity to finally create samples 
applicable for lipid-bilayer measurements.  
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4.2 Transcription analysis of pc1489 during an infectious cycle 
 
Recent studies demonstrated that the porin pc1489, one member of the novel putative porin 
family of P. amoebophila, is present throughout the whole developmental cycle by using specific 
antibodies (Aistleitner, 2009). Hence, the presence of this protein in EBs as well as in RBs was 
proven, comparable to results of studies with MOMP of clinical chlamydiae (Hatch et al., 1986). 
However, increased signal intensity at later time points could not be clearly explained. 
Incorporation of newly synthesized pc1489 into the outer membrane or structural changes of 
pc1489, which led to better binding of anti-pc1489 antibodies to its target protein, could be 
responsible for this increase in signal intensity at later time points of the developmental cycle 
(Aistleitner, 2009). 
 
We studied the expression pattern of pc1489 during a developmental cycle, based on studies with 
clinical chlamydiae (Belland et al., 2004; Maurer et al., 2007). Accordingly, we chose distinct 
time points for the transcription analysis of pc1489 until 96 h post infection (h p.i.). This last 
time point represents the end of one complete developmental cycle of P. amoebophila and is 
characterized by the release of infectious EBs (König, 2008). 
 
 
4.2.1 Gene expression profiles - early vs. late genes 
 
Studies of pathogenic chlamydiae identified subsets of genes belonging to different clusters, 
according to their transcriptional pattern throughout an infectious cycle (Belland et al., 2003; 
Gomes et al., 2005; Maurer et al., 2007)). Different gene categories, like the “early” and the 
“late” gene-clusters, were proposed. Additionally to the third “mid” genes, Mäurer et al proposed 
a fourth cluster class, the so called “tardy” genes (Maurer et al., 2007). 
 
A previous study concentrated on the expression pattern of the heat shock protein GroEL of P. 
amoebaphila, identifying GroEL as a member of the immediate-early genes (Haider, 2004). 
According to the findings of Belland et al., this heat shock protein is involved in processes 
occurring quite early during an infection. Haider et al. observed an increase of transcription at 24 
h p.i. (Haider, 2004), whereas GroEL of C. trachomatis showed changes in the expression levels 
already within 6 h p.i. (Belland et al., 2003; Gomes et al., 2005). 
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We focused on the expression profile of the porin pc1489 of P. ameobophila. Previous studies 
with C. trachomatis and C. pneumoniae could show that especially genes encoding structural 
components for outer membrane stability are associated with the late gene cluster, like the 
cysteine-rich proteins OmcA and OmcB (Belland et al., 2003; Gomes et al., 2005; Maurer et al., 
2007). Moreover, it was shown that expression of ompA encoding MOMP of C. trachomatis was 
upregulated later in the development in comparison to the heat shock protein GroEL (Gomes et 
al., 2005). Hence, we aimed to identify the cysteine-rich porin pc1489 as a possible member of 
the “late” gene-cluster expecting a similar expression pattern as outer membrane components of 
clinical chlamydiae. 
 
Transcription analysis showed a 10-fold increase of normalized pc1489 RNA at the latest time 
point 96 h p.i., being in accordance with characterization as a late gene. However, it does not 
demonstrate the drastic differences like the expression profile of ompA in C. trachomatis, where 
a 17-fold increase between 6 and 24 h p.i. was observed (Gomes et al., 2005). In C. trachomatis, 
the time point 24 h p.i. is associated with the beginning of late stages of the developmental cycle. 
At this growth phase a lot of membrane components for newly formed organisms are needed 
(Hatch et al., 1986). 
 
 
4.2.2 pc1489 carry-over mRNA 
 
Interestingly, the copy numbers of pc1489 seem to be notably high throughout the whole 
developmental cycle. This observation suggests that high rates of carry-over mRNA from RBs to 
EBs correlate with the high importance of pc1489 in the outer membrane. This would be in 
accordance with findings of MOMP, as Gomes et al. detected a constantly higher level of ompA 
mRNA in comparison to groEL mRNA throughout the development, including a high level of 
carry-over mRNA at 2 h p.i. (Gomes et al., 2005). 
 
The decrease of transcripts 24 h p.i. is not reflecting a transcriptional decrease but since not all 
EBs are able to infect a host cell at 0 h p.i., the excess EBs and their mRNA were removed after 
this initial infection, leading to a decrease in detectable mRNA 24 h p.i.. Carry-over mRNA does 
not always appear to be translationally active immediately, since studies of clinical chlamydiae 
could show that omcA mRNA is not directly linked to omcA synthesis early in infection (Hatch et 
al., 1986; Douglas and Hatch, 2000).  
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Findings of qPCR of the present study primarily reflect that the expression profile of pc1489 
resembles those of other outer membrane proteins of the Chlamydiaceae (Belland et al., 2003; 
Maurer et al., 2007). An up-regulation during late stages of the developmental cycle identified 
pc1489 as a member of the “late” gene-cluster and clearly visualizes the importance of pc1489 in 
processes of re-differentiation from RBs to infectious EBs. High amounts of carry-over mRNA 
further suggest a high importance of pc1489 as an outer membrane component in general. 
 
 
 
 
4.3 Conclusion 
 
4.3.1 Characterization of novel porins from P. amoebophila 
 
Outer membrane proteins of P. amoebophila are considered to be key players in the initial steps 
of host cell invasion. In this work, preliminary insights into the nature of the four members of a 
recently discovered putative porin family were obtained. Although porin function and 
localization were not clearly identified, constitutive experiments promise to show significant 
results. Successful overexpression of each of the four putative porins represents the optimal basis 
for future studies focusing on the nature, structure or function of outer membrane proteins. 
 
Moreover, the developmental expression of pc1489, one member of the putative porin family, 
was analyzed. An increased transcription of pc1489 towards the end of the cycle identified this 
porin as a “late” gene with an important role throughout the whole cycle. High amounts of 
transcripts were detectable in both EBs and RBs validating the results of previous 
immunofluorescence experiments (Aistleitner, 2009). 
 
 
4.3.2 Generation of an internal standard for immunofluorescence experiments 
 
The heat-shock protein DnaK was chosen for the generation of a new standard antibody 
characterized by intracellular localization. These intracellular signals for DnaK help to show 
permeability of cells if other antibodies were applied simultaneously.  
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Since DnaK is a highly conserved protein throughout different organisms, antibodies against 
DnaK of P. amoebophila also detect homologues of this protein in Waddlia chondrophila and 
Simkania negevensis (analyses done by Karin Aistleitner and Barbara Sixt). 
 
As a conclusion, anti-DnaK antibodies were created and the usage as a new standard antibody in 
immunofluorescence experiments was successfully tested. 
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5 Summaries 
 
5.1 Abstract 
 
The phylum Chlamydiae comprises important pathogens for humans and animals. They all share 
an obligate intracellular lifestyle and a characteristic biphasic developmental cycle. Attachment 
and entering a host cell represent crucial steps, and outer membrane proteins are considered to be 
key players during these first steps of infection. 
 
This work focused on the characterization of four putative porins from P. amoebophila - pc0870, 
pc1077, pc1489 and pc1860 - which are proposed for being responsible for the substitution of the 
major outer membrane protein (MOMP) of the Chlamydiaceae. Using E. coli for heterologous 
expression of these four porin candidates, various expression vectors were tested in different E. 
coli strains under optimized conditions. Finally, all members of the putative porin family were 
successfully overexpressed, as shown by SDS-PAGE and Western blot analysis, and used for 
further analysis. 
 
During heterologous expression we tried to detect toxic effects of the putative porins if processed 
correctly and incorporated into the outer membrane of E. coli. Thereby formed channels are 
supposed to have lethal effects on the foreign host. However, measurements of the optical 
density did not contribute to a functional characterization of the putative porins. Also lipid-
bilayer measurements, suitable for an accurate determination of existing pore-forming proteins, 
did not validate the function of the putative porins because of contaminations with the E. coli 
porin OmpF in the negative control. Moreover, antibodies against one of the putative porins, 
namely pc1077, were generated to visualize localization of the proposed porin in the outer 
membrane of P. amoebophila by immunofluorescence analysis. 
 
Additionally, qPCR promised new insights into the transcriptional profil of the porin pc1489. 
Based on findings of outer membrane proteins of clinical chlamydiae, pc1489 is regarded as a 
member of the late gene cluster, being important during late stages of the developmental cycle. 
This supports the theory of pc1489 as a key player during the process of re-differentiation from 
RBs to EBs, where outer membrane stability is of particular importance. 
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A third project focused on the generation of a standard antibody for immunofluorescence 
analyses. If antibodies targeting outer membrane components of P. amoebophila are applied, a 
standard antibody against an intracellular protein has to be used simultaneously in order to 
demonstrate permeability of the cells. For this purpose, the cytoplasmic protein DnaK was 
successfully overexpressed in E. coli, followed by generation of specific antibodies. The 
specificity of these anti-DnaK antibodies was successfully tested in immunofluorescence 
experiments by showing intracellular localization and was also proven by Western blot analysis. 
In addition, cross-reactivity of this new standard antibody was tested, since DnaK is a highly 
conserved protein throughout different organisms. As a result, antibodies against DnaK of P. 
amoebophila also detect homologues of this protein in Waddlia chondrophila and Simkania 
negevensis. 
 
This work is regarded as a basis for follow-up studies of the structure and function of outer 
membrane components from P. amoebophila and their involvement during initial stages of host-
cell invasion. 
 
 
5.2 Zusammenfassung 
 
Das Phylum Chlamydiae beinhaltet einige wichtige bakterielle Krankheitserreger, die sowohl für 
den Menschen als auch für die Tierwelt eine potentielle Gefahr darstellen. Alle Chlamydien 
zeichnen sich durch eine obligat intrazelluläre Lebensweise aus, die mit einem charakteristischen 
Lebenszyklus in Verbindung gebracht werden kann. Eine kritische Phase stellt dabei das 
Eintreten des Bakteriums in die eukaryotische Wirtszelle dar, bei der Außenmembranproteinen 
eine wichtige Rolle spielen. 
 
Im Zuge dieser Diplomarbeit wurde an der Charakterisierung einer kürzlich entdeckten Porin-
Familie aus P. amoebophila gearbeitet, deren Mitglieder - pc0870, pc1077, pc1489 und pc1860 - 
möglicherweise die Funktion des „major outer membrane protein“ (MOMP) der klinischen 
Chlamydien ersetzen könnten. E. coli wurde als geeignetes Modelsystem herangezogen, um die 
vier potentiellen Porine unter optimalen Bedingungen heterolog zu exprimieren. Dafür wurden 
verschiedene Expressionsvektoren in unterschiedlichen E. coli Stämmen eingesetzt. Als Ergebnis 
konnte schlussendlich die Überexpression von allen vier Porin-Kandidaten mittels SDS-PAGE 
und Western Blot Analyse detektiert und für weiterführende Experimente verwendet werden. 
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Mit Hilfe heterologer Expression sollten mögliche toxische Auswirkungen der potentiellen 
Porine auf die E. coli Wirtszelle nachvollzogen werden. Mittels Messungen der optischen Dichte 
konnte jedoch nicht eindeutig gezeigt werden, dass die Porine Kanäle in der Außenmembran 
bilden und somit letale Auswirkungen auf die Wirtszelle haben. Zusätzlich sollten Messungen an 
künstlichen Lipid-Membranen eine klare Aussage über die Funktion der potentiellen Porine 
liefern, aber auch diese Methode erzielte leider nicht die gewünschten Resultate. Es konnte 
jedoch eine Grundlage für Verbesserungen zukünftiger Experimente geschaffen werden und 
aussagekräftige Messungen zur Bestimmung der Funktion als Porin scheinen durchführbar und 
auch viel versprechend. 
Weiters wurde die Produktion von Antikörpern als geeignete Methode gewählt, um die 
Lokalisierung des Porins pc1077 in der Außenmembran von P. amoebophila zu zeigen.  
 
In einem zusätzlichen Projekt wurde das Transkriptionsprofil von pc1489 mittels qPCR 
untersucht. Die daraus resultierenden Ergebnisse entsprachen den Erwartungen, die von Studien 
der Außenmembrankomponenten von klinischen Chlamydien abgeleitet werden konnten. pc1489 
wurde somit dem „late gene“ Cluster zugeordnet, dessen Mitglieder vor allem zu späteren 
Zeitpunkten des Entwicklungszyklus große Wichtigkeit zugesprochen wird. Dieses Ergebnis 
unterstützt die Theorie, pc1489 als Schlüsselfaktor im Prozess der Umstrukturierung von RBs zu 
EBs zu sehen, während dem hohe Stabilität der Außenmembran von größter Bedeutung ist. 
 
Im Rahmen eines dritten Projektes wurde ein neuer Standardantikörper generiert, um mit 
Immunfluoreszenz Zellpermeabilität zu demonstrieren. Bei der Verwendung von Antikörpern, 
die gezielt Komponenten der Außenmembran von P. amoebophila detektieren sollen, ist der 
Vergleich zu intrazellulären Signalen essentiell, um signifikante Aussagen machen zu können. 
Zu diesem Zweck wurde das cytoplasmatische Protein Dnak erfolgreich in E. coli überexprimiert 
und spezifische Antikörper wurden generiert. Die Spezifität dieser Antikörper konnte mittels 
Immunfluoreszenz visualisiert und durch Western Blot Analysen bestätigt werden. Außerdem 
wurde der neu generierte Standardantikörper gegen DnaK von P. amoebophila erfolgreich für die 
Detektion homologer Proteine in Waddlia chondrophila und Simkania negevensis eingesetzt. 
 
Diese Arbeit bietet eine viel versprechende Grundlage, um unser Wissen im Hinblick auf die 
Außenmembranbestandteile von P. amoebophila, ihrer Funktionen und Strukturen und 
letztendlich ihrer Rolle während des ersten Kontakts von Chlamydien mit ihren Wirtszellen zu 
vertiefen. 
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6 List of abbreviations 
 
16S rRNA small ribosomal subunit RNA 
1D one-dimensional 
2D two-dimensional 
3` three prime end of nucleic acids 
5` five prime end of nucleic acids 
% percentage 
°C degree celcius 
λ wavelength 
μ micro (10-6) 
Ø  diameter 
A. Acanthamoeba 
A adenine 
ab antibody 
ACN acetonitrile 
Amp ampicillin 
APS ammonium persulfate 
ARB software package for phylogenetic analyses (from lat. arbor) 
ATP adenosine-5'-triphosphate 
bidest. bidestillatus (double destilled) 
BLAST basic local alignment search tool 
bp base pairs 
BSA bovine serum albumin 
c centi (10-2) 
C. Chlamydia or Chlamydophila 
C cytosine 
CA California 
Cam Chloramphenicol 
CBs crescent bodies 
cDNA complementary DNA 
CLSM confocal laser scanning microscope 
COMC chlamydia outer membrane complex 
Corr  correlation coefficient 
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Cy2 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy2.18-derivative N-hydroxysuccimidester  
Cy3 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy3.18-derivative N-hydroxysuccimidester  
Cy5 5,5`-di-sulfo.1,1`-di-(X-carbopentynyl)-3,3,3`,3`-tetra-methylindol-
Cy5.18-derivative N-hydroxysuccimidester 
Da Dalton, unit of mass 
DAPI 4’, 6-diamidino-2-phenylindole 
ddNTPs didesoxynucleotides 
DDT dithiothreitol 
DEPC di-ethyl-pyrocarbonate 
DIC differential interference contrast 
DNA desoxyribonucleic acid 
DNase desoxyribonuclease 
dNTP desoxyribonucleotide triphosphate 
E. Escherichia 
EB(s) elementary bodies 
EDTA ethylenediaminetetraacetic acid 
e.g. exempli gratia (lat., “example given”) 
et al. et alteri (lat., “and others”)  
EtBr ethidium bromide 
EtOH ethanol 
EtOHabs.  ethanol absolute 
F forward (used for labelling of primers) 
FA formamide; formaldehyde 
Fig. figure 
FITC fluorescein isothiocyanate 
g gram 
G guanine 
GST glutathion-S-transferase 
h hour(s) 
H2O water 
H2O2 hydrogen peroxide 
H2Odd double distilled and filtered water 
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HCl hydrochloric acid 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
h p.i. hours post infection 
HPLC high performance liquid chromatography 
His histidine  
HRP horseraddish-peroxidase  
Hsp heat shock protein  
Hsp60 heat-shock protein 60 
i. induced (by 1mM IPTG) 
IF immunofluorescence 
Ig Immunglobulin 
in prep. in preparation 
IPTG Isopropyl-β-D-thiogalactopyranosid 
k kilo 
Kan kanamycin 
KBL kilobase-ladder (DNA length standard) 
KCL potassium chloride 
KH2PO4 potassiumdihydrogenphosphate 
l liter 
LB Luria Bertani 
LC liquid chromatography 
LPS lipopolysaccharides 
m milli (10-3), meter 
M molar 
MALDI matrix-assisted laser desorption/ionization 
Mg magnesium 
MgCl2*6 H2O magnesium chloride hexahydrate 
MgSO4*7 H20 magnesium sulfate heptahydrate 
min minute(s) 
MOI multiplicity of infection 
MOMP major outer membrane protein 
mRNA messenger RNA 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
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MW molecular weight 
n nano (10-9) 
Na2HPO4*2 H2O disodiumhydrogenphosphate dihydrate 
NaH2PO4*H2O sodiumdihydrogenphosphate monohydrate 
NaCl sodium chloride 
NaOH sodium hydroxide 
NCBI National Center for Biotechnology Information 
Neff Acanthamoeba castellanii Neff 
Neff/E25 A. castellanii Neff asynchronously infected with P. amoebophila 
n.i. not induced (by 1mM IPTG) 
n.- i. non-infected 
NJ New Jersey 
OD optical density 
o/n over night 
p pico 
P. Protochlamydia 
p.a. pro analyticum (grade of purity) 
PAGE polyacrylamide gel electrophoresis 
PAS Page’s amoebic saline 
PBS phosphate buffered saline 
PCR polymerase-chain-reaction 
PFA paraformaldehyde 
pgEX vector pgEX-4T-3 
PMP polymorphic outer membrane protein 
pQE vector pQE-30 
PYG peptone-yeast extract-glucose 
qPCR quantitative polymerase-chain-reaction 
r radius 
R reverse (used for labelling of primers) 
RB(s) reticulate bodies 
rcf relative centrifugal force 
RNA ribonucleic acid 
rpm revolutions per minute 
rRNA ribosomal RNA 
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RT room temperature, reverse transcriptase 
S Siemens 
sec seconds 
SD standard deviation 
SDS sodium dodecyl sulfate 
sp. species 
SPG sucrose-phosphate-glutamate 
T thymine 
Ta annealing temperature 
tab. table 
TAE Tris-acetate-EDTA 
Taq thermostable DNA-polymerase from Thermus aquaticus 
TB Terrific Broth 
TCA tricarboxylic acid cycle 
TEMED N,N,N´,N´-tetramethylethane-1,2-diamine 
Tm melting temperature 
TOF time-of-flight mass analyzer 
Tris trishydroxymethylaminomethane 
TSY trypticase soy broth with yeast extract 
u unit 
UK United Kingdom 
USA United States of America 
UV ultraviolet 
UWE University of Washington environmental isolate 
V volt 
Vol. volume(s) 
v/v volume to volume 
vs. versus 
WA Washington 
WI Wisconsin 
w/v weight to volume 
w/w weight per weight 
x times 
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